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ABSTRACT
The m olecular basis o f  neural fold adhesion and fusion in closure o f  the m ouse spinal 
neural tube is a crucial process, since failure may result in spina bifida. Previous studies 
have shown that cleavage o f  glycosyl phosphatidylinositol (GPl)-anchored proteins causes 
neural tube defects in the mouse. In this study, m ouse em bryos undergoing neural tube 
closure were treated with phosphatidylinositol specific phospholipase C (PIPLC) enzyme; 
known to cleave GPI-anchored m olecules, and then cultured for 8 hours. PIPLC treatment 
inhibits spinal neural tube closure, as shown by an enlarged posterior neuropore. 
EphrinAs are GPI-anchored cell surface proteins, and were considered as candidates for a 
role in adhesion. Perturbation o f  ephrinA ligand binding to EphA receptors by injecting 
EphA3 fusion protein into the amniotic sacs o f  cultured em bryos, inhibits neural tube 
closure. Further microinjection experiments with EphAl fusion protein, which also  
inhibits closure, suggests that the specific ephrinA ligand, ephrinA 1, is required for spinal 
neurulation. Expression studies show localization o f  ephrinA 1, ephrinA3 and the EphA2 
receptor in the spinal neural tube. Further work has involved RT-PCR to investigate the 
expression o f  possible ephrin binding partners and has shown that E p h A l, EphA3, 
EphA4, EphA5, EphB2, EphB3, EphB4 and EphB6 are also expressed in the spinal neural 
tube. The ephrinA 1 ligand is currently being studied further by constructing a conditional 
knockout murine model o f  the gene. The EphA2 receptor shows an interesting pattern o f  
expression in the spinal neuroepithelium and surface ectoderm during neurulation. The 
EphA2 receptor is expressed specifically at the point o f  closure and displays fluctuating 
amounts o f  expression on the tips o f  apposing neural folds. The fluctuating m RNA  
expression o f  EphA2 in apposing tips o f  neural folds may indicate a genetic role o f  an 
asymmetrical protrusion from the tip o f  the left neural fold as view ed via electron 
m icroscopy. EphA2 is expressed on the lam ellipodia-like protrusion which emanates from  
the left neural fold. The findings strongly suggest that the Eph/ephrin system  plays a role 
in determining the structure o f  the initial attractive properties o f  the tips o f  the apposing  
neural folds during adhesion and fusion o f  the spinal neural tube which culm inates in the 
appearance o f  an apoptotic cell at the front line o f  closure.
ABBREVIATIONS
AP Anterior to posterior
BMP Bone morphogenetic protein
CD1 wild-type mouse
CE Convergent extension
DAB diaminobenzidine
DIG Digoxygenin
DLHP Dorsolateral hinge point
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IP3 Inositol triphosphate
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Me Mesoderm
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MRP MARCKS-related protein
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NCAM Neural cell adhesion molecule
Nt Notochord
NTDs Neural tube defects
OD Optical density
PAK1 p21 activating kinase 1
PAX Paired box
PBS Phosphate buffered saline
PBT PBS, 0.1% Tween 20
PCR Polymerase chain reaction
PCP Planar cell polarity
PFA Paraformaldehyde
PIPLC phosphatidyl-inositol specific phospholipase C
PKC Protein kinase C
PNP Posterior neuropore
POAF Point of adhesion and fusion
PTK7 Protein tyrosine kinase 7
RAR Retinoic acid receptor
SDS Sodium lauryl sulphate
SE Standard error of the mean
Se Surface ectoderm; also known as non-neural ectoderm
SEM Scanning electron microscopy
Shh Sonic hedgehog
ssc Sodium chloride/ sodium citrate buffer
TAE Tris acetate buffer
TE Tris-EDTA
TEM Transmission electron microscopy
tRNA Transfer RNA
UV Ultra violet
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11.1 Neural tube defects
Neural tube defects (NTDs) are severe birth defects which result from incomplete 
development o f the neural tube, the embryonic structure which develops into the brain 
and spinal cord (Wyszynski 2006). This is shown pictorially in Fig. 1.1. Disruption o f 
the discontinuous process o f neurulation (Golden & Chem off 1993) leads to different 
forms o f NTDs which vary in severity. Craniorachischisis, occurs when the whole 
length o f the axis o f the neural tube (neuraxis), from the brain to low spinal cord, is 
exposed and unprotected (Copp et al. 1990). Cranial neural tube defects occur when 
closure o f the rostral neural tube fails. This condition is known as exencephaly which 
often leads to a more degenerative phenotype termed as anencephaly whereby the 
brain tissue is lost (Copp et al. 1990; van Allen et al. 1993; Copp et al. 2003; 
Padmanabhan 2006).
Another condition often associated with failure o f cranial neural tube closure is 
encephalocele, although this is not strictly a neural tube defect, as the neural tube is 
closed in the herniated region. Encephaloceles occur in the occipital region in 70-80% 
of cases (Ingraham & Scott 1943; Matson 1969; Mealey et al. 1970; Brown & 
Sheridan-Pereira 1992), but their pathogenesis remains unknown (Volpe 1995).
O f NTDs affecting the spine, spina bifida is the best known and usually results in live 
births. Spina bifida causes a range o f disabilities from partial to full paralysis o f the 
lower extremities including a neurogenic bladder (Volpe 1995; Copp et al. 2003). 
NTDs remain the most common central nervous system malformation surviving to 
late pregnancy in humans (Pinar et al. 1998; Boyd et al. 2004). The incidence o f 
NTDs is high, at 1 in 1000 births, making it the second commonest cause of 
congenital neurological disability, next to cerebral palsy (Miller & Bachrach 2006) 
and the second commonest birth defect, after heart defects (Manning & Archer 2001; 
Henderson et al. 2006). Approximately 80% of NTDs in humans are non-syndromic 
where failure o f the neural tube to completely close is the only obvious primary 
defect, as opposed to syndromic forms, where the NTD is associated with other 
defects (Harris & Juriloff 1997; Padmanabhan 2006).
2*
TV.
Fig. 1.1 Pictorial representations of various forms of neural tube defects and its
associated conditions in humans. A & B represents craniorachischisis; C & 
D depict anencephaly; E shows a neonate with spina bifida; F is a newborn 
with spina bifida with the lesion indicated by a red arrow and an associated 
NTD lesion encephalocele at the occipital region shown by a blue arrow; G is 
a picture of a child with hydrocephalus which is very prevalent amongst spina 
bifida patients and H represents a newborn with a large occipital 
encephalocele. A, B, C, D, F & H were reproduced from Volpe 1995; E from 
Great Ormond Street Hospital files (with permission) and G from Holgate & 
Batchelor (1999).
31.1.1 Spina bifida
The occurrence o f spina bifida, which is the commonest non-lethal malformation in 
the spectrum o f NTDs, is generally around 0.5 per 1,000 births, although higher 
frequencies have been reported (Jobe 2002). In the UK, prevalence o f spina bifida in 
the population is 7.8-8.4 per 10,000 for males and 9.0-9.4 per 10,000 for females 
(Lawrenson et al. 2000). In patients that survive the perinatal period, Bowman et al. 
(2001) in their 25 year follow up o f 71 myelomeningocele patients, found that at least 
75% of children bom  with myelomeningocele can be expected to reach their early 
adult years. As many as 85% are attending or have graduated from high school and/or 
college. More than 80% o f young adults with spina bifida have social bladder 
continence. However, complications are frequent. In the same study, 49% had 
scoliosis, with 43% eventually requiring a spinal fusion. As many as 23% of these 
patients suffered seizures at least once. Approximately one-third o f patients were 
allergic to latex, with six patients having experienced a life-threatening reaction. Renal 
failure was 6.8-9.0 times commoner for males, and 9.2-11.5 commoner for female 
patients, compared with the general population in each o f the years 1994-1997 in the 
UK (Lawrenson et al. 2001).
Spina bifida is usually clearly visible at birth as a protruding sac at the site o f the 
lesion, usually at the lower end o f the spinal axis. In myelomeningocele, the most 
severe condition, the spinal cord protmdes from the spinal canal into a sac resulting 
from incomplete closure o f the posterior neural tube. The extent and severity o f the 
neurological deficits depend on the location o f the lesion along the neuraxis (Jobe
2002). Meningocele is a less severe, variant form o f spina bifida in which the spinal 
cord is not found in the sac (Volpe 1995; van der Put et al. 2001).
A third type o f spina bifida, where closure o f the posterior neuropore is not 
compromised, is spina bifida occulta (SBO) (Volpe 1995). SBO occurs when the 
vertebrae develop abnormally leading to absence o f the neural arches. The neural tube 
and spinal cord are usually not damaged although in some cases, cord damage 
coexists. Patients with SBO generally do not suffer neurological impairments and the 
condition often remains undiagnosed. In symptomatic cases, tethering o f the spinal
4cord within the vertebral canal can result in pain, weakness and incontinence in 
otherwise normal, healthy children or adults (Iskandar et al. 1998).
Myelomeningocele is often associated with type II Chiari hindbrain malformation and 
hydrocephalus (Stevenson 2004). Chiari type II malformation is a downward 
displacement o f the cerebellar vermis into the cervical vertebral canal (Jobe 2002). It 
is often symptomatic and diagnosed early in postnatal development (Stevenson 2004). 
This malformation causes an elongation of the brain stem and obliteration o f the 
fourth ventricle leading to obstruction o f cerebrospinal fluid circulation which, in 90% 
of cases, causes the development o f hydrocephalus (Jobe 2002). Treatment o f 
hydrocephalus involves the draining o f cerebrospinal fluid into the peritoneal or other 
body cavity via a subcutaneous shunt.
Treatment o f patients with myelomeningocele has improved drastically from the mid 
1970s when patients were sometimes denied treatment according to the severity o f 
their condition (Lorber 1974). Neonatal surgical closure o f the lesion is routinely 
practised and fetal surgery to correct the defect is being developed in some centres 
although, as yet, very few clinics perform this highly specialised surgery (Jobe 2002; 
Bruner & Tulipan 2005).
NTDs have a profound impact on society as the mortality rate o f spina bifida patients 
decreases with better medical care. Longer life equates with the need for progressively 
better quality o f life. The costs involved in maintenance o f spina bifida patients which 
includes urostomy appliances and orthoses as well as various medications, amount to 
significant monetary expenditure, in addition to the cost o f modifications o f public 
utilities that are required to enable disabled access (Ireys et al. 1997; Macias et al. 
2006; Verhoef et al. 2006).
1.1.2 Syndromic and non-syndromic spina bifida
Among the NTDs, craniorachischisis has the highest rate o f syndromic association 
with other anomalies (Seaver & Stevenson 2006). Anencephaly and high spina bifida 
are less often syndromic and spina bifida has the lowest syndromic occurence.
5Conditions that are associated with NTDs fall into 3 groups; autosomal recessive 
conditions, autosomal dominant conditions and X-linked conditions (Seaver & 
Stevenson 2006). These are summarised in Table 1.1 below.
Conditions References
Autosomal recessive conditions 1. Neu-Laxova syndrome (spina bifida, severe 
intrauterine growth retardation, microcephaly, 
protruding eyes, abnormal skin & limb defects)
2. PHAVER syndrome (spina bifida, pterygia, heart 
defects, segmentation defects of the spine and 
radioulnar synostosis)
Naveed et al. 
1990; Rode et al. 
2001; Powell et 
al. 1993
Autosomal dominant conditions 1. Cerebrocostomandibular syndrome
(spina bifida, posterior gap in ossification of the ribs 
and severe micrognathia with Robin sequence)
2. Split-hand with obstructive uropathy, spina bifida 
and diaphragmatic defects
3. Waardenburg syndrome type I (spina bifida, white 
forelock, heterochromia irides, sensorineural 
deafness, dystopia canthorum, high nasal bridge)
4. Waardenburg syndrome type III
(spina bifida, dystopia canthorum, white forelock, 
hearing loss and upper limb anomalies)
van den Ende et 
al. 1998; Cziezel 
& Losonci 1987; 
Chatkupt & 
Johnson 1993; 
Nyeet al. 1998
X-linked conditions 1. Focal dermal hypoplasia (male lethality, atrophy 
and linear pigmentation of the skin, papillomas of skin 
and mucosae, ocular defects, hypoplastic teeth and 
digital anomalies apart from spina bifida)
2. Zic3 (spina bifida with abdominal situs inversus, 
complex cardiac defects, asplenia and polysplenia)
3. Congenital hemidysplasia with ichthyosiform 
erythroderma and limb defects (CHILD syndrome)
Almeida et al. 
1988; Temple et 
al. 1990; Mathias 
et al. 1987; 
Gebbia et al. 
1997; Hebert et 
al. 1987; Grange 
et al. 2000
Table 1.1 Classification of syndromic NTDs
6It is extremely important to make a distinction between syndromic and non-syndromic 
NTDs, because syndromic NTDs have more well-defined genetic causative 
components in comparison to non-syndromic NTDs. The causative factors o f non- 
syndromic NTDs as described below are attributed to multi-factorial conditions, both 
genetic and environmental.
1.2 Causative factors, detection and prevention of 
neural tube defects
The etiology o f NTDs is heterogenous (Holmes et al. 1976; Khoury et al. 1982a; 
Khoury et al. 1982b; Martin et al. 1983). Most non-syndromic NTDs are thought to be 
o f multi-factorial origin (Rampersaud et al. 2006) with influence o f both genetic and 
environmental factors (Hall & Solehdin 1998; Aguiar et al. 2003). Among the 
environmental factors associated with increased risk o f NTDs are increased pregnancy 
weight (Dietl 2005; Hall & Neubert 2005; Mojtabai 2004; Andreasen et al. 2004), 
maternal smoking (Jensen et al. 2005), drug intake specifically o f antiepileptic drugs 
(Omoy 2006; Yerby 2003) and maternal illnesses such as diabetes (Kucera 1971; Fine 
et al. 1999; Pani et al. 2002) and hyperthermia (Moretti et al. 2005). Dietary factors, 
including water chlorination (Hwang et al. 2002; Bove et al. 2002; Graves et al. 2001), 
inositol intake (Cavalli & Copp 2002), simple sugar intake (Shaw et al. 2003) and the 
intake o f trace elements and other micronutrients (de Lourdes Carrillo-Ponce et al. 
2004; Ulman et al. 2005; Martin et al. 2004; Groenen et al. 2004a; Groenen et al. 
2004b; Cengiz et al. 2004) have been proposed to act either as contributory or 
preventive factors for NTDs. Isolated NTDs are caused by cytogenetic abnormalities 
in 2-16 % o f cases (Harmon et al. 1995; Hume et al. 1996; Coerdt et al. 1997).
Ultrasonography is the routine method o f detection for NTDs during pregnancy in 
many countries. However, this method fails to detect closed spina bifida (Alfirevic 
2005; Game et al. 2005; Bricker et al. 2000). Elevated levels o f maternal serum alpha- 
fetoprotein are indicative o f open spina bifida or anencephaly (Dashe et al. 2006), but 
can be associated with other conditions (e.g. twins) and ultrasound is needed to 
confirm the diagnosis.
7It has been over 15 years since the Medical Research Council Vitamin Trial involving 
33 centres around the world, conclusively showed that 72 % o f recurrent NTD cases 
could be prevented by folic acid supplements in the periconceptional period (Wald et 
al. 1991). A further study (Czeizel & Dudas 1992) showed that the first occurrence of 
spina bifida could also be prevented by folic acid. However, not all NTDs are 
responsive to folic acid and inositol has been suggested as possible additional therapy, 
based on prevention o f spina bifida in folate-resistant NTDs in mice (Greene & Copp 
1997). Inositol has yet to be tested formally in human pregnancy although there exists 
one documented case in which inositol was taken in a high-risk pregnancy, with a 
normal outcome (Cavalli & Copp 2002). It will perhaps take many more years before 
conclusive results are obtained on which vitamins are best for human pregnancies.
What is very clear, however, is that the molecular basis for neural tube closure in 
humans and in the many models where the neural tube is carefully studied, including 
fish, frog, chick or mouse, remains elusive (Ciruna et al. 2006; Davidson & Keller 
1999; Schoenwolf 1991; Copp et al. 2003). How folic acid and inositol work in 
promoting neural tube closure remains poorly understood (Greene & Copp 1997). 
What is almost certain is that, without understanding how the neural tube structure is 
formed, we will remain far from understanding how the various genes and 
environmental factors (Wyszynski 2006) work together in predisposing to, or 
preventing, this very common congenital defect.
1.3 Mechanisms of neural tube closure
In vertebrates, the development o f the CNS starts with the formation o f the neural 
plate on the dorsal surface o f the embryo during late gastrulation (Gilbert 2003; Keller 
2005). A complex morphogenetic process transforms the neural plate into the hollow 
neural tube in a process known as neurulation (Gilbert 2003). Primary neurulation is 
responsible for formation o f the neural tube throughout the brain and the spinal cord 
rostral to the mid-sacral level (Copp et al. 2003). At more caudal levels, an alternative 
mechanism (secondary neurulation) operates whereby the neural tube is formed by 
canalisation o f a condensed rod o f mesenchymal cells in the tail bud (Copp et al.
81990). The embryology o f neural tube closure has been studied in many animal 
models (Ciruna et al. 2006; Davidson & Keller 1999; Schoenwolf 1991; Copp et al.
2003).
The process o f neurulation in mammals and some other vertebrates is considered 
discontinuous because it occurs simultaneously at multiple sites along the neuraxis 
(Copp et al. 1990; Golden & Chemoff 1993; van Allen et al 1993; O ’Rahilly & Muller 
2002; Copp et al. 2003). There are three points o f de novo neural tube fusion in the 
mouse which is the most studied mammalian model (Copp & Bemfield 1994; see Fig. 
1.2A). Closure 1 occurs adjacent to somite 3 in embryos with 6-7 somites, closure 2 
occurs at the midbrain-forebrain boundary at around the 10 somite stage, and closure 3 
occurs at the neural rostral extremity o f the forebrain, soon after closure 2.
Considering this discontinuous process o f neurulation, it can be understood why 
NTDs are such a complex group o f heterogenous birth defects, with various 
phenotypic representations. Thus, failure o f closure 1 fails leads to 
craniorachischischisis (Fig.l.2B), failure o f closures 2 and/or 3 causes exencephaly 
and anencephaly (Fig.l.2C), while failure o f neurulation to progress from the site o f 
closure 1 caudally along the entire spinal axis leads to spina bifida aperta (Fig. 1.2D).
During neurulation, the neuroepithelium must undergo various structural changes in 
order to achieve closure. The advent o f molecular biology has allowed scientists to 
identify the genes which are required for these structural changes to occur. The next 
section gives a brief overview o f the research to date on how gene expression affects 
structural changes in neural tube development, with an emphasis on gene regulation in 
the spinal region.
9Fig. 1.2 Points of fusion in the mouse embryo and phenotypes of failure of 
closure of the various points of fusion along the neuraxis. (Modified 
from Copp & Bemfield 1994.) A, Schematic figure illustrating the 
multiple points o f fusion o f the neural tube, directions o f closure and 
the different locations o f neuropores (final sites o f closure) in the 
developing mouse embryo. 1, site o f closure 1 which occurs at the level 
o f somite 3 in the 6-7 somite embryo. Closure 1 is the initiation event 
o f neurulation. Closure then progresses caudally and is completed by 
closure o f the posterior neuropore (PNP) at the 29-30 somite stage o f 
development; 2, second closure site at around the 10 somite stage; 3, 
closure 3 site which begins soon after closure 2. Arrows depict 
spreading o f neural tube closure to neighbouring regions with 
completion o f anterior neuropore closure soon after initiation of closure 
3 and closure o f the hindbrain neuropore at the 18 to 20 somite stage. 
B, Phenotype resulting from failure o f closure 1: craniorachischisis, 
(Murdoch et al. 2001); C, Phenotype resulting from failure o f closure 
2: exencephaly (van Straaten & Copp 2001); D, Phenotype of failure 
o f the caudal wave o f spinal closure,leading to an enlarged PNP and 
later development o f spina bifida (van Straaten & Copp 2001).
a: Posterior neuropore 
b: Branchial arches 
c: Developing heart 
d: Hindbrain 
e: Midbrain 
f: Forebrain
ANP: Anterior neuropore 
HNP: Hindbrain neuropore
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1.3.1 The structural changes of the neural tube during the 
process of closure In vertebrates
Morphologically, the vertebrate neural tube undergoes distinct structural changes prior 
to its closure (Davidson & Keller 1999; van Straaten et al. 1993; Colas & Schoenwolf 
2000; Copp et al. 2003). These changes were defined originally in amphibian and 
avian embryos and comprise five main structural changes in the spinal region. The 
neuroepithelium narrows and lengthens, a process that involves “convergent 
extension” (Fig. 1.3A) in which the polarized cells which form the neuroepithelial 
plate converge towards the midline, elongate antero-posteriorly, and then intercalate. 
This process o f intercalation has been detected experimentally in the frog (Shih & 
Keller 1992; Wallingford & Harland 2001), although it has not yet been shown 
experimentally to occur in the mouse.
Convergent extension leads to the narrowing and lengthening o f the neuropithelium, a 
process that has been suggested also to assist neural fold elevation via axial elongation 
(Kibar et al. 2001). However, amphibian embryos in which lengthening o f the body 
axis is disrupted by manipulation o f gene function required for convergent extension, 
can still elevate their neural folds, even though convergent extension fails 
(Wallingford & Harland 2002; Zohn et al. 2003). Hence, convergent extension and 
neural fold elevation are separable processes. Elevation o f the neural folds at high 
levels o f the spinal neuraxis results from the formation o f a median hinge point (MHP) 
(Fig.l.3B) in a process termed Mode 1 neurulation (Shum & Copp 1996). The neural 
folds remain straight along both apical and basal surfaces, resulting in a neural tube 
with a slit-shaped lumen. Mode 1 neurulation occurs during formation o f the spinal 
neural tube in 6 to 10 somite stage embryos, as shown in Fig. 1.4 A & B.
A second set o f hinge points are formed, dorsolaterally, at more caudal levels o f the 
spinal neuraxis, a process that appears to enhance the ability o f the apposing tips o f 
the neural folds to come close to each other (Fig. 1.3 C). In Mode 2, a median hinge 
point is also present, whereas the remaining portions o f the neuroepithelium do not 
bend. Mode 2 generates a diamond-shaped lumen. Mode 2 occurs during formulation 
o f the spinal neural tube in 12 to 15 somite stage embryos, as depicted in Fig. 1.4 C &
12
Fig. 1.3 Schematic representation of the formation of the mouse spinal 
neural tube. Process o f closure o f the PNP o f  embryos undergoing 
Mode 1 (A, B, D) or Mode 2 (A, C, D) neurulation. A, neuroepithelium 
thickens and converges; B, formation o f bilateral neural folds which 
elevate (Mode 1); C, apposing tips o f  neural folds aided by bending at 
the dorsolateral hinge points (DLHP) o f the bilateral neural folds 
(Mode 2); D, adhesion and fusion at the tips o f the neural folds; E, 
remodelling o f neural tube. Abbreviations: Ne, neuroepithelium; Se, 
surface ectoderm; Me, Mesoderm; MHP, Median hinge point; DLHP, 
dorsolateral hinge points; POAF, Point o f adhesion and fusion; Nt, 
notochord.
neuroepithelium
lamellipodial protrusions
possible site o f apoptosis to allow 
separation o f  neuroepithelium and 
surface ectoderm
DLHP
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D. At the 17 to 27 somite stage, the neural tube closes without a median hinge point, 
whereas dorsolateral hinge points are retained. This is known as Mode 3 neurulation, 
as shown in Fig. 1.4 E & F. Mode 3 generates an almost circular shaped lumen.
The reason for this transition from MHP to DLHP-type bending is not known. 
Bending o f the neural folds at these two sites has been observed in the developing 
spinal neural tube in rodents (Shum & Copp 1996). The existence o f dorsolateral 
hinge points in chick spinal neural tube development, however, is debatable as the 
bilateral hinge points are not regarded as true hinge points (Schoenwolf & Smith 
1990). The two other vertebrate species widely studied in development, zebrafish 
(Danio rerio) and frog (Xenopus laevis) do not acquire dorsolateral hingepoints during 
spinal neural tube closure (Kimmel et al. 1995; Davidson & Keller 1999). A recent 
paper by Saitsu et al (2004) did not note formulation o f dorsolateral hinge points in 
the spinal neural tube o f Carnegie stage 12 to stage 13 human embryos (comparable to 
embryonic day (E)9.5 to 10.5 mouse embryos) in a total o f 20 embryos studied. In that 
report, a transverse section o f a human spinal neural tube o f one embryo shows a 
slightly bent neural tube at the site where dorsolateral hinge points occur, albeit on 
only one side o f the neural fold (Saitsu et al. 2004). However, recent work done in our 
laboratory has identified 2 human embryos (both at Carnegie stage 12) which display 
clear dorsolateral hinge points (Ms. S. Castro, personal communication). This 
suggests that dorsolateral neural plate bending may be a common feature o f low spinal 
neurulation in mammalian embryos.
Adhesion and fusion o f the tips o f the apposing neural folds is the final step in primary 
neurulation, enabling the neural tube to complete its fusion (Copp et al. 2003). The 
tips o f the apposing neural folds and the eventual point o f fusion are reported to 
contain cell to cell recognition molecules (as demonstrated in red in Fig. 1.3C) which 
may be required for the specific adhesion and fusion process to occur (Moran & Rice 
1975; Waterman et al. 1975; Lee et al. 1976; Waterman et al. 1976; Rice & Moran 
1977; Mak 1978; Sadler 1978; Geelen & Langman 1979; Smits-van Prooije 1986; 
Takahashi & Howes 1986; Takahashi 1988 & Holmberg et al. 2000). This is 
supported by previous evidence that the cell surface o f the neuroepithelium is lined by
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A
6 - 1 0  somite stage (E8.5)
B
Mode 1
(V)
C
1 2 - 1 5  somite stage (E9.5)
D Mode 2
(V)
E
1 7 - 2 7  somite stage (E10.5)
F Mode 3
Fig. 1.4 Schematic figure showing progressive developm ental stages of the 
mouse em bryo and sections through the PNP a t these stages. A,
schematic o f embryo at 6-10 somite stage, which has already 
undergone closure 1; B, section through PNP o f A depicting Mode 1 
neurulation; C, schematic o f embryo at 12-15 somite stage; D, section 
through PNP of C exhibiting Mode 2 neurulation; E, schematic o f 
embryo which has undergone closures 1,2 & 3 with PNP being the only 
remaining unfused section of neural tube; F, section through PNP of E 
depicting Mode 3 neurulation.
Level o f spinal axis sectioned
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carbohydrate rich material which is not observed in the rest o f the neuroepithelium 
(Sadler 1978). The neural fold tips are characterised by protrusions that interdigitate 
leading to adhesion and fusion o f the neural folds, as suggested by Copp et al. (2003) 
(Fig. 1.3D).
Ultimately the newly-formed neural tube undergoes remodelling via apoptosis to 
enable the neural tube to separate from its surface ectoderm (Harris & Juriloff 1999) 
(Fig. 1.3E). An oft neglected structure in the formation o f the spinal neural tube is the 
surface ectoderm, despite evidence pointing to its requirement for successful closure 
(Ybot-Gonzalez et al. 2002; Alvarez & Schoenwolf 1992; Hackett et al. 1997). 
Removal o f the surface ectoderm leads to failure o f the formation o f the dorsolateral 
hinge points in the mouse, so that closure cannot occur (Ybot-Gonzalez et al. 2002). 
W hether or not the surface ectoderm plays a role in successful neural tube fusion is 
still unknown. This dilemma is compounded by the fact that the origin o f the adhering 
cells which are responsible for neural fold fusion, be it the surface ectoderm or 
neuroepithelium, has yet to be conclusively shown in any previous study o f  any 
species.
1.3.2 The genetics behind the structural changes in spinal 
neural tube closure
This section summarises the various genes which are switched on during neurulation 
and whose functions have been implicated in the various structural changes that the 
spinal neural tube undergoes, in order for closure to be achieved.
Table 1.2 Summary of genes expressed during mouse 
neurulation at various levels of the spinal neural tube
Neural tube structure Genes expressed at
(Y) NeuroepitheliumZic2 (Elms et al. 2003) Vangl2 (Kibar et al. 2001)
(V)
(V)
(V)
(V)
Floor plate and notochord
HNF3/3 (Ang & Rossant 1994)
Vangll (Doudney et al. 2005)
Wnt3a (Galceran et al. 1999)
Notochord
BMP7 (Solloway & Robertson 1999)
Shh (Marti et al. 1995a; Weinstein et al. 1994; 
Chiang et al. 1996; Ding et al. 1998)
Tips o f neural folds (surface ectoderm)
Grainyhead-like 3 (in non-neural ectoderm at 
E8.5) (Auden et al. 2006)
Surface ectoderm
Fg/8 (Dubrulle & Pourquie 2004) 
Grainyhead-like 2 (Auden et al. 2006) 
BMP7 (Elms et al. 2003)
Wnt6 (Elms et al. 2003)
Notchl (Galceran et al. 1999)
Dorsolateral hingepoints
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Tips of neural folds at E9.5
Axin2 (Jho et al. 2002)
Pax3 (Goulding et al. 1991)
Dorsal roof of closed neural tube bridge
Zic2 (Elms et al. 2003)
M sxl (Elms et al. 2003)
Wntl (Ramos & Robert 2005; Bulgakov et al. 2004) 
BMP6 (Ramos & Robert 2005)
1.3.3 Planar cell polarity and convergent extension
Planar cell polarity (PCP) is a process in which cells develop with uniform orientation 
within the plane o f an epithelium (Montcouquiol et al. 2006). The PCP pathway is a 
non-canonical Wnt pathway (Wallingford & Habas 2005). Various Wnt molecules are 
known to play roles in the PCP pathway in vertebrates, such as W ntl l and Wnt5a 
(Wallingford & Habas 2005).
PCP signalling has been suggested to be primarily required for cytoskeletal activity, 
for example, cellular protrusion, cell-cell adhesion and cell-matrix adhesion (Keller
2002). Skin development, body hair orientation, polarization o f the sensory epithelium 
in the inner ear and the directed movement o f mesenchymal cell populations during 
gastrulation are among the processes requiring proper PCP signalling in vertebrates 
(Keller 2002; Wallingford et al. 2002; Montcouquiol et al. 2003; Dabdoub et al.
2003). In vertebrates, function o f the PCP pathway appears to be required for
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convergent extension (CE), cell movements which are thought to be required for 
neural tube closure.
CE in the vertebrate embryo is required to enable the neuroepithelial sheet-like 
structure to elongate antero-posteriorly. Lamellipodia has been the type o f cell shown 
to drive CE. These broad sheet-like protrusions exert traction on adjacent mesodermal 
cells causing mediolateral intercalation as described in amphibians (Shih & Keller 
1992). PCP signalling causes the regulation o f cytoskeletal organization which 
redistributes subcellular PCP components asymmetrically causing polarization of 
these cells (Klein & Mlodzik 2005). Moreover, components o f the signalling cascade 
converge or are expressed asymmetrically in the lamellipodia (Wallingford & Habas
2005).
Among the genes implicated in this net movement o f cells, known as convergent 
extension, are Vangl2, Celsrl, Dishevelled-1 and -2 plus Scribble 1, although there are 
no publications which unite the functions o f all these genes in vertebrates. Vangl2 
(formerly known as Ltap and Lppl) has been identified as the causative gene in the 
loop-tail mouse (Murdoch et al. 2001; Kibar et al. 2001). Mutations in Celsrl cause 
craniorachischisis in the Crash mouse (Curtin et al. 2003). The Dishevelled-1 and -2 
double knockout mouse also has craniorachischisis (Hamblet et al. 2002), as does the 
Protein Tyrosine Kinase 7 (PTK7) knockout mouse (Lu et al. 2004). The gene 
responsible for the circletail mouse phenotype is Scribble (Murdoch et al. 2003). All 
o f these genes have been implicated in the PCP pathway. Failure o f CE to occur 
results in an open neuraxis (the entire neural tube from midbrain to low spine remains 
exposed) and shortened embryos. The latter have only been shown experimentally to 
occur in Xenopus (Wallingford & Harland 2000), although this mechanism of cell 
movement has been implicated in other species such zebrafish (Ciruna et al. 2006) and 
mouse (Copp et al. 2003).
2 0
1.3.4 Neural fold elevation and bending
1.3.4.1 Dorsoventral specification within the neural tube
Dorsoventral patterning o f  the vertebrate nervous system is controlled in large part by 
the inducing and polarizing properties o f the floor and roof plates o f the neural tube 
(Placzek et al. 1991). Secretion o f Sonic hedgehog (Shh) from the notochord and floor 
plate, and secretion o f bone morphogenetic proteins (BMPs) and Wnts from the 
surface ectoderm and roof plate, determine the pattern o f cell types that appear along 
the dorsoventral axis o f the neural tube (Placzek et al. 1991). The mechanism by 
which this cell specification process occurs is initiated by Shh which is secreted by 
notochordal cells, and later by floor plate cells, and establishes a ventral-to-dorsal 
gradient in the embryonic spinal cord (Jessell 2000). Shh represses the transcriptional 
activity o f certain neural tube-expressed genes (Class 1) and activates other genes 
(Class 2) leading to an initial patterning o f the dorso-ventral axis into broad territories 
o f gene expression. In a second phase, Class 1 and 2 genes themselves refine the 
dorsoventral pattern, through induction or repression o f  homeobox-containing genes, 
to provide a more fine-grained gene expression pattern. Ultimately, this process 
results in the specification o f  groups o f cells to form particular types o f neurons or glia 
at particular dorso-ventral positions in the spinal cord.
1.3.4.2 Dorsoventral regulation of neural tube morphogenesis
The process o f dorso-ventral cell specification also influences the morphogenesis o f 
the neural tube (Marti et al. 1995a; Marti et al. 1995b; Solloway & Robertson 1999; 
Ang & Rossant 1994; Doudney et al. 2005). In particular, the formation o f  the median 
hinge point (MHP) appears to depend on the differentiation o f axial mesoderm, with 
the notochord signalling to the overlying neuroepithelium to induce the midline cells 
to adopt the wedge shape that characterises the MHP (van Straaten et al. 1988; 
Placzek et al. 1990; Placzek et al. 1991; Yamada et al. 1991; Yamada et al. 1993; 
Goulding et al. 1993; Ericson et al. 1995). Subsequently, the MHP differentiates to 
form the floor plate.
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Implantation and ablation experiments which manipulated the notochord in both chick 
and mouse embryos (van Straaten et al. 1985; van Straaten et al. 1988; Smith & 
Schoenwolf 1989; Davidson et al. 1999; Ybot-Gonzalez et al. 2002) verified that the 
notochord is required for formation o f the MHP. It was proposed that the notochord 
releases a morphogen which may regulate MHP formation. Shh protein is expressed in 
the notochord at this stage (Marti et al. 1995a) and application o f either Shh- 
expressing cells or purified protein to intermediate neural plate explants leads to 
induction o f the floor plate (Marti et al. 1995b), suggesting that Shh is the MHP- 
inducing morphogen. However, MHP formation is not totally abolished in Shh-null 
mouse embryos suggesting that other factors from the notochord may also have MHP- 
inducing properties (Ybot-Gonzalez et al. 2002).
The second site o f  neural fold bending as described in Section 1.3.1 and Fig. 1.3 is the 
dorsolateral hinge point (DLHP). Bending o f  the neuroepithelium at the DLHP is 
regulated by mutually antagonistic signals external to the neural fold, as reviewed by 
Greene & Copp (2006). In contrast to midline bending, Shh has been shown to inhibit 
dorsolateral bending in the mouse (Ybot-Gonzalez et al. 2002) consistent with an 
absence o f NTDs in Shh-null embryos, in which ectopic DLHPs ensure neural tube 
closure. Moreover, recent work from our lab suggests that signal(s) arising from the 
surface ectoderm (SE) comprise a second antagonistic signal involved in regulation 
and formation o f the DLHPs. This has been suggested as further evidence that bending 
o f the neural folds involves signalling from the SE. BMPs are candidates to mediate 
this signalling. Three BMPs (BMP2, BMP4 and BMP7) are expressed in the spinal 
neural tube. BMP2 and BMP7 are expressed in the surface ectoderm adjacent to the 
open spinal neural tube, while BMP4 is expressed in the surface ectoderm overlying 
the closed spinal neural tube (Dr. Ybot-Gonzalez, personal communication).
Recent studies suggest that Noggin may also play a role in regulating DLHP bending 
(McMahon et al. 1998; Stottman et al. 2006). Noggin is an inhibitor o f  BMP 
signalling and is expressed at the tips o f the apposing neural folds (Stottmann et al.
2006). Homozygous mouse embryos null for Noggin exhibit both exencephaly and 
spina bifida (100%) (Brunet et al. 1998; McMahon et al. 1998), although spina bifida 
does not arise in homozygous Noggin mutants until embryonic day 11-12 when the
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neural tube ruptures. The spinal neural tube o f homozygous null Noggin embryos 
during neurulation takes on the appearance o f  a wavy neural tube before the neural 
tube re-opens (Stottmann et al. 2006), possibly suggesting an unstable initial closure 
mechanism. Shh works in an antagonistic manner towards Noggin, as does Noggin 
towards BMP signalling. This suggests that Noggin may facilitate bending o f  the 
spinal neural tube (Stottmann et al. 2006), by overcoming the inhibitory influence o f 
BMPs.
Stottmann et al. (2006) suggest that the spinal defect in Noggin null embryos result 
from a failure to maintain a closed neural tube due to a defective paraxial mesoderm. 
Yip et al. (2002) also had shown that the mesodermal extracellular matrix plays an 
important role in maintaining neuroepithelial rigidity o f the spinal neural tube during 
neurulation. Embryos were cultured in the presence o f chlorate, which functions to 
inhibit sulphation o f heparan sulphate proteoglycans (HSPGs) in the extracellular 
matrix o f the mesoderm. This treatment resulted in an expedited bending o f  the 
DLHPs, but also elicited an unnatural shape o f  neural tube due to a convex shaped 
mesoderm. However, work done by Ybot-Gonzalez et al. (2002) shows that removal 
o f the paraxial mesoderm does not prevent closure o f  the spinal neural tube.
There are however, 3 genes which when mutated, not only affect paraxial mesoderm 
production in the mouse (Abu-Abed et al. 2003; McMahon et al. 1998; Ciruna & 
Rossant 2001) but also result in an NTD phenotype in the mouse. These are Cyp26, 
Noggin and Fgfrl (Abu-Abed et al. 2003; Stottmann et al. 2006; Deng et al. 1997). 
The Wnt3a (Takada et al. 1994), Lefl/Tcfl double null (Galceran et al. 1999) and 
Raldh2 (Niederreither et al. 1999) mutants also have defective paraxial mesoderm 
production, with an abnormal neural tube during neurulation. W hether or not the 
abnormal paraxial mesoderm plays a primary role in the failure o f neurulation in these 
mutants remains unknown.
Neural tube closure does not depend exclusively on the MHP or DLHPs since closure 
can occur in the absence o f the MHP, as in Mode 3 neurulation, or in the absence o f 
DLHPs, as in Mode 1 spinal neurulation. However, cell shape changes o f  some type, 
affecting morphogenesis o f the spinal neural tube, are clearly required for closure to
23
occur in all species studied, including the mouse (Keller 2002). There are also no 
genes known to be expressed specifically at the dorsolateral hinge points as 
summarised in Table 1.1. However, overlapping gene expression throughout the 
neuroepithelium and tips o f neural folds may facilitate the bending mechanism seen in 
the DLHPs.
1.3.5 Adhesion and fusion in the spinal neural tube of 
vertebrates
In all animal species studied, a zone o f altered cell morphology with numerous 
rounded cell blebs, has been observed along the tips o f the spinal neural folds, 
immediately prior to fusion. The observed surface alterations may reflect a change in 
the properties o f the cells at the fusion site which correlate with initial adhesion 
between the folds (Waterman et al. 1975; Waterman et al. 1976; Rice and Moran 
1977; Hung et al. 1986; Lawson & Englund 1998). Structural observations o f the 
point o f fusion in human embryos have not yet been reported, possibly due to 
insufficient material or poor preservation o f  material so that surface structures cannot 
be observed.
Adhesion and fusion is the final process in the sequence o f primary neurulation 
events, during what has been described as a physical zippering state o f the neural tube 
(van Straaten et al. 1997) which has been suggested, in previous studies, as evidence 
that neural tube closure is a continuous process (van Straaten et al. 1997). However, a 
debate exists as to whether the physical process o f neurulation actually equates to 
continuous zippering or, more accurately, to a button-like process in which neural tube 
fusion initially occurs at various slightly separated points along the axis. According to 
the latter idea, neural tube fusion is actually a discontinuous process o f  closure (van 
Straaten e ta l. 1993a).
PCP regulation may play a role in adhesion and fusion as suggested in both zebrafish 
and Xenopus studies. Firstly, cell division regulated by PCP signalling leads to rescue 
o f neural tube morphogenesis in the trilobite zebrafish mutant (Ciruna et al. 2006). 
Secondly, the Xenopus adhesion and fusion molecules, NF-protocadherin and its
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cytosolic partner TA Fl/Set, have been suggested to participate in CE after the neural 
folds are formed as disruptions in NF-protocadherin and TAF1 can lead to a shortened 
AP axis which was not evident until stages 22-25, some time after neural tube closure 
(Rashid et al. 2006).
Ultrastructures which emanate from the neural folds at the site o f  closure have been 
regarded as a secondary process in the frog. This is because wound healing which acts 
via actin purse-string contraction is thought to be the primary cause o f closure in the 
frog neural tube (Davidson et al. 2002). Fusion o f the neural tube and epidermis have 
been suggested to be separate events based upon the observation that the epidermal 
ectoderm is still able to migrate and cover the open neural tube in both the chick and 
the frog (Lawson & Englund 1998; Rashid et al. 2006). However, the issue o f  whether 
or not the neural folds could fuse even in the absence o f  epidermal fusion in both the 
chick and the frog has yet to be answered.
Adhesion and fusion in the neural tube o f rodents has been described previously but 
the mechanism o f this highly specialised process is poorly understood (de Diego et al. 
2002; Holmberg et al. 2000; Brouns et al. 2000; Xu et al. 1998; Hung et al. 1986; 
Smits-van Prooije et al. 1986). In a recent study, a direct requirement was shown for 
the binding o f a specific ligand (ephrinA5) to a specific type o f receptor (EphA7) in 
order to enable adhesion and fusion to occur in the neural tube (Holmberg et al. 2000).
Cell to cell adhesion provides an impetus for positional cell migration (Keller 2006). 
This may suggest that PCP driven events in the surface ectoderm may play a role in 
neural tube closure, as suggested for the chick embryo (Hackett et al. 1997). 
Epidermal constriction has also been shown to be crucial for spinal neural tube closure 
in the frog, while the surface ectoderm was shown to be necessary for spinal neural 
tube closure in the mouse (Haigo et al. 2003; Ybot-Gonzalez et al. 2002).
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1.3.5.1 Cellular structures at site of fusion
Adhesion and fusion occurs in many developmental systems including the eye 
(Mohamed et al. 2003), palatal shelf (Cuervo et al. 2002; Vaziri-Sani et al. 2005) and 
closing neural tube (Holmberg et al. 2000). Moreover, cellular protrusions at the point 
o f fusion have been described in the spinal region o f the mouse embryo during 
neurulation (Waterman 1975; Waterman 1976), although the mechanisms of adhesion 
and fusion in this region of the neural tube remain poorly understood.
Cellular protrusions originating from the surface ectoderm were described by Geelen 
& Langman (1979) in the cranial neural tube, although the precise layer o f origin o f 
similar cellular protrusions in the spinal region is unclear (Waterman 1975; Waterman 
1976). These cellular protrusions have been described as mechanically bridging 
together the neural fold tips via a cytoplasmic body o f tissue that crosses the midline 
(Geelen & Langman 1979). The protrusions appear to be broad and sheet-like or thin 
and spike-like, structures which are thought to correspond to lamellipodia and 
filopodia respectively (Waterman 1975; Waterman 1976). These structures are shown 
in detail in Fig. 1.5.
1.3.5.2 Lamellipodia and filopodia
Protrusions, lamellipodia and filopodia, have been suggested to emerge from the tips 
o f the neural folds and link with each other across the midline somewhat like a zip 
(Geelen & Langman 1979). Lamellipodia contain a branched network o f actin 
filaments which grow at their barbed ends, whilst pushing the plasma membrane 
forward (Bray 2001). Extension o f the leading margin o f the cell is caused by the 
polymerization o f actin microfilaments driven by the Arp2/3 complex (Vasioukhin et 
al. 2000). Rac is classically known to induce lamellipodia formation and membrane 
ruffling whereas Cdc42 has been shown to induce filopodia which comprise thin, 
spike-like protrusions with an actin filament core, in fibroblastic cells (Kozma et al. 
1995; Nobes & Hall 1995). However, recent work done by Biyasheva et al. (2003) 
and Innocenti et al. (2004) have shown that this is an over-simplification as Rac and
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Cdc42 can both induce formation of filopodia. Rac induces WAVE (Wiskott-Aldrich 
syndrome protein-family verprolin homologous protein) which is also capable of 
inducing the formation o f lamellipodia (Biyasheva et al. 2003). A bil is also known to 
be essential for Rac-dependent lamellipodia protrusions (Innocenti et al. 2004). It is 
not known whether these or other cytoskeleton-associated proteins are involved with 
the protrusions that arise from the neural fold tips.
Fig. 1.5 Electron microscopy images showing ultrastructures during
adhesion and fusion of the spinal and cranial neural tube. A, B & C
depict lamellipodial and filopodial protrusions emerging from the 
neural folds o f a hamster during spinal neurulation (Waterman 1976). 
D is an image showing protrusions (blue arrow), termed ruffles, 
emanating from the surface ectoderm o f the rhomboencephalon taken 
from Geelen & Langman (1979); E is an image o f a transverse section 
through the midbrain-hindbrain region also showing protrusions (blue 
arrow) at the point of fusion (Morriss-Kay 1981). F shows a highly 
stained cell shown by a red arrow which is thought to be apoptotic at 
the point o f fusion (Geelen & Langman 1979). Yellow arrows in B & C 
point to small blebs, possible cell lysis, and some flattened cells which 
are seen between the surface ectoderm cells and cells o f the 
presumptive neural tube.
R: ruffles
SE: surface ectoderm 
NE: neuroepithelium
27
2 8
1.3.5.3 Molecular requirements for adhesion
The neural tips o f mouse embryos are covered with extracellular carbohydrate-rich 
material which stains with ruthenium red (Sadler 1978). A high incidence o f sugar 
residues (alpha-D-mannose, alpha-D-glucose and N-acetyl-D-glucosamine) are found 
at the point o f fusion in mouse and rat embryos during neurulation (Smits-van Prooije 
et al. 1986). Removal o f this extracellular material using an enzyme, phospholipase 
C, produced embryos with neural tube defects during whole embryo culture (O’Shea 
& Kaufman 1980). Since a specific form of phospholipase C, phosphatidylinositol- 
specific phospholipase C (PIPLC) cleaves glycosyl phosphatidyl-inositol (GPI)- 
anchored molecules (Low et al. 1988), this finding o f inhibition o f neural tube closure 
by exposure to phospholipase C raises an important question about the role o f GPI- 
anchored molecules in neural fold fusion.
GPI-anchors link proteins to the plasma membrane o f the cell (Ikezawa 2002; 
Ferguson 1999). Such proteins are connected to the GPI anchor by an amide bond 
between ethanolamine and the a-carboxyl group o f the protein’s C-terminus 
(Ferguson & Williams 1988). The GPI anchor consists o f phosphoethanolamine 
linked through a phosphodiester bond to a trimannosyl-non-acetylated glucosamine 
core. The glucosamine core is linked to phosphatidylinositol (PI). The core structure 
of a GPI anchor is as shown in Fig. 1.6.
GPI-anchored proteins include enzymes, antigens and adhesion molecules 
(Lepperdinger et al. 2001; Mastrangelo & Westaway 2001; Holmberg et al. 2000). 
They contribute to the overall organization of membrane bound proteins and are 
important in apical protein positioning (Pang et al. 2004). GPI-anchored proteins also 
play a critical role in a variety of receptor-mediated signal transduction pathways 
(Sabharanjak & Mayor 2004). Although a GPI anchor can be considered primarily as 
an alternative to a hydrophobic transmembrane polypeptide anchor, several other 
functions have been proposed for GPI anchors. These include roles in intracellular 
signalling or as soluble mediators of hormone action (Chatteijee & Mayor 2001). A 
GPI anchor may also allow a protein to associate with cholesterol and 
glycosphingolipid-rich lipid rafts, to be more laterally mobile in the bilayer and to be
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PLASMA MEMBRANE
Fig. 1.6 Core structure of a GPI anchor. Site for phospholipase C mediated
hydrolysis of GPI-achored proteins situated in the outer leaflet of the plasma membrane is 
indicated by dotted line.
Ethanolamine
Mannose
Glucosamine
Protein
Inositol
Phosphate group
Fatty acid chain of 
plasma membrane
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GPI-
Anchored
Protein
Distribution Function of Protein or Disease 
Phenotype
Reference
Brevican
(isoform)
Rat brain Synaptic plasticity Seidenbacher et 
al. 2002
CD59 Human Cell adhesion or attachment to cell matrix Rocketal. 1989
Contactinl Node of Ranvier; 
Astrocyte surface
Surface transport of paranodin/ contactin- 
associated protein via glycosphingolipid 
cholesterol rafts
Schmitt-Ulms et 
al. 2004; Faivre- 
Sarrailh et al. 
2000
ephrinA Ubiquitously expressed in 
man, mouse & chick
Angiogenesis, axon guidance, nervous system 
development and embryogenesis
Holder & Klein 
1999
Folate binding 
protein (Folbp)
Cranial region of 
neurulating mouse embryo
Folate transporter Piedrahita et al. 
1999; Saitsu et al. 
2003
GDNF-family 
receptor (GFR) 
a(1-4)
Ubiquitously expressed in 
man, mouse, chick & 
amphibians
Interacts with heparan sulphate 
glycosaminoglycans to activate Met receptor 
tyrosine kinase
Homma et al. 
2000; Sariola & 
Saarma 2003
Glypicans
(Heparan
Sulphate
Proteoglycan)
Ubiquitously expressed in 
mouse and amphibians
Glypican-3 plays a role in cell proliferation and 
survival
Song & Filmus 
2003
GPI-anchored 
molecule-like 
protein (GML)
Human tissue Suppresses cancer (induced by p53), cell 
adhesion or attachment to cell matrix
Kimura etal. 1997
GPI-80 Human leukocyte, 
Human neutrophil
Associated with (32 integrin,
Regulates cell adhesion and migration
Watanabe & 
Sendo 2002
Hyaluronidase 2 
(Hyal2)
Mouse, Xenopus Tumour growth, inflammation & 
embryogenesis
Lepperdinger et 
al. 2001
Limbic system 
associated 
membrane 
protein (LSAMP)
Surface of somata and 
proximal dendrites of 
neurons in cortical and 
subcortical regions of the 
limbic system in rodents 
and humans
Plays major role in the formation of the limbic 
circuits
Schmitt-Ulms et 
al. 2004; Pimenta 
& Levitt 2004
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Ly-6 Mouse Cell adhesion or attachment to cell matrix Rocketal. 1989
Meprin, A5 
antigen, protein 
tyrosine 
phosphatase y  
(MAM)
Human tissues & tumours Tumour metastasis De Juan et al. 
2002
Neural cell 
adhesion 
molecule-1 
(N-CAM1)
Human brain Cell movements, aggregation and migration. 
Influences cell proliferation and differentiation. 
Mediates adhesive interactions among neural 
and other cells by a self binding mechanism
Schmitt-Ulms et 
al. 2004; Arai et 
al. 2004
Neural cell 
adhesion 
molecule-2 
(N-CAM2)
Chick embryonic lens 
tissue
Cell movements, aggregation and migration. 
Influences cell proliferation and differentiation. 
Mediates adhesive interactions among neural 
and other cells by a self binding mechanism
Schmitt-Ulms et 
al. 2004; 
Watanabe et al. 
1989
Neurotrimin Rat olfactory bulb, 
cerebral cortex, 
diencephalon, 
hippocampus & 
cerebellum
Provides specific guidance cues required for 
correct targeting
Schmitt-Ulms et 
al. 2004; Miyata et 
al. 2003; Gil et al. 
1998
Opioid binding 
cell adhesion 
molecule 
(OBCAM)
Neurons of rodents Mediates bifunctional effects on neurite 
outgrowth
Schmitt-Ulms et 
al. 2004; Gil et al. 
1998
Pig-a Mouse Skin development Tarutani et al. 
1997
Prion protein Bovine and human brain 
cells
Binds strongly to lipid membranes Schmitt-Ulms et 
al. 2004; Critchley 
et al. 2004
RgmA Mouse embryo dentate 
gyrus
Repulsive guidance molecule; Involved in 
formation of afferent connections in the 
dentate gyrus; RgmA mouse mutant exhibits 
exencephaly
Brinks et al. 2004; 
Niederkofler et al. 
2004
T-cadherin Trunk of chick embryo Influence pattern of neural crest cell migration 
& maintenance of somite polarity
Ranscht &
Bronner-Fraser
1991
Table 1.3 List of GPI-anchored molecules in vertebrate tissues.
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selective) y released from the cell-surface by the action o f phospholipases (Chatteijee 
& Mayor 2001). A list o f selected GPI-anchored proteins and their functions in 
vertebrate tissues are shown in Table 1.3.
1.3.5.4 Is apoptosis required for neural fold adhesion and 
fusion?
Cell death has been suggested to be an integral part o f neural tube development crucial 
for closure in previous studies of mammals (Ernst 1925; Glucksmann 1930) and more 
recently of chicks (Weil et al. 1997; Lawson & Englund 1998). Dying cells have been 
described not only at the tips of the unfused neural folds but also in the dorsal midline 
immediately after fusion has taken place.
A structural study o f the site of neural fold adhesion showed that a cell, present 
directly at the point where the neural folds meet (red arrow, Fig. 1.5F, Geelen & 
Langman 1979), showed the classic features of apoptosis. In transmission electron 
microscopy, it comprised an electron-dense structure which had taken up substantial 
amounts of staining material (Jacobson et al. 1997).
There are only 2 studies thus far that shows apoptosis plays a direct role in successful 
neurulation. The first shows that peptide caspase inhibitors block neural tube closure 
in explanted chick embryos, while the second shows that neural tube defects in splotch 
mutants can be rescued when the function o f p53, which causes cells to undergo 
apoptosis, is abolished in splotch embryos which are associated with an increase in 
neuroepithelial apoptosis (Phelan et al. 1997; Weil et al. 1997; Pani et al. 2002).
Apart from neurulation, apoptosis has also been described in other mammalian tissue 
fusion events. For example, apoptotic cells are located at the leading front o f epithelial 
sheets in the formation o f eyelids (Hero 1990; Mohamed et al. 2003) and in palatal 
shelf fusion (Cuervo et al. 2002).
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1.4 Ephs and ephrins
Ephs and ephrins were first identified as orphan receptors and orphan ligands which 
were eventually characterized as binding partners through the observation o f the 
expression pattern o f  the corresponding ligand/receptor fusion protein (Gale et al.
1996). Ephs and ephrins may have a conserved role in multicellular animals as they 
are found not only in vertebrates but also invertebrates such as sponges (Suga et al. 
1999), Drosophila (Scully et al. 1999) and Caenorhabditis elegans (George et al. 
1998).
Eph (erythropoietin producing human hepatocellular carcinoma) kinases constitute the 
largest family o f receptor protein tyrosine kinases, with 16 distinct members 
encompassing mammalian, bird, amphibian and fish genomes (Gale & Yancopoulos 
1997; Sasaki et al. 2003; Bach et al. 2003; Aasheim et al. 2005; Cooke et al. 2005; 
Scalia & Feldheim 2005; Jevince et al. 2006; Katoh & Katoh 2006). Each Eph protein 
has an extracellular region containing an immunoglobulin-like m otif with a cysteine- 
rich domain and two fibronectin type III repeats (Fig. 1.7). The cytoplasmic region 
contains a tyrosine kinase domain and a non-catalytic tail o f  approximately 100 amino 
acids (Hubbard & Till 2000). The Eph receptor isoforms contain insertions either in 
the extracellular domain (between transmembrane and kinase domains) or within the 
kinase domain (Conner & Pasquale 1995; Maisonpierre et al. 1993; Ciossek et al.
1996).
Ephs are classified into two groups, A and B (Fig. 1.8). In the mouse, there are eight 
EphAs which predominantly bind to ephrinA proteins (Eph receptor interacting 
proteins), while the other five Ephs make up the B group that predominantly bind to 
ephrinBs (O ’Leary & Wilkinson 1999). Interestingly, EphB5 (also known as Cek9 
and Hek9) had initially been identified by Labrador et al. (1997) but this sequence has 
since been discontinued by the Mouse Genome Informatics (MGI: 1096339). 
Therefore the fifth member o f the EphB group is named EphB6 (Shimoyama et al.
2002). EphB5 and ephrinB6 have only been designated in the chick genome and not 
the mouse (Sajjadi & Pasquale 1993; Soans et al. 1996; Menzel et al. 2001).
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A-ephrins
INTRACELLULAR
B-ephrins
EXTRACELLULAREph receptor
INTRACELLULAR
Dimerization Tetramerization
Fig. 1.7 S tructure of Eph receptors and ephrin ligands. Eph receptors are grouped 
into 2 subclasses: A and B, and are characterized by a cysteine rich and two fibronectin type 
III domains in their extracellular region and also by tyrosine kinase and SAM domains in 
their intracellular region. The ligands for the Eph receptors, the ephrins, are also grouped into 
2 subclasses: A and B. Ephrins belonging to the A subclass comprise an extracellular domain 
attached to the cell membrane by a GPI anchor, while ephrins of the B subclass have a 
transmembrane segment and a short conserved domain in their intracellular region. 
Dimerization and tetramerization of Ephs and ephrins are required to enable activation of 
downstream signalling. Modified from Hubbard & Till (2000).
Eph receptor ligand binding 
Cysteine rich domain 
Fibronectin type III domain 
Tyrosine kinase domain
i
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Binding capabilities of the Eph As and ephrinA s and the ir alternative 
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There are 2 other members o f the EphA receptor family, EphA9 and EphA 10, which 
have been identified in the chick (Sasaki et al. 2003) and human genomes (Aasheim et 
al. 2005). Although in most cases EphAs bind to ephrinAs and EphBs to ephrinBs, 
there are exceptions to this rule. For example, EphA4 binds to both ephrinB2 and 
ephrinB3 (Bergemann et al. 1998), while ephrinA5 has been shown to bind to EphB2 
(Himanen et al. 2004). The latter binding has no known functional significance and 
appears to result from heterodimerization o f ephrinA5 with EphB2 (Himanen et al. 
2004). In contrast, the binding o f ephrinB2 to EphB2 creates a tetramer (Himanen et 
al. 2001) and has been experimentally shown to be functionally significant (Adams et 
al. 1999; Himanen et al. 2001). The Ephs share sequence homology and preferential 
binding to the ephrins (Eph Nomenclature Committee 1997).
1.4.1 Cellular function of Ephs and ephrins
Ephs and ephrins regulate various processes including axonal pathfinding (Winslow et 
al. 1995; Drescher et al. 1997a; Dutting et al. 1999), cell migration (Duffy et al. 2006), 
cell intermingling (Gale et al. 1996; Xu et al. 1995; Mellitzer et al. 1999), cell identity 
(Cooke & Moens 2002; Adams 2003), neural crest cell migration (Santiago & 
Erickson 2002) and cell adhesion (Winning et al. 1996; Drescher 1997; Zisch et al. 
1997; Holmberg et al. 2000). These various actions are ultimately mediated by 
cytoskeletal re-organization driven by downstream effectors o f Ephs and ephrins 
(Kullander & Klein 2002).
The interaction o f  Ephs and ephrins result in a variety o f actions by shifting cellular 
responses (Compagni et al. 2003; Davy et al. 2004; Twigg et al. 2004; Wieland et al.
2004). Depending on the cellular context, Eph-ephrin interactions can mediate cell to 
cell repulsion, or cell to cell attraction (Hattori et al. 2000; Marston et al. 2003). 
Repulsive interactions between Ephs and ephrins have been well established through 
studies in the retinotectal-retinocollicular system (Frisen et al. 1998), and during 
formation and fasciculation o f brain commissures (Henkemeyer et al. 1996), 
somitogenesis (Durbin et al. 1998) and establishment o f arteriovenous boundaries 
(Adams 2002). Attractive interactions between Ephs and ephrins have studied in less
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detail, with evidence emerging mainly from the cranial neural tube in mice and mouse 
cloacal fusion systems (Holmberg et al. 2000; Dravis et al. 2004).
Binding between Ephs and ephrins can lead to different levels o f activation that affect 
cellular responses, for example ephrinA2 at high concentrations inhibited growth o f  
retinal axons (Hansen et al. 2004). However at, low concentrations, ephrinA2 
promoted growth o f axons (Hansen et al. 2004). Moreover, high levels o f  Eph-ephrin 
activation result in repulsion whereas low levels result in attraction (Klein 2004, 
Hansen et al. 2004; Pasquale 2005).
1.4.2 Signal transduction by Ephs and ephrins
Signal transduction downstream o f  Ephs and ephrins depends on alterations in the Eph 
receptor consequent upon binding and activation o f the ephrin ligand. In order to bind 
and activate Eph receptors, ephrin ligands must undergo clustering. The minimum 
active complex comprises two receptors and two ligands, creating a structure known 
as a 2:2 circular heterotetramer (Stein et al. 1998; Huynh-Do et al. 1999; Himanen & 
Nikolov 2003; Poliakov et al. 2004). In both EphA-ephrinA and EphB-ephrinB 
interactions, Eph-ephrin signalling complexes form tetramers that can further 
assemble into larger signalling clusters (Himanen et al. 2001; Smith et al. 2004).
Eph receptors can promote adhesion or repulsion depending on the level o f  activation 
and clustering o f  ephrin ligands (Poliakov et al. 2004). Systems which have been 
shown to be affected by the level o f ephrinA activation include retinal topographic 
mapping (Hansen et al. 2004) and the mammalian olfactory system (Cutforth et al.
2003). EphrinAs are expressed at low density in the anterior midbrain, giving rise to 
interactions in the relative absence o f ephrin clustering. Unclustered ephrinA triggers 
EphA forward signalling which results in the growth o f axons, in what is assumed to 
be an adhesive interaction (Hansen et al. 2004). In contrast, in the posterior midbrain, 
ephrinA is expressed at a high density and the ephrinA molecules are clustered 
inducing EphA receptor-dependent axon disassembly, in what appears to be a 
repulsive interaction (Hansen et al. 2004).
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Hence, the interaction o f Ephs and ephrins 'in trans', when expressed on different, 
opposing cells has been predominantly studied. However, more recently it has been 
shown that co-expression o f  Ephs and ephrins on the same cell may lead to cis- 
interaction o f Ephs and ephrins (Yin et al. 2004; Marquadt et al. 2005; Egea & Klein
2007). Such interactions can lead to silencing o f cellular responses.
Although there is a high degree o f promiscuity between ephrins and Eph receptors o f 
the same class, they may not be functionally interchangeable (Frisen et al. 1999).
The ephrins and Eph receptors are unusual in that they can simultaneously act as both 
ligand and receptor. Binding o f Eph receptor may not only activate signalling 
downstream o f the Eph receptor, but also downstream o f the ephrin such that signals 
are transmitted into the interior o f both Eph and ephrin-expressing cells. Therefore, an 
interaction between an ephrin on one cell and Eph on another cell can lead to 
bidirectional reciprocal signalling that changes the behaviour o f both cells (Alberts et 
al. 2002). This has been shown to limit cell migration through embryonic boundaries 
(Mellitzer et al. 1999). However, two Eph receptors, EphAlO and EphB6, do not 
participate in bidirectional signalling because both lack a functional tyrosine kinase 
domain (Mellitzer et al. 2000; Murai & Pasquale 2003; Pasquale 2005). Lateral 
interaction o f Ephs and ephrins expressed on the same cell can limit bidirectional 
signalling by emitting opposite signalling guidance cues (Marquadt et al. 2005; 
Pasquale 2005). Hence, a complex variety o f intracellular signalling events can result 
from Eph-ephrin interactions depending on the relative expression and interaction o f 
the two protein types.
1.5 Mouse mutant models with spinal neural tube 
defects
The mouse is the most extensively studied mammalian experimental model for NTDs, 
as reviewed by Greene & Copp (2006). Mouse models with NTDs have occurred 
spontaneously, as well as being obtained through mutagenesis studies. Next to 
humans, the mouse has the most well characterised mammalian genome. Moreover,
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the mouse embryo is easily accessed and can be manipulated by various techniques 
with comparative ease, making experimental analysis a feasible approach.
There are currently 17 known mouse mutants that exhibit both spina bifida and 
exencephaly (Copp et al. 2003) and 6 that exhibit spina bifida alone (see also section 
1.5.1). They are curly tail, splotch, Zic2, Zic3, Apafl and forebrain overgrowth, 
Napl/2, Tubby like protein 3, Brea 1, Noggin, Open brain, CYP26A1, Shroom, 
MARCKS related protein, Nfl/Pax3 double mutant, Pax3/Pax7 double mutant, Patch 
(PDGFaR) and Sp8 (Copp et al. 2003; Bell et al. 2003). Among the mechanisms that 
have been associated with failure o f neural tube closure in these models are cell 
proliferation, apoptosis and actin cytoskeletal defects (Brook et al. 1991; Cecconi et 
al. 1998; Gowen et al. 1996; Hildebrand & Soriano 1999), although in no case is the 
mechanism o f failure o f neural tube closure fully understood.
Among the most well studied o f these mutants is splotch (Sp2H) which is the result o f 
semidominant mutation that arises as a result o f  deletion or disruption o f the Pax3 
gene (Epstein et al. 1991). The heterozygote adults exhibit a white belly spot, the 
result o f  a neural crest associated pigmentation defect. The homozygous mutant 
embryos display spina bifida and/or exencephaly and a range o f other abnormalities 
such as neural crest defects, skeletal malformations and an absence o f limb, body wall 
and intercostal musculature (Bober et al. 1994; Moase & Trasler 1989; Franz 1993; 
Gruss & W alther 1992; Henderson et al. 1999). Folate metabolism is perturbed in 
homozygous embryos (Sp2H/ Sp2H) at the time o f neural tube closure (Fleming & 
Copp 1998). Although the NTD causing mechanism in the splotch mutant is unknown, 
splotch is a useful model for folate sensitive NTD in which there is evidence for a 
defect in folate metabolism and in which NTD can be prevented or exacerbated by 
supplementation with various folate-related compounds.
Another well known mutant which is considered a good mouse model o f human 
thoracolumbar spina bifida is the curly tail mouse (van Straaten & Copp 2001). Curly 
tail is a semidominant mouse mutation with a high incidence o f spina bifida 
(Gruneberg 1954; Seller & Adinolfi 1981). Caudal neural tube closure in affected 
curly tail embryos is caused by enhanced ventral curvature o f the caudal region (Copp
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et al. 1988a; Copp et al. 1988b). The underlying cause o f  this curvature is reduced 
proliferation in the hindgut region with an associated reduction in retinoic acid 
receptor (RAR) expression (Brook et al. 1991; Chen et al. 1995). The incidence o f 
defects in this mutants is not reduced by treatment with folic acid (Seller 1994; van 
Straaten et al. 1995), although, supplementation by inositol reduces the incidence o f 
spinal NTDs (Greene & Copp 1997). Inositol acts by stimulating protein kinase C 
(PKC) which leads to upregulation o f RAR in the hindgut region (Greene & Copp
1997). Recently, a gene known as the Grainyhead-like 3 has been elucidated as the 
causative gene o f this mutation (Ting et al. 2003). However, neither folic acid nor 
inositol produce an ameliorating effect in the Grainyhead-like 3 mutant.
The 17 mutants which display both spina bifida and exencephaly as phenotypes are 
explained in more detail in Table 1.4.
Mutant Name NTD Gene Mutated Function of 
Protein
Possible 
Mechanism of 
NTD
References
Apafl and 
forebrain 
overgrowth 
(fog, mutation 
of Apafl)
Exencephaly and/ 
or Spina bifida 
(gene trap)
Apafl Protease 
activating factor 
in the caspase- 
dependent 
apoptosis 
pathway
Reduced 
apoptosis and 
increased cell 
proliferation
Cecconi et al. 
1998; Yoshida 
et al. 1998; 
Harris et al. 
1997;
Honarpour et al. 
2001
Brcal Exencephaly and 
Spina bifida 
(knockout)
Brcal Transcription
factor
Increased
apoptosis
Gowen et al. 
1996
CYP26A1 Exencephaly and 
Spina bifida 
(knockout)
Cyp26A1 Retinoic-acid
metabolic
enzyme
Increased 
retinoic acid 
signalling
Abu-Abed et al. 
2001; Sakai et 
al. 2001; 
Niederreither et 
al. 2002
MARCKS- 
related protein 
(Mrp)
Exencephaly with/ 
without Spina 
bifida (knockout)
M/p Cytoskeleton- 
related protein 
with function in 
signal
transduction
Cytoskeletal
function
disrupted
Wu etal. 1996
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Nf1 /  Pax3 
double mutant
Exencephaly with/ 
without Spina 
bifida ((NF1 
knockout crossed 
with splotch 
heterozygote)
Nf1, Pax3 Negative 
regulator of 
p21ras protein
Unknown Lakkis et al. 
1999
Noggin Exencephaly and 
Spina bifida, or 
Craniorachischisis 
(knockout)
Nog BMP antagonist Premature 
activation of 
BMP
downstream
signalling
McMahon et al. 
1998
Nucleosome 
assembly 
protein-1-like 
(Nap 1/2)
Exencephaly and 
Spina bifida 
(knockout)
Nap 1/2 Nucleosome
assembly
Unknown Rogner et al. 
2000
Open brain 
(opb)
Exencephaly and 
Spina bifida 
(spontaneous 
mutant)
Rab23 Rab family of 
vesicle- 
transport 
proteins
Excessive Shh 
signalling. 
Absence of 
dorsal neural 
tube
specification
Gunther et al. 
1994;
Eggenschwiler 
et al. 2001
Patch
(PDGFaR)
Exencephaly and/ 
or Spina bifida 
(knockout)
Pdgfra Growth-factor
receptor
Unknown Soriano 1997; 
Morrison- 
Graham et al. 
1992
Pax7/Pax3 
double mutant
Exencephaly and 
Spina bifida 
(spontaneous 
mutant)
Pax7/Pax3 Transcription
factors
Unknown Mansouri & 
Gruss 1998
Shroom Exencephaly and 
Spina bifida 
(gene trap)
shrm PDZ domain- 
containing 
cytoskeletal 
protein
Cytoskeletal
function
disrupted
Hildebrand & 
Soriano 1999
Splotch
(SpW ")
Exencephaly and 
Spina bifida
Pax3 Transcription
factor
Unknown Epstein et al. 
1991
Tubby-like 
protein 3
Exencephaly and 
Spina bifida 
(spontaneous mutant)
Tulp3 Not known Increased
apoptosis
Ikeda et al. 
2001
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Zic2 Exencephaly and 
Spina bifida 
(knockdown)
Zic2 Transcription
factor
Loss of dorsal 
neural tube 
specification
Nagai et al. 
2000
Zic3 and Bent- 
tail (Bn, deletion 
including Zic3)
Exencephaly and 
Spina bifida 
(spontaneous 
mutant)
Zic3 Transcription
factor
Unknown Carrel et al. 
2000; Klootwijk 
et al. 2000; 
Purandare et al. 
2002
Curly tail Exencephaly and 
Spina bifida 
(spontaneous 
mutant)
Not determined Not determined Defective 
ventral cell 
proliferation 
causing axial 
curvature
van Straaten & 
Copp 2001
Sp8 Exencephaly and 
Spina bifida 
(knockout)
Sp8 Transcription
factor
Unknown Bell et al. 2003
Table 1.4 NTDs mutants exhibiting exencephaly and spina bifida.
1.5.1 Mouse mutant models with spinal defects
Table 1.5 summarises the ten mouse mutants which exhibit spinal defects alone. This 
encompasses 6 mouse mutants that have spina bifida but without any other NTD 
phenotype (e.g. exencephaly and/or craniorachischisis), and 4 mutants with an 
abnormal spinal neural tube but where there is no spina bifida.
The mutants which display spina bifida are the FG F R la  chimeric mutant (Deng et al.
1997), Traf4 mutant (Regnier et al. 2002), the Shp2 chimeric mutant (Saxton & 
Pawson 1999), the axial defects mutant (Essien et al. 1990), glial cell missing-1 (Nait- 
Oumesmar et al. 2002) and vacuolated lens (Wilson & Wyatt 1986). As well as 
exhibiting incomplete closure o f the spinal neural tube, 4 out o f 6 o f  these mutants 
have a second phenotype: a duplicated caudal neural tube. Thus, the vacuolated lens 
mutant embryos develop spina bifida and, in addition, an ectopic neural tube is 
observed, ventral to the open neural tube (Wilson & Wyatt 1986). In Shp2, F G F R la
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and vacuolated lens mutants, an ectopic neural tube is observed during the period o f 
neurulation between E8.5 and E9.5 (Saxton & Pawson 1999; Deng et al. 1997). In 
contrast, an ectopic neural tube has only been observed at E l2.5 and later stages in 
Gcml mutant embryos (Nait-Oumesmar et al. 2002). The prevalence o f  an ectopic 
neural tube in 4 out o f 6 mutants with spina bifida seems to suggest that a second 
neural tube may be a common occurrence and that this predisposition may be the 
result o f an underlying fault in primary neurulation instead o f purely a failure o f 
secondary neurulation.
Table 1.5 Mouse mutant models with spinal defect
(ND= not determined)
neuroepithelium
Nt: neural tube
Ht: Heart
Mutant
Name
Gene
Mutated
Function of 
protein
Possible 
mechanism 
of NTD
Schematic 
Representations 
of ectopic spinal 
neural tube
Rate of 
Occurrence 
Of Spina 
Bifida
Phenotype
and
Reference
Fibroblast 
growth factor 
receptor 1 
(knockout 
producing 
chimeras)
Fgfrl Growth factor 
receptor
Unknown 
(NTDs occur 
only in 
chimaeras)
orV
E10.5, 29.5% 
have spina bifida 
and 15 % have 
ectopic neural 
tube
Spina bifida, 
Second NT; NT 
in NT & Kinky 
tail
Deng etal. 1997
Tumour 
necrosis factor 
receptor 
associated 
factor 4 
(knockout)
Traf4 Intracellular
signalling
adaptor
Unknown No ectopic neural 
tube
40%
homozygous 
nulls have spina 
bifida
Spina bifida
Regnier et al. 
2002
4 4
Shp2
(knockout
producing
chimeras)
Shp2 Tyrosine
phosphatase
(dephosphorylates
proteins)
Unknown 
(NTDs occur 
only in 
chimaeras) (9 E10.5, 36% of high content chimaeras have I second neural tube and 59 % have spina bifida Spina bifida, Second NTSaxton & Pawson 1999
Axial Defects 
(spontaneous 
mutant; gene 
not identified)
ND ND ND No ectopic neural 
tube
10 % penetrance 
in CD1
Spina bifida
Essien et al. 
1990
Glial Cells 
Missing-1 
(knockout)
Gcm1 Transcription
factor
Ectopic 
expression 
causes NTDs 
by unknown 
mechanism
(9
And
*o)
25.8 %
transgenics have 
spina bifida; 100 
% trangenics 
have ectopic 
neural tube
Spina bifida; 
Multiple NT
Nait-Oumesmar 
et al. 2002
Vacuolated
lens
(spontaneous
mutant)
ND ND Suggested 
failure in 
apposition and 
fusion ? (VI 50 % ofhomozygous null show spina bifida at 12 dpc Spina bifidaWilson & Wyatt 1986
EphA2
(knockout)
EphA2 Adhesion and 
fusion ?
Receptor 
tyrosine kinase
None Kinky tail with 
double neural 
tube
No spina bifida
Naruse-Nakajima 
et al. 2001
WASP
(knockout)
WASP Cytoskeletal
organization
Formation of 
cell-surface 
projections 
(filopodia) 
required for cell 
movement and 
actin-based 
motility
a None Wavy neural tube
No spina bifida
Snapper et al. 
2001
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Vinculin 
(knockout) 
(E10 Lethal)
Vinculin Cytoskeletal
organization
Major 
constituent of 
cell junctions 
(cell matrix & 
cell-cell)
%
None Wavy neural 
tube
No spina 
bifida
Xu et al. 1998
PAK4
(knockout)
PAK4 Cytoskeletal
organization
Target for Rho 
GTPase Cdc42
None Double neural 
tube with one 
notochord
No spina 
bifida
Qu et al. 2003
The remaining 4 mutants in Table 1.5 (Pak4, EphA2, Wasp and vinculin) are examples 
o f mouse mutants in which the caudal neural tube is abnormal but the phenotype 
differs from spina bifida. Mutants o f this type are often described as having ‘spinal 
neural tube defects’ (Snapper et al. 2001; Qu et al. 2003; Xu et al. 1998; Naruse- 
Nakajima et al. 2001) but there is no evidence o f a persistently open posterior 
neuropore. Interestingly, however, 2 o f  these 4 mutants, the EphA2 null mouse 
(Naruse-Nakajima et al. 2001) and PAK4 null mouse (Qu et al. 2003), also have a 
duplicated neural tube in association with a single notochord, as was seen in 4 o f the 6 
mutants with spina bifida. Another abnormal spinal neural tube phenotype is a wavy 
spinal neural tube which occurs in the WASP null mouse and the Vinculin null mouse 
(Snapper et al. 2001; Xu et al. 1998). Vinculin is a large protein that binds multiple 
cytoskeletal proteins including actin, a-actinin, talin, paxillin, VASP, ponsin and 
vinexin. Together with protein kinase C (PKC), these proteins have been suggested to
4 6
be required for forming the adhesion scaffold that connects early adhesion sites to 
actin-driven protrusive machinery in enabling motility (Bailly 2003).
This survey o f mouse mutants with spinal neural tube abnormalities suggests that 
duplication and formation o f ectopic neural tubes may be common morphological 
associations o f NTDs. Ectopic neural tubes may occur in different ways, including 
neural tubes positioned side-by-side, or one above the other. In addition, the wavy 
neural tube phenotype could also be a further manifestation o f the tendency to form 
multiple neural tubes. It is important to note that sections through the wavy neural 
tube o f  the WASP and Vinculin knockout mice were not presented in the publications 
on these mutants, leaving open the question o f the precise status (closed versus open, 
single versus duplicated) o f  the neural tube in these cases.
Meningomyelocele or spina bifida aperta in humans is frequently accompanied by 
various physical abnormalities such as lipoma, rachischisis and diastematomyelia. In 
the latter case, there is an apparent neural tube duplication which is strikingly similar 
to that observed in the mouse mutants in Table 1.5. These associated defects occur in 
both syndromic or non-syndromic NTDs. It is interesting to speculate whether other 
anomalies, such as lipoma formation, occurs more commonly than has been realised in 
mice with NTDs. Currently the Gcml mutant is the only example o f a mouse model in 
which such abnormalities have been well described. Gcml mutants exhibit both 
lipoma and diastematomyelia (Nait-Oumesmar et al. 2002) in addition to 
meningomyelocele.
1.6 Objectives and Experimental Approaches
The objective o f  this PhD project was to study adhesion and fusion in the closure o f 
the spinal neural tube. The role o f adhesion and fusion was analysed by removing 
GPI-anchored proteins from the cell surface o f neurulating mouse embryos. Among 
the known GPI-anchored proteins listed in Table 1.2, the ephrinAs were investigated 
in detail because ephrinA5 had been previously implicated in cranial neural tube 
adhesion and fusion (Holmberg et al. 2000). Treatment with PIPLC to remove
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ephrinA ligands from a diverse array o f tissues has been widely performed (Monschau 
et al. 1997; Hornberger et al. 1999) and this approach has been adopted in the present 
study.
Chapter 2 describes a series o f detailed gene expression studies to determine which 
Eph receptors and ephrins may be expressed on the tips o f the apposing neural folds 
during adhesion and fusion. The expression patterns that emerge from this analysis 
indicate which Eph-ephrin interactions may be required when the neural folds adhere.
Chapter 3 then takes an experimental approach in order to determine whether these 
adhesion and fusion-related Ephs and ephrins are physiologically required for closure 
o f the spinal neural tube. The function o f specific candidate molecules was perturbed 
in whole embryo culture, the PNP length and width was measured, and statistical 
analysis was performed in order to identify any effects o f PIPLC enzyme and/or 
specific Eph/ephrin blockers.
Chapter 4 describes detailed studies o f the structure o f the spinal neural tube during 
adhesion and fusion, using electron microscopy. The expression o f particular adhesion 
and fusion-related Ephs and ephrins was also examined to determine whether they are 
present on the ultrastructures detectable by electron microscopy.
The studies in Chapters 2-4 suggest, first, that particular members o f the Eph-ephrin 
families may be crucial to the process o f adhesion and fusion in the mouse spinal 
neural tube and, second, that some aspects o f the adhesion/fusion process are 
asymmetric.
Chapter 5 then discusses these findings, with particular reference to the apparent 
asymmetry involved in spinal neural tube fusion. Various arguments are considered 
which support as well as argue against asymmetrical cellular structures being involved 
in adhesion and fusion. An attempt is made to integrate the role o f Ephs and ephrins 
into an asymmetrical system o f neural fold adhesion and fusion. Chapter 5 ends by 
documenting initial progress towards construction o f a conditional gene targeting 
vector designed to knock out the function o f one o f  the target molecules, ephrinA 1, in
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order to be able to further test, experimentally, the hypothesis that Eph/ephrin 
interactions are required for adhesion and fusion o f the mouse neural tube.
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CHAPTER 2
Gene Expression During Neural Tube Fusion
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2.1 Introduction
In order to analyse genes that are specifically required for the spinal neural folds to 
adhere and eventually  fuse, the expression o f  genes at the tips o f  the apposing and 
fusing neural folds w as investigated in detail. A m ong the genes that have been noted  
in the literature to be expressed at the junction  o f  the non-neural and neural ectoderm  
in the spinal region prior to closure in m ouse are Grainyhead-like 3 (A uden et al. 
2006), Axin2 (Jho et al. 2002) and Pax3 (Goulding et al. 1991). G enes expressed soon 
after closure include Zic2  (Elm s et al. 2003), M sxl (Elm s et al. 2003), W ntl (Ram os & 
Robert 2005; B ulgakov et al. 2004) and BM P6 (Ram os & R obert 2005), as 
sum m arized in section 1.3.2 o f  C hapter 1. There are, how ever, m any m ore genes that 
are reported to be expressed throughout the surface ectoderm  and at the tips o f  the 
neural folds although specificity  for the non-neural or neural ectoderm  is often not 
distinguished in these studies. Such genes include Fgf8  (D ubrulle & Pourquie 2004), 
Grainyhead-like 2 (A uden et al. 2006), BM P7  (Elm s et al. 2003), Wnt6 (Elm s et al. 
2003), N otch l (G alceran et al. 1999) and BM P4 (Hu et al. 2004), as sum m arized in 
section 1.3.3.
In this chapter, the expression pattern o f  ephrinAs w as exam ined during m ouse spinal 
neural tube closure. The corresponding binding partners, the Eph group o f  m olecules, 
w ere also analysed. The Ephs and ephrins are prim e candidates to be involved in 
spinal neurulation as they have already been im plicated in  cranial neurulation, w here 
EphA 7 and ephrinA 5 w ere found to be expressed at the tips o f  the apposing neural 
folds (H olm berg et al. 2000).
2.1.1 Expression pattern of Ephs and ephrins
Ephs and ephrins are m ost often expressed in com plem entary  dom ains, although there 
are also overlaps in expression (Flenniken et al. 1996; G ale et al. 1996; C onnor et al. 
1998; A dam s et al. 1999; Sobieszcuk & W ilkinson 1999). W hile non-overlapping 
expression is im plicated in boundary form ation in several system s (D urbin  et al. 1998; 
Zhang & H ughes 2006), the significance o f  overlapping Eph and ephrin  expression is
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still being elucidated. The expression patterns o f  ephrinA s, as no ted  from  the available 
literature, are as show n in Table 2.1. V arious Eph and ephrin m olecules are expressed 
throughout the ectoderm , m esoderm  and endoderm  o f  the developing em bryo, as w ell 
as in the adult (F lanagan & V anderhaeghen 1998; H older & K lein  1999; W ilkinson 
2000).
2.1.2 Aims and objectives
The aim  o f  the studies described in this chapter w as to determ ine w hich ephrinA  
gene(s) are expressed in the spinal neural tube during the period w hen it is undergoing 
neural fold fusion. E xpression o f  the EphA binding partners o f  the ephrinA s w as also 
studied in detail during this developm ental stage.
2.2 Materials
All the reagents used in this chapter were obtained from  Sigm a unless specified. The 
com ponents o f  individual solutions are described in the text. A ll ephrinA s and EphA 2 
and EphA 4 cD N A  plasm ids were kindly provided by  Dr. D avid W ilkinson o f  the 
N ational Institute for M edical Research, M ill Hill. The insert size o f  these different 
probes and the G enB ank accession num ber o f  the corresponding product are as listed 
in Table 2.2.
All other Eph receptor nucleotide sequences w ere obtained from  G enB ank database 
(h ttp ://w w w .ncbi.nlm .nih.gov) . The accession num bers for these sequences are as 
shown in Table 2.3 and w ere cloned into pG EM -T Easy vector (Prom ega).
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Ephrin Distribution Function of Protein Expression  
Pattern in the 
developing  
embryo
R eferences
A1 Caudal end of primitive streak and allantois 
in mouse; Anterior pharyngeal endoderm in 
mouse; Mouse presumptive endocardial 
cells (E8.0-E8.5); Mouse Primitive streak 
(E8.5); Mouse Tailbud (E9.5); Intersomitic 
vessels and limb bud vasculature in mouse 
(E9.5-E10.5); Mouse Tailbud (E10.5); 
Mouse Lung and Gut; Sites of 
neovascularization in mouse; Rat 
thymocytes
Plays a role in 
angiogenesis; 
angiogenic and 
endothelial cell 
chemoattractant 
activity; impairs cell 
spreading; induces c- 
Cbl phosphorylation 
and EphA down- 
regulation in T-cells
2) Flenniken et al. 1996; Gale et al. 1996; Shao et al. 1995; Deroanne et al. 2003; McBride & Ruiz 1998; 
Sharfe et al. 
2003
A2 Mouse midbrain (E8 & E9), In E95 primate 
cortical plate; Medial hippocampal axons in 
rat
Promotes growth and 
branching of axons in 
rats
§ )
Donoghue & 
Rakic 1999; 
Gaoet al. 1999; 
Flenniken et al. 
1996
A3 Low levels throughout in cortical plate 
(highest in middle region) in E80 of primate; 
Medial hippocampal axons of rat; cortex in 
mouse; Granular cell layer of the dentate 
gyrus of P2 stage in mouse
Promotes growth and 
branching of axons in 
rats; entorhino- 
hippocampal axon 
targeting in mouse
Pattern of 
expression  not 
determined
Donoghue & 
Rakic 1999; 
Gao et al. 1999; 
Stein et al, 
1999
A4 Diffuse pattern of expression in the 
ectoderm of branchial arches in mouse 
(E9.5); Human lymphocytes; epidermis 
during late embryogenesis and early 
postnatal period (E16-P3) in rats
Directs cell specific 
gene expression in 
lymphocytes; inhibits 
sensory neurite 
outgrowth and 
regulated by neonatal 
skin wounding
Flenniken et al. 
1996; Munthe & 
Aasheim 2002; 
Moss et al. 
2005
A5 Throughout cortical plate (E80: primate); 
Medial hippocampal axons; Midbrain, 
diencephalon, optic placode in mouse at 
E8; Midbrain, branchial arches, eye and 
forebrain (E9); Ectoderm of branchial 
arches in mouse at E9.5
Promotes growth and 
branching
§ )
Donoghue & 
Rakic 1999; 
Gao etal. 1999; 
Flenniken et al. 
1996
Table 2.1 Expression of ephrinAs in the developing embryo. E xpression 
pattern  o f  the 5 ephrins as noted in literature.
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Probe Insert
Size
GenBank 
A ccession  No.
Vector Restriction Enzyme to  
Linearise
RNA Polym erase 
for Transcription
ephrinAI 1.5 kb NM_010107 pBSK Sa/1 T3
ephrinA2 1.6 kb NM_007909 pBSK Hind III T3
ephrinA3 2.2 kb XM_204001 pBSK Bam H1 T7
ephrinA4 2.0 kb NM_007910 pBSK Xba 1 T7
ephrinA5 0.7 kb NM_207654 pBSK Sa/1 17
EphA2 1.3 kb BC006954 pBSK Hind III 17
EphA4 1.2 kb NM_007936 pBSK Hind III 17
Table 2.2 Ephrin and Eph cDNA plasmids used for anti-sense whole mount embryo
in situs. These probes were obtained from D. Wilkinson. The restriction enzyme and RNA 
polymerase used to linearise and transcribe are as indicated.
Eph
Receptor
A ccession
Number
Primers Restriction Enzyme/ 
RNA Polymerase
Corresponding
nucleotide
Size of
RT-PCR
product
A1 NM_023580 5’ CAAGATTGCAAGACTGTGGC 3’ 
5’ CCTCCCACATTACAATCCCA 3’
Sad:17 (Anti-sense) 
Sacll: SP6 (Sense)
nt (2004-2517) 514 bp
A3 NM_010140 5' GGCCATCATTGTCCTCACGG 3' 
5’ GTCGGATGATGTTGGGATGG 3'
Sad: 17 (Sense) 
Sacll: SP6 (Anti­
sense)
nt (1764-2167) 404 bp
A5 NM_007937 5’ GGAGAACGGCTCCTTAGACA 3' 
5’ GAGCCACAGCGTCCATTGAA 3’
Sad: 17 (Sense) 
Sacll: SP6 (Anti­
sense)
nt (2662-3389) 728 bp
A6 NM_007938 5’ GGCGATTGGGGTGGAAGCCT 3’ 
5' CTCCCACATGACAATCCCGT 3'
Did not clone into 
pGEM-T
nt (2396-2885) 490 bp
A7 NM_010141 5’ CCATCAATTCGCCAAGGAGC 3’ 
5’ GGGAAAGGCCAAAATCTGAC 3’
Did not clone into 
pGEM-T
nt (2095-2573) 479 bp
A8 NM_007939 5’ T CT GGAT CTGCCT GACACT C 3’ 
5’ T AGCCAGCTTT GAGAGCCTT 3’
Did not clone into 
pGEM-T
nt (1706-2117) 412 bp
B1 NM_173447 5’ AT GAGGACCCCAAT GAAGCC 3' 
5’ GGTAGCGAGAGAGACCAAAG 3’
Did not clone into 
pGEM-T
nt (2093-2599) 507 bp
B2 NM_010142 5' CGTATGTAACAGACGGGGGT 3' 
5’ CATGACAGGTGTGCTCTTGG 3’
Sad: 17 
Sacll: SP6
nt (1794-2193) 400 bp
B3 NM_010143 5' AAT GAGGCCGT CCGAGAGTT 3’ 
5’ CCAAGTTGCTGTTGACAAGG 3’
Sad: 17 (Sense) 
Sacll: SP6 (Anti­
sense)
nt (2212-2671) 460 bp
B4 NM_010144 5’ CTGGTCTGCAAGGTGTCCGA 3 
5’ AGAGCGCTGACCACCTGGGG 3'
Sad: 17 (Anti-sense) 
Sacll: SP6 (Sense)
nt (2695-3062) 368 bp
B6 NM_007680 5' CGACTCCGATCGTGACACCG 3’ 
5' GCCGGTAGTAAAGGGTGAAG 3’
Sad: 17 
Sacll: SP6
nt (4 -  826) 823 bp
Table 2.3 Ephs generated by RT-PCR and Eph cDNA (expressed in PNP) plasmids 
cloned into pGEM-T Easy. Ephs and ephrins generated and cloned into commercial T-tailed 
vector for whole mount in situ purposes. The restriction enzyme and RNA polymerase used to 
linearise and transcribe are as indicated.
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2.3 Experimental procedures
The experim ental procedures in this section cover all pro tocols used  for m icrotom e 
and vibratom e sectioning. All gene expression analysis w as done b y  non-rad ioactive 
w hole m ount in situ  hybridization to detect m R N A  expression. P ro te in  expression w as 
detected by  w hole m ount im m unohistochem istry and paraffin  section 
im m unohistochem istry.
2.3 .1 Gene expression analysis using RT-PCR
The objective o f  this technique was to rapidly screen for E ph receptor expression, 
since m any m em bers o f  this fam ily are potentially  expressed in  the posterio r 
neuropore o f  m ouse em bryos during neurulation.
2.3.1.1 Isolation of RNA from mouse cranial and caudal tissues
M ouse cranial and caudal tissue were isolated as show n in Fig. 2.3. R N A  w as iso lated  
using Trizol (G ibco BRL). Each tube o f  Trizol reaction contained a m inim um  o f  5 
m ouse em bryonic day  8.5 or 9.5 cranial tissue (excised above the first branchial arch) 
and caudal tissue (excised at the first som ite above presom itic m esoderm ).
1 m l o f  Trizol w as added to the tissue and using the m icropipette, the solution and 
tissue w ere p ipetted  up and down a few  tim es and left for 5 m inutes at room  
tem perature. A  200 jul volum e o f  chloroform  was added, the tubes w ere shaken 
v igorously b y  hand for 15 seconds and left for 3 m inutes at room  tem perature. The 
sam ple w as then centrifuged for 10 m inutes at 4°C at 12,000 x g. The supernatant, 
w hich contained the R N A , w as then decanted into a new  tube. A  volum e o f  500 p i o f  
isopropanol w as added to the supernatant to precipitate RN A . The m ix  w as left for 10 
m inutes at room  tem perature before being centrifuged at 12,000 x g for 10 m inutes at 
4°C. The supernatant w as then rem oved and the pellet w as w ashed  w ith  1 m l 75%  
ethanol.
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Fig. 2.1 Schematic figure showing the level at which cranial and caudal 
tissues were excised from the mouse embryo. A, schematic figure o f  
embryo at E8.5; B, schematic figure o f embryo at E9.5. Tissue for 
RNA isolation was obtained from the cranial region, as marked by blue 
arrows (4 — ►) and from the caudal region as marked by red arrows
The sample was then vortexed briefly before being centrifuged at 7,500 x g for 5 
minutes at 4°C. The pellet was then air-dried before being resuspended in 30 pi 
MilliQ sterile water. First strand cDNA was generated using random hexamers by 
reverse transcription using Superscript II kit (Invitrogen).
2.3.1.2 Primer design for RT-PCR
The forward and reverse primers for RT-PCR were designed using the PrimerPremier 
4 program (Biosoft). The primers were designed to span an intron, as listed in Table
2.3.
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2.3.1.3 Cloning into pGEM-T Easy
PC R products w ere cloned into pG EM -T Easy w hich allow s d irect c loning o f  PC R  
products ow ing to a T overhang and blue-w hite co lour selection  o f  recom binant 
plasm ids. A  3:1 m olar ratio o f  PC R product (generated using  prim ers in Table 2.3) 
was added to pG E M -T  Easy vector, 5 pi o f  2x Rapid L igation B uffer and 1 p i T4 
D N A  Ligase w hich w as in a final volum e o f  10 pi m ade up w ith  M illiQ  w ater. The 
ligation m ix w as then  kept at 4°C overnight.
A  2 pi volum e o f  the ligation product was added to 50 p i D H 5 a  com petent cell 
(section 2.3.2.1), heat-shocked for 90 seconds at 42°C, then left on  ice for 15 m inutes 
before the addition o f  800 pi SOB (2% bacto peptone, 0.5%  yeast extract, 10 m M  
NaCl and 2.5 m M  KC1 in distilled w ater and autoclaved) and grow n for an hour and 
subsequently p lated  on to plates containing 100 pg/m L A m picillin , 0.5 m M  IPTG  and 
80 pg/m L X-gal. The plated  Petri dishes w ere then incubated at 37°C overnight (not 
m ore than 16 hours), the w hite colonies w ere picked, grow n and subsequently  
characterized. The resulting recom binant plasm ids w ere m ade into probes for w hole 
m ount in situ  hybridization.
2.3.2 RNA expression analysis using whole mount in situ 
hybridisation
Expression o f  m R N A  w as investigated using the w hole m ount in situ  hybrid ization  
technique (W ilkinson 1992). Plasm ids containing cD N A  probes w ere transform ed into 
D H 5 a  com petent cells. The transform ed cells were then p lated  on to am picillin  p lates 
and the p lasm ids containing the genes o f  interest w ere then  iso lated  using Q iagen 
plasm id preps. The D N A  w as linearised and transcribed w ith  the relevant R N A  
polym erases. These labelled probes were then used in  w hole  m ount in situ  
hybridization, analysed and then sectioned and re-analysed.
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2.3.2.1 Preparation of competent cells (method modified from 
Inoue et al. 1990)
A  249 m l volum e o f  SOB was inoculated w ith 10 D H 5 a  colonies and left in  an 
incubator shaker at 37°C until the optical density (600 nm ) o f  the b ro th  reached 0.6. 
The culture w as then decanted into pre-chilled falcon tubes on ice. The culture w as 
centrifuged for 10 m inutes at 2500 x g at 4°C.
Supernatant w as then decanted and the pellets were gently  resuspended  in a total 
volum e o f  80 m l ice-cold TB buffer (10 m M  Pipes, 15 m M  C aC h , 250 m M  KC1, 55 
m M  M nC h in d istilled w ater and filter sterilised). The cells w ere left on ice for a 
further 10 m inutes.
A  volum e o f  1.5 m l D M SO  w as then added to the cell suspension w hich w as left on 
ice for another 10 m inutes. The cell suspension w as aliquoted into 50 pi am ounts 
w hich w ere snap frozen in liquid nitrogen before being stored at -80°C.
2.3.2.2 Preparation of plasmid DNA for whole mount in
situ hybridisation
W hole m ount in situ  hybridization was perform ed using probes sum m arized in  Table
2.2 and Table 2.3. P lasm ids were resuspended in 5 p i TE. O nly  1 pi o f  this solution 
was then added to 50 p i com petent cells and incubated at 42°C  for 90 seconds. The 
cells w ere grow n at 37°C for 1 hour w ith the addition o f  800 p i SOB. A  sm all volum e 
o f  the cells (20 pi) w as plated on a 50 pg/m l am picillin LB agar plate and grow n at 
37°C overnight. The colonies w ere picked and grow n overnight in  am picillin  before 
perform ing a p lasm id  m idiprep to obtain the recom binant D N A  o f  the genes o f  
interest.
2.3.2.3 Sequencing
All probes received, as w ell as the ones constructed in-house, w ere sequence verified. 
An autosequencing reaction w as prepared containing 300 ng  o f  p lasm id  D N A , 5 pm ol
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o f  either forw ard o r reverse prim er, 4 pi o f  m egabace m ix, 4 p i o f  better buffer and 
M illiQ  w ater to m ake a final volum e o f  20 pi. PC R  w as perfo rm ed  using  a program m e 
consisting o f  20 seconds at 95°C, followed by  15 seconds at 50°C and 1 m inute at 
60°C. The program m e w as run for 25 cycles.
The autosequencing PC R  product was then m ixed w ith  2 p i 7.5M  N H 4OAC and 55 p i 
100% ethanol. The sam ple tube was given a quick flick to ensure hom ogenous m ixing  
and centrifuged for 15 m inutes at room  tem perature at 13,000 rpm . The supernatant 
was then aspirated and the pellet w ashed w ith 250 pi 70%  ethanol w hich  w as then 
vortexed for 5 seconds. The samples were centrifuged for 5 m inutes at room  
tem perature at 13,000 rpm . The supernatant was aspirated and the pellets w ere left to 
air dry. Sam ples w ere stored dry  at -20°C until sequenced on a M egaB ace sequencer.
2.3.2.4 Midiprep and linearization of probe
1 pg  D N A  from  a m idiprep w as linearized in a 50 p i total volum e reaction containing
2 pi restriction enzym e and 5 p i lOx restriction buffer and incubated at 37°C for 2 
hours. A  1% agarose gel w as electrophoresed w ith  1 p i o f  the d igestion product to 
ensure that the p lasm id  had  been fully linearized. The rest o f  the d igestion product w as 
de-proteinized b y  adding 1 pi Proteinase K  (10 m g/m l) and incubated for 30 m inutes 
at 50°C. A  volum e o f  50 pi o f  phenol, chloroform  and isoam yl alcohol m ixture at a  
ratio o f  25:24:1 w as then added to the digestion product for further purification. The 
m ix w as centrifuged at 13,000 x g for 10 m inutes. The supernatant w as decanted into a 
fresh tube and ethanol precipitation was perform ed by  adding 2 volum es o f  100%  
ethanol and 1/10 volum e o f  sodium  acetate pH  5.2. The supernatant w as centrifuged at 
13,000 x g for 30 m inutes before the pellet was subsequently  w ashed  and resuspended 
in sterile M illiQ  water.
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2.3.2.5 Generation of riboprobe
In vitro  transcrip tion o f  riboprobe w as perform ed by  p reparing  a reaction  m ixture  
containing 1 p g  D N A  (linearized plasm id), 2 pi 1 Ox transcrip tion  buffer, 2 p i D IG - 
RN A  labeling m ix, 1 pi RN A se inhibitor, 2 p i R N A  Polym erase and D E PC -treated  
w ater to m ake a final volum e o f  20 pi. The reaction m ixture  w as centrifuged and 
incubated for 2 hours at 37°C. The reaction w as then purified  using BD  C H R O M A  
SPIN -100+ D E PC -H 2O colum ns which were pre-centrifuged em pty  for 3 m inutes. 
The sam ple w as loaded onto the colum n and centrifuged for 5 m inutes. T he purified  
product w as collected and stored at -20°C until further use.
2.3.2.6 RNA whole mount in situ hybridisation (modified from 
Wilkinson 1992)
Em bryos w ere rehydrated  in m ethanol prepared in PB T (PBS containing 0.1%  v/v 
Tw een-20) beginning w ith  75%  m ethanol for 10 m inutes, follow ed w ith 50%  
m ethanol for 10 m inutes and for another 10 m inutes w ith  25%  m ethanol. The em bryos 
were then w ashed w ith  tw o changes o f  PBT for 10 m inutes each. A ll the w ashing 
procedures w ere perform ed on ice on a shaker.
Em bryos w ere then  bleached for 1 hour w ith a 17% sodium  peroxide solution. Care 
w as taken w hen sodium  peroxide was added to prevent bubbles from  form ing. PB T 
w ashes w ere done 3 tim es for 10 m inutes each. Fresh 4%  PFA  and fresh  glycine (2 
m g/m l) in  PB T w ere prepared during the bleaching period. Em bryos w ere then  
perm eabilized b y  treatm ent w ith Proteinase K  (10 m g/m l in  PB T) for 1 m inute for 
E8.5 em bryos and 2 m inutes for E9.5 embryos.
Proteinase K  w as inactivated by  incubating the em bryos on  ice for 10 m inutes in 2 
m g/m l glycine. PB T w ashes were done three tim es for 5 m inutes each. A  0.8%  v/v 
glutaraldehyde in  4%  PFA  buffered in PBT was added to the em bryos w hich  w ere left 
shaking on ice for 20 min.
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The em bryos w ere then w ashed in PBT three tim es for 5 m inutes each at room  
tem perature and then prehybridized for 2 hours at 70°C  in a w ater bath. 
Prehybridization m ixture com prised 50%  form am ide, 5x SSC pH  4.5, 50 pg/m l tR N A , 
1% SDS and 50 pg/m l heparin. A fter prehybridization, the solution w as replaced w ith  
1 ml fresh prehybridization solution and 1 pg o f  probe added and left to  hybrid ize 
overnight at 70°C.
The em bryos w ere w ashed tw ice in Solution 1 (50%  form am ide, 5x SSC pH  4.5 and 
1% SDS in distilled, autoclaved water) for 40 m inutes each at 70°C. This step w as 
then follow ed b y  another two washes in Solution 2 (50%  form am ide and 2 x SSC pH  
4.5 in distilled, autoclaved water) at 70°C for 40 m inutes each. The em bryos w ere 
w ashed three tim es in  TB ST for 10 m inutes each and then  blocked  in 10% sheep 
serum  in TB ST for 90 m inutes at 4°C.
Em bryo pow der (pre-prepared from sonicated em bryos) w as added to 10 m l o f  TB ST 
(3 m l o f  TB ST for each sam ple tube). The em bryo pow der m ixed  w ith  TB ST w as then 
incubated at 70°C for 30 m inutes. This m ixture w as then left on ice for 20 m inutes. 
The supernatant o f  this blocking buffer m ixture w as then filtered through a 0.45 pm  
filter and kept cold. A nti-digoxigenin tagged alkaline phosphatase antibody w as then 
added to the filtered supernatant (1 pi antibody for each 3 m l o f  buffer) w hich w as 
subsequently kept shaking at 4°C for 90 m inutes. Em bryos w ere incubated in  this 
antibody dilution overnight at 4°C.
The em bryos w ere then  w ashed tw ice w ith TBST for 5 m inutes each, follow ed b y  1 
hour TB ST w ashes for the next 5 hours. The embryos w ere then  left shaking in  TB ST 
solution overnight. The em bryos were w ashed w ith  N T M T solution (100 m M  N aC l, 
100 m M  KC1, 50 m M  M gC b, 1% Tween-20) for 10 m inutes. G ene expression w as 
then detected by  adding 1 m l o f  N TM T and 18 pi N B T/B C IP solution to the em bryos 
w hich w ere left shaking in the dark at room  tem perature until the co lour reaction 
developed.
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2.3.2.7 Preparation of vibratome sections
A 200 m l em bedding m ixture was prepared by  m ixing 0.9 g gelatine (300 B loom ) 
w ith 20 m l PB S w hich w as heated and stirred continuously  until it dissolved. A  
further 160 m l o f  PBS w as then added. The m ixture w as then cooled to room  
tem perature and 56 g o f  grade II album in was m ixed in.
The m ixture w as left stirring overnight at room  tem perature before 36 g o f  sucrose 
w as added. The m ixture w as continually stirred w ith  a m agnetic stirrer, and 
occasionally w ith  a plastic pipette, to produce a hom ogenous substance. The m ixture 
was aliquoted into universal tubes w ith a volum e o f  5 m l each before being  frozen for 
storage at -20°C.
Em bryos w ere transferred  directly from PBS into 2 m l em bedding m ixture w hich w as 
then left for at least 30 m inutes. Each embryo w as coated w ith  em bedding m ix  and 
placed on the side o f  an em bedding mould. One volum e o f  em bedding m ixture w as 
then m ixed thoroughly  w ith 0.1 volum e o f  25%  glutaraldehyde. The em bryo w as 
quickly orientated using a needle. The m ould w as left to set at room  tem perature for 
an hour, covered in  clingw rap and kept at 4°C overnight. The em bryo b lock  w as then  
ready for sectioning or kept in  PBS at 4°C for future use.
The em bryo block  w as attached to the vibratom e m ounting tray  using superglue. The 
m ounting tray  w as then filled w ith PBS to prevent the b lock  from  drying out. The 
vibratom e m achine w as set to m axim um  amplitude and m edium  speed before  50 pm  
o f  section w as slow ly  sliced o ff  the block. This process w as repeated until all the 
relevant sections w ere obtained and put on glass slides. D rops o f  60%  glycerol in  PB S 
were then added to the sections as a m ounting agent before sealing the sections w ith  a 
coverslip and nail varnish  to keep the coverslip in place and prevent condensation.
2.3.2.8 Microscopic and photographic analysis
Photographs o f  w hole em bryos w ere taken on a Leica m icroscope at a reso lu tion  o f  
150 dpi. G raticule pictures at various m agnifications w ere also taken  on  the Leica
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m icroscope at the sam e resolution. Photographs o f  sections w ith  th ickness o f  7-15 pm  
were taken on the A xiophot m icroscope w ithout the polarizer. Photographs o f  sections 
w ith thickness o f  50 pm  w ere taken using d ifferential-in terference-contrast (D IC) on 
the A xiophot w ith  the polarizer.
2.3.3 Analysis of protein expression by
immunohistochemistry
This section covers the sectioning m ethod used to study pro tein  expression, and the 
antibody detection protocol used to visualize protein expression.
2.3.3.1 Preparation of Paraffin Sections
Em bryos w ere d issected free o f  extra-em bryonic m em branes, rinsed in PBS and fixed 
in 4%  paraform aldehyde (PFA) for two hours. The em bryos w ere then dehydrated 
through a series o f  ethanol w ashes beginning w ith  PBS, 30%  ethanol, 50%  ethanol 
and 70%  ethanol. Each o f  these washes was for 20 m inutes. The em bryos w ere then 
kept in 70%  ethanol and stored at 4°C.
Before the em bryos w ere em bedded in paraffin, the em bryos w ere w ashed w ith  100% 
ethanol for 30 m inutes twice. The embryos w ere next equilibrated w ith  100%  
histoclear tw ice for 20 m inutes each. The embryos w ere then m oved into a glass pot 
w hich contained 1:1 ratio o f  histoclear and w arm  paraffin  w ax and incubated at 60° 
for 20 m inutes. The em bryos w ere equilibrated in 2 changes o f  100%  paraffin  w ax for 
20 m inutes each, and then orientated in a glass pot under a m icroscope using a hot 
needle. The w ax w as left to set at room  tem perature overnight.
W ax blocks w ere rem oved from  glass pots after placing at -20°C  for 15 m inutes and 
m ounted on a w ooden block using m elted paraffin  wax. The m ounted  b lock  w as left to 
cool on ice for 5 m inutes before placing on to the m icrotom e and sectioning at 7 pm  
thickness. Sections w ere arranged on sterile M illiQ  w ater p ipetted  on Superfrost plus 
slides. W arm ing to 30°C allow ed spreading o f  sections. The slides w ere collected  on a
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rack and kept in a 30°C oven overnight, before storing at room  tem perature until 
further use.
2.3.3.2 Antibody detection
Sections w ere deparaffinized by  two histoclear w ashes for 5 m inutes each. The 
sections w ere then rehydrated in 100% ethanol by  two w ashes o f  5 m inutes each, 
follow ed by  5 m inute w ashes in 75% ethanol, 50%  ethanol and 25%  ethanol and 
finally in PBS. Endogenous peroxidase was quenched next in  b locking  solution (1 part 
30%  hydrogen peroxide to 9 parts m ethanol) for 10 m inutes. Subsequently, the slides 
were w ashed three tim es in PBS for 5 m inutes each.
The slides w ere then placed in a plastic trough filled w ith 1 m M  ED TA  pH  8.0 w hich 
was then heated in  a steam er for 10 m inutes. The slides w ere allow ed to cool for 20 
m inutes at room  tem perature and then rinsed thoroughly w ith  PBS.
N on-specific antibody binding sites were blocked by  covering the tissue sections w ith  
10% norm al goat serum  in PBS. The sections w ere incubated for 15 m inutes at room  
tem perature and the excess blocking serum  w as rem oved. A ppropriate dilutions o f  
prim ary antisera w ere prepared in 10% norm al goat serum  in PBS and incubated on 
sections for 1 hour at 37°C.
N egative controls (prim ary antisera om itted or inclusion o f  prim ary  antibody b locking 
peptides) and positive controls (tissues o f  know n expression pattern) w ere also 
included. The sections w ere then washed three tim es for 5 m inutes each in  PBS. 
D iluted secondary H R P antibody (goat anti-rabbit) (1:100) w as then  added to the 
sections follow ed b y  incubation for 30 m inutes at room  tem perature. A  second 
detection m ethod using fluorescent antibody (TRITC goat anti-rabbit) w as also 
em ployed as a control m easure.
Sections w ere w ashed three tim es for 5 m inutes each in  PB S. D iam inobenzid ine 
(DAB) solution consisting o f  2 drops buffer in 5 m l dH 20, 4 drops o f  DA B and 2 
drops o f  hydrogen peroxide was prepared. DAB w as left on  the sections for 2 to 8 
m inutes. The reaction w as observed using a m icroscope and the reaction  w as stopped
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by im m ersing slides in  w ater as soon as sufficient signal w as observed, but no longer 
than 8 m inutes after addition o f  DAB.
The slides w ere then dehydrated in a series o f  alcohol w ashes beginning  w ith  25%  
ethanol for 5 m inutes, follow ed by  50%  ethanol, 75%  ethanol and tw o w ashes w ith 
100% ethanol for 5 m inutes each. This was then follow ed by  tw o h istoc lear w ashes for 
5 m inutes each and the slides were then m ounted in D PX  and coverslips applied.
2.3.3.3 Whole mount immunohistochemistry
W hole em bryos w ere dissected in D M EM  containing 10% FBS before  being  quickly  
washed in ice-cold PBS. The em bryos were transferred to an ice-cold solution o f  
0.05%  glutaraldehyde and 2%  PFA  buffered in PBS and w ere fixed for 2 hours. A ll 
following steps w ere perform ed on ice. The em bryos w ere w ashed extensively  in 
0.01%  T riton-100 buffered PBS for a total o f  3 hours w ith  3 changes o f  w ashing 
solution. These w ashing steps are extrem ely critical to prevent background staining.
The em bryos w ere then  incubated w ith  prim ary antibody, dilu ted  as listed in Table
2.4, overnight at 4°C. The next day the em bryos w ere w ashed extensively  as 
previously explained. The embryos w ere then incubated overnight at 4°C w ith  
secondary antibody, goat anti-rabbit horseradish peroxidase, diluted 1:100 in  0.01%  
Triton-100 buffered PBS. The next day the em bryos w ere w ashed extensively  as 
previously  explained. DA B solution (Vectastain) w as prepared  in  a 5 m l volum e. The 
em bryos w ere im m ersed in DAB for 1 m inute and then w ashed in d istilled  water.
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Antibody Source Dilution Catalog
no
Secondary antibody
Rabbit anti- 
ephrinAI
Zymed Invitrogen 1:800 18-2301 Polyclonal Goat Anti- 
Rabbit Immunoglobulins/ 
HRP, DakoCytomation 
(P0448)
Rabbit anti- 
ephrinA3
Zymed Invitrogen 1:800 36-7500 Polyclonal Goat Anti- 
Rabbit Immunoglobulins/ 
HRP, DakoCytomation 
(P0448)
Rabbit anti- 
EphA2
Zymed Invitrogen 1:500 34-7400 Polyclonal Goat Anti- 
Rabbit Immunoglobulins/ 
HRP, DakoCytomation 
(P0448)
Blocking Peptides Source Ratio of antibody Catalog no:
ephrinAI blocking 
peptide
Santa Cruz 
Biotechnology
1:100 V-18
ephrinA3 blocking 
peptide
Santa Cruz 
Biotechnology
1:100 K-19
EphA2 blocking 
peptide
Santa Cruz 
Biotechnology
1:100 C-20
Table 2.4 Summary of primary and secondary, antibodies and blocking 
peptides, used for immunohistochemistry.
2.4 Results
W hole m ount R N A  in situ  hybridization w as perform ed using p rev iously  published  
probes as described in section 2.2 (Table 2.2.). The gene expression  patterns described
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below  are based on at least 3 embryos per probe per stage, as sum m arized  in Table
2.5.
Probe E8.5 Late E8.5 -  Early 9.5 E9.5 to Early 10.5
6-10 som ite stage 12-15 som ite stage 17-27 som ite stage
ephrinAI 4 3 3
ephrinA2 2 3 3
ephrinA3 3 3 3
ephrinA4 3 3 3
ephrinA5 3 3 3
Table 2.5 Number and stage of embryos subjected to whole mount in situ  
hybridization with ephrinA probes.
Sense probes w ere m ade for genes for w hich probes w ere produced in-house, as 
described in section 2.2 (Table 2.3). Exam ples o f  em bryos hybrid ized w ith  sense 
probes are show n in Fig. 2.8 and F ig 2.19
2.4.1 EphrinAI and ephrinA3 are expressed in the spinal 
neural tube during neurulation
EphrinAI is expressed strongly in the PNP from  E8.5 to E9.5 but the expression 
seem s to gradually  decrease in m ore proxim al regions so that, by  E l 0.5, it is m ostly  
expressed in the tailbud (Fig.2.2 A-F). There is expression in the h indgut region 
throughout neuru lation  (Fig. 2.2 A-D), a feature that can be seen m ost clearly  in 
vibratom e sections o f  the PN P (Fig. 2.15 and Fig. 2.16). EphrinAI is also expressed in 
the branchial arches from  E8.5 to E l 0.5.
EphrinA2 is expressed in a broad dom ain o f  the m idbrain at E8.5 (Fig. 2.3 A  & B) 
w ith the expression gradually  becom ing m ore localized in  the m esencephalon as 
neurulation progresses from  E9.5 to E l 0.5 (Fig. 2.3 C-F).
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Expression o f  ephrinA3  is strong in the entire PN P throughout neurulation. From  E8.5 
to E9.5, expression o f  ephrinA3 is exclusive to the PN P (Fig. 2.4  A -D ). Thereafter, the 
pattern o f  expression encom passes m any other areas (Fig. 2.4  E, F). B y  E l 0.5, 
ephrinA3 is expressed in the m yelencephalon, m etencephalon, isthm us, auditory  
vesicle, eye and infundibulum  (Fig. 2.4 F). EphrinA3 is also expressed in the h indgut 
(Fig. 2.4 A -F), a dom ain that can be visualized clearly in sections (Fig. 2.15 and Fig. 
2.16).
Expression o f  ephrinA4  is ubiquitous throughout neurulation (Fig. 2.5 A -F), although 
the expression pattern  o f  this gene becom es m ore pronounced  in  m ore m ature 
embryos (Fig. 2.5 E, F). There is a m arked increase in  expression in  the 
prosencephalon, branchial arches, forelim b and the surface ectoderm  o f  the 
rhom boencephalon at E l 0.5 (Fig. 2.5 E, F).
EphrinA5 is expressed predom inantly  in the developing eye and m idbrain  from  E8.5 
to E10.5 (Fig. 2.6 A -F ). B y E10.5, expression o f  ephrinA5 is also w idespread in  the 
prosencephalon (Fig. 2.6 E, F).
In sum m ary, two m em bers o f  the G PI-anchored ephrinA s, ephrinA I and ephrinA 3, 
are expressed in  the PN P during neurulation. A ll genes exam ined show ed expression 
in other tissues consistent w ith previous literature descriptions.
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Fig. 2.2 Expression pattern of ephrinAI at various stages of development of 
the mouse embryo.
Expression o f ephrinAI as demonstrated by whole mount in situ 
hybridization throughout neurulation, from the 6 somite (B) to 23 
somite stage (F). EphrinAI mRNA is localized in the PNP (red arrows) 
and branchial arches. The somite stage o f the embryos shown are as 
follows: (A) 8 somites, (B) 6 somites, (C) 13 somites, (D) 15 somites, 
(E) 21 somites, (F) 23 somites.
D= diencephalon, M= mesencephalon, R= rhomboencephalon,
F= forebrain (telencephalon), N= neural tube
Dashes in 2.2C indicate branchial arches 1-4 (arch 1 is most cranial).
The scale bar represents 0.5 mm.
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Fig. 2.3 Expression pattern of ephrinA2 at various stages of development of 
the mouse embryo.
Expression o f ephrinA2 as demonstrated by whole mount in situ 
hybridization throughout neurulation, from 6 somite (A) to 25 somite 
stage (F). ephrinA2 mRNA is localized in the midbrain at all stages 
(red arrows).
M = mesencephalon
The scale bar represents 0.5 mm.
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Fig. 2.4 Expression pattern  o f ephrinA3 a t various stages of developm ent o f 
the mouse em bryo.
Expression o f ephrinA3 as demonstrated by whole mount in situ 
hybridization throughout neurulation from the 7 somite (A) to the 22 
somite stage (F). EphrinA3 mRNA is localized in the PNP (red 
arrows). White arrow point to the infundibulum and arrowhead points 
to isthmus.
P = prosencephalon, My = myelencephalon, Mt = metencephalon,
M = mesencephalon, e = eye, av = auditory vesicle
The scale bar represents 0.5 mm.
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Fig. 2.5 Expression pattern of ephrinA4 at various stages of development of 
the mouse embryo.
Expression o f ephrinA4 as demonstrated by whole mount in situ 
hybridization throughout neurulation, from 7 somite stage (A) to 25 
somite stage (E).
P = prosencephalon, F = forelimb bud, R = rhombencephalon 
The scale bar represents 0.5 mm.
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Fig. 2.6 Expression pattern  o f ephrinAS a t various stages o f developm ent o f 
the mouse em bryo.
Expression o f ephrinA5 as demonstrated by whole mount in situ 
hybridization throughout neurulation, from the 7 somite stage (A) to 27 
somite stage (F). EphrinA5 mRNA is localized in the midbrain (shown 
by red arrows), optic vesicle and forebrain.
The scale bar represents 0.5 mm.
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2.4.2 Multiple Eph receptors are expressed in the spinal neural 
tube during neurulation
The localization o f ephrinsAl and A3 in the PNP during neurulation suggests a role 
for ephrins in spinal neural tube closure. As the most well established ephrin binding 
partners, the Ephs represent the likely receptors for ephrins in neural tube closure. The 
Ephs make up the largest group o f receptor tyrosine kinases, with 13 members in the 
mouse family. There are 8 EphA receptors (EphAl - A8) and 5 members o f  EphB 
(EphBl- B4 and B6) receptors. In order to analyse the possible role o f  Eph receptors 
during adhesion and fusion o f the spinal neural tube, RT-PCR was performed to 
rapidly detect Ephs which are expressed in the posterior neuropore o f  mouse embryos 
during neurulation.
RT-PCR, as performed in this study, on the members o f the Eph family in the PNP 
during neurulation can only be regarded as a semi-quantitative exercise, as the amount 
o f RNA as starting material was not quantified. However, the same amount o f tissue 
(5 cranial and 5 caudal fragments) was used as starting material in each assay.
EphAl, EphA2, EphA3, EphA4, EphA5 and EphB4 are expressed in the posterior 
neuropore o f E8.5 and E9.5 CD1 embryos (Fig. 2.7). EphB2 and EphB3 are expressed 
only in the caudal region at E9.5 and not at E8.5, while EphB6 is also expressed in the 
PNP at E9.5 (Fig. 2.7). The faint band seen for EphA7, EphA8, EphBl, EphB2 at E8.5 
and EphB3 in caudal fragments at E8.5 (Fig. 2.7) could mean very low caudal 
expression o f these genes during neurulation. However, transcripts were not detected 
in subsequent whole mount in situ analysis, nor are they noted in published work.
Whole mount in situ hybridization was performed on embryos undergoing neurulation 
(Fig. 2.8). Expression was analysed for all Eph receptors with the exception o f  EphA3, 
EphB2 and EphB6 due to shortages o f material and time.
Expression o f EphAl is widespread throughout the PNP during neurulation. It is 
expressed throughout the neuroepithelium and also very strongly in the paraxial
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mesoderm directly adjacent to the neuroepithelium (Fig. 2.9). EphAl is also expressed 
in the dorsal region o f the hindgut and in the wall o f the hindgut (Fig. 2.9).
EphA5 is expressed throughout the neural folds o f the PNP at E8.5 and E9.5 (Fig. 2.8 
and Fig. 2.9) and throughout the neuroepithelium at Mode 2 stage during neurulation 
(Fig. 2.9). At E l0.5 both EphAl and EphA5 are expressed in similar patterns (Fig. 
2.10) in the otic placode, myelencephalon, metencephalon, isthmus, mesencephalon, 
prosencephalon and eye. The infundibulum is completely free o f expression. 
Expression o f both o f these genes at this period o f development appears to be 
extremely strong in the hindgut and needs to be studied further via sectioning.
EphA2 and EphA4 are expressed predominantly in an asymmetric manner at the tip o f 
the left neural fold prior to adhesion o f the neural folds (Fig. 2.9). The asymmetrical 
pattern o f expression o f EphA2 can be seen in another embryo which was sectioned at 
10 pm (Fig. 2.14). The asymmetrical pattern o f expression was first observed in initial 
50 pm sections done on EphA2 whole mount in situ hybridization embryos throughout 
neurulation (Fig.2.13). There was a predominantly darker expression seen on the left 
tip o f the neural fold (Fig. 2.13) which was followed by a distinct expression at the 
point o f adhesion and fusion (Fig. 2.13).
Expression o f EphA2 at the point o f adhesion and fusion occurs in a wider domain in 
comparison to EphA4 (Fig. 2.9) at the same axial level. Expression o f EphA4 is 
expressed at a lower level o f intensity at the tip o f the left neural fold in comparison to 
EphA2, but it appears to be distinctly expressed at the left tip (Fig. 2.9).
EphA2 is expressed strongly throughout the neuroepithelium although the expression 
varies along the spinal body axis. The expression is present throughout the 
neuroepithelium in the open PNP but it becomes more restricted dorsally as it 
approaches the point o f closure (Fig. 2.9). The expression o f EphA2 is very distinct at 
the point o f adhesion and fusion (Fig. 2.9). Due to its distinct expression pattern at the 
point o f adhesion and fusion, EphA2 expression was looked at closely throughout 
neurulation (Fig. 2.11 -  2.14). EphA2 takes on a salt and pepper appearance in the 
PNP with distinct expression in the notochord (Fig.2.12A) after 2 hours o f
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development o f colour reaction. A longer period o f colour development enables 
clearer visualization o f gene expression (Fig. 2.12B-D). EphA2 is expressed as 
staggered spots all along the left and right tips o f the neuroepithelium (Fig.2.12). 
EphA2 is also distinctly expressed in the fourth rhombomere from E8.5 to E9.5 but is 
absent at late E9.5 and E l0.5 (Fig. 2.11).
Upon close inspection o f EphA2 mRNA expression, there appears to be a fluctuation 
o f expression between the left tip and right tip o f the neural folds prior to closure 
whereby the expression flips from the left tip to the right tip (Fig. 2.14). The amount 
o f EphA2 expression appears to be similar on both tips during adhesion and fusion 
(Fig. 2.13). However, expression flips again to the left tip during closure (after 
adhesion and fusion) (Fig. 2.13). These variation in intensity may indicate the 
observation o f fluctuation o f EphA2 gene expression between the left and right tips o f 
the spinal neural tube. There also remains the possibility that the embryos were not 
sectioned in a completely transverse plane and had been sectioned slightly obliquely 
which may have led to the distinct fluctuation pattern observed. However, this is 
unlikely, as the same fluctuating pattern had been observed in 3 different embryos.
The pattern o f expression o f EphA2 mRNA and protein supports a possible role 
during adhesion and fusion. EphA2 is expressed from E8.5 to E l0.5 in the PNP and its 
mRNA is specifically present prior to adhesion and at the point o f  adhesion and 
subsequent fusion. The whole mount in situ for this gene was repeated on several 
occasions, and the same association between EphA2 expression and the point o f 
neural tube closure was repeatedly observed (Fig. 2.12).
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Fig. 2.7 RT-PCR analysis detects EphAl, EphA2, EphA3, EphA4, EphA5, EphB2, EphB3, EphB4 
and EphB6 expression in the PNP of wild-type embryos at E8.5 and E9.5 (posterior 
neuropore). PC R  product am plified  from  cD N A  derived from: A, cranial region o f  E8.5 m ouse 
em bryos; B, cranial region o f  E9.5 m ouse em bryos; C, PN P region o f  E8.5 m ouse em bryos; D, 
PNP region o f  E9.5 m ouse em bryos; E, N egative control for PC R  am plification using w ater 
instead o f  cDN A. The size o f  the R T -PC R  products are as follow s; E p h A l, 495 bp; EphA 2, 389 
bp; EphA 3, 384 bp; EphA 4, 557 bp; EphA 5, 708 bp; EphA 6, 470 bp; E phA 7, 459 bp; EphA 8, 
392 bp; E p h B l, 487 bp; EphB 2, 380 bp; EphB 3, 440 bp; EphB 4, 348 bp; EphB 6, 823 bp. Lanes 
boxed in red highlight expression o f  the respective Eph receptor in the PN P region.
EphAl
EphA2
EphA3
EphA4
EphA5
EphA7
EphA8
EphBl
EphB2
EphB3
EphB4
EphB6
oo
Fig. 2.8 Expression of Eph family members in the PNP of E9.5 CD1 embryos. A, EphA l is
expressed in the foregut region and PN P; C, EphA2 is expressed in the h indbrain and PN P; D, 
EphA4 is expressed in the rhom bom ere, otic vesicle (yellow  arrow ) and PN P (white arrow);
E, EphA5 is expressed in the prosencephalon, m esencephalon, m etencephalon  and PN P 
(w hite arrow); G, EphB3 is expressed specifically  in the m idbrain, at the boundary betw een 
the m etencephalon and diencephalon, in the telencephalon and som ites. E xpression is also 
detected in foregut and hindgut regions, and in the presom itic m esoderm ; I, EphB4 is 
expressed ubiquitously. Sense probes for EphA l EphA5, EphB3 and EphB4 do not reveal any 
expression (B, F & H & J). W hite arrow s indicate expression in the PNP.
The scale bar represents 0.5 mm.
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Fig. 2.9 Whole mount in situ hybridization analysis of Eph receptor family members. Whole mounts 
(A-D) and expression pattern in sections through PNP (E-V) are shown. A, E, I, M  & S: E phA l 
is expressed throughout the neural p late, presom itic  m esoderm , notochord and h indgut endoderm  o f  
the PN P region (50 pm  vibratom e sections); B, F, J, N  & T: EphA2 is expressed throughout the 
neural p late  and no tochord  in  the PN P reg ion  (10 pm  paraffin  sections) N ote  the localization  o f  
EphA 2 transcrip ts to the neural fold tips at the site o f  fusion; C, G, K ,0  &  U: EphA4 is expressed 
strongly  in the presom itic  m esoderm  and w eak ly  in the neural plate, w ith  strongest expression at the 
neural fold tips (10 pm  paraffin  sections); D , H , L, Q & V  EphA5  is expressed uniform ly  throughout 
the neural p late  o f  the PN P (10 pm  paraffin  sections).
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Fig. 2.10 Expression p a tte rn  o f E p/iA l and  EphA5 a t  E10.5 as show n by 
w hole m ount in situ hybridisation. EphAl and EphA5 are expressed in 
the otic placode, myelencephalon, m etencephalon, isthmus, 
mesencephalon, prosencephalon and eye. The infundibulum  is 
completely free o f  EphAl expression. There is also expression in the 
hindgut region o f  both EphAl and EphA5 (arrow).
The scale bar represents 0.5 mm.
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Fig. 2.11 E xpression p a tte rn  o f EphA2 th ro u g h o u t neu ru la tion .
Expression o f  EphA2 as demonstrated by whole m ount in situ 
hybridization from 6 somite (B) to 23 somite stage (F). EphA2 mRNA 
is localized to the rhombomere and to the PNP and tail bud (red 
arrows).
The scale bar represents 0.5 mm.
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Fig. 2.12 E xpression o f EphA2  m RNA in the PN P of 4 d iffe ren t em bryos (A-
D). EphA2 expression appears as a “dot” at the point o f  adhesion and 
fusion o f the spinal neural folds (red arrows). Elsewhere in the PNP, 
EphA2 expression gives an overall salt and pepper appearance. Intense 
expression o f  EphA2 can be seen in the notochord beneath the neural 
plate in (A).
Scale bar: 0.1 mm.
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Fig. 2.13 EphA2  mRNA is expressed at the tips of the neural folds prior to closure and at the point of 
adhesion and fusion throughout neurulation (10 som ite stage to 21 som ite stage). Sections 
(50 pm  vibratom e) in  each colum n relate  to the w hole m ount em bryo at the top, w ith  section 
levels as show n by  the dashed lines.
Scale bar: 0.2 m m
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Fig. 2.14 EphA2  mRNA expression fluctuates between left and right neural folds immediately prior to 
and during closure. E xpression o f  EphA2 detected  by  w hole m ount in situ  hybrid isation  in  two 15 
som ite stage em bryos. A  series o f  10 pm  sections are show n, through the posterio r neuropore from  
caudal (left sections) to rostral (right sections). A  & B, EphA2  expressed on left tip o f  neural fold; C 
& D, EphA2 expressed on  right tip o f  neural fold; E & F, EphA2 expressed on  left and righ t neural 
folds w ith  sim ilar intensity , EphA2 is also expressed predom inan tly  on the right side o f  notochord; 
G  & H, EphA2 is expressed p redom inantly  on left tip and at the poin t o f  fusion; I, EphA2 is 
expressed on bo th  left and right tips o f  neural folds but w ith  a  w ider dom ain  on the righ t neural fold 
tip; J, expression o f  EphA2 at the poin t o f  fusion gradually  decreases; K  & L, expression o f  EphA2  
in the dorsal ro o f  o f  the neural tube has decreased in intensity.
Scale bar: 0.2 m m .
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E8.5 Cranial E9.5 Cranial E8.5 Caudal E9.5 Caudal
EphAl V V V a/
EphA2 V a/ AI " "  7' ~ ~ .....~ ...........
EphA3 V >/ V AI
EphA4 V V A/ V
EphA5 V AI V V
EphA6 a/
EphA7 V V
EphA8 V AI
EphB1 V AI
EphB2 V V A/
EphB3 a/ a/ V AI
EphB4 V V V V
EphB6 Not determined Not determined Not determined AI
Table 2.6 Summary of expression of Eph family members in the PNP 
during neurulation.
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2.4.3 Comparison of mRNA expression between ephrins 
and Ephs in the PNP during neurulation
Having examined the expression o f all ephrinAs and EphAs during neurulation, it was 
noted that ephrinAl and ephrinA3, and EphA2, are the most likely candidates for 
mediating the process o f adhesion and fusion o f the spinal neural folds. A more 
detailed comparison o f  expression o f these three genes was then performed in both 
Mode 1 (Fig 2.15) and Mode 2 (Fig 2.16) PNPs.
Abundance o f ephrinAl mRNA peaks in the neuroepithelium in Mode 1, at E8.5, but, 
by Mode 2, at E9.5, ephrinAl expression is completely absent from the 
neuroepithelium (Fig.2.16 B-D). In complete contrast, expression o f  EphA2 is largely 
absent from the neuroepithelium in Mode 1, whereas it is present throughout most o f 
the neuroepithelium o f Mode 2. The only neural plate regions that do not express 
EphA2 in Mode 2 are the dorsolateral hingepoints (Fig 2.16 G, H). EphA2 shows 
strong expression in the notochord at both Modes 1 and 2 (Figs 2.15, 2.16).
Expression o f ephrinA3 can be detected in both Modes 1 and 2, although the 
expression level is low at both stages. EphrinA3 is expressed predominantly in the 
paraxial mesoderm during Mode 1 (Fig. 2.15 K -  O) and this pattern o f expression is 
retained in Mode 2 (Fig. 2.16 I -  L). Neither the ephrinAl nor ephrinA3 are present at 
the points o f adhesion and fusion during Modes 1 or 2, in contrast to the distinct 
expression o f EphA2 at this location (2.16 G).
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Fig. 2.15 Expression of ep h rin A l, EphA2, an d  ephrinA S  at the 8 somite stage 
(Mode 1). E m bryos w ere  sub jec ted  to  w ho le  m o u n t in  situ  hybrid ization  and 
sectioned  at 50 p m  th ickness. A , eph rin A l is ex p ressed  in  the  neu roep ithe lium  (red 
arrow ) and in  the  la tera l aspects  o f  the  h indgu t (w h ite  arrow head ); B, expression  o f 
ephrinA l b eco m es g rad u a lly  m ore  ven tra lized  as sec tions  m o v e  tow ards the rostral 
end o f  the  P N P ; C , ex p ressio n  o f  eph rin A l in  ven tra l n eu ro ep ith e liu m  reduces in 
in tensity , w h ereas  ep h rin A l is still exp ressed  stro n g ly  in  the  h indgu t; D , expression  o f 
ephrin A l p e rs is ts  in  la tera l h indgu t w alls  b u t is co m p le te ly  absen t from  the 
neu roep ithe lium ; E , ex p ressio n  o f  eph rin A l is ab sen t from  the  c lo sed  neural tube; F, 
EphA2  is ex p ressed  in  the  no to ch o rd  and floo rp la te , w ith  d iffu se  low -level expression 
in  the  ven tra l n eu ra l p la te ; G , a  g rad ien t o f  EphA 2  ex p ress io n  is p resen t, w ith  m ost 
in tense ex p ress io n  in  the  ven tra l neu roep ithe lium ; H , ex p ress io n  o f  EphA2  decreases 
at m ore  ro stra l levels; I, J, exp ression  o f  EphA2  is ab sen t from  the  rostral PN P and 
closed  n eu ra l tube; K , ephrinA 3  is exp ressed  s tro n g ly  in  the  parax ia l m esoderm  as 
w ell as w ith in  the  n eu ra l p la te ; L, exp ression  o f  ephrinA 3  appears  s tronger in  the tip o f 
the left n eu ra l fo ld  and  left m esoderm  than  on  the  righ t side; M , ephrinA3  is expressed 
equally  in  b o th  left and  righ t parax ial m esoderm ; N , ephrinA 3  con tinues to be 
expressed  in  the  p a rax ia l m esoderm , w hereas ex p ress io n  level in  the  neuroepithelium  
has decreased ; O , ex p ressio n  o f  ephrinA3  is v e ry  low  in  the  c losed  neural tube. 
EphrinA3  e x p ress io n  con tinues to be de tec tab le  at low  level in  the  parax ial m esoderm .
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Fig. 2 .16 E x p re ss io n  o f  eph rin A l, E phA 2 and ephrinAS  m R N A  a t  th e  15 
som ites s ta g e  (M o d e  2). A , E xpression  o f  eph rin A l encom passes the entire 
m esoderm  and  h indgu t bu t is absent from  the neuroep ithelium ; B, expression o f 
ephrinA l p e rs is ts  in  the  m esoderm  and h indgu t reg ion  b u t is absent from  the 
neu roep ithelium ; C , n ear the  po in t o f  neural fold contact, exp ression  o f  ephrinA l is 
less in tense  th ro u g h o u t m esoderm , bu t rem ains strong  a round  h indgut. N ote  punctate 
expression  o f  eph rin A l in  sp lanchnic com ponent o f  lateral p la te  m esoderm , form ing 
the w all o f  the  h indgu t. T he neural p late  is en tire ly  nega tive  for ep h rin A l; D, 
ephrin A l is ex p ressed  around  dorsal aortae, and very  strong ly  around  and below  the 
h indgut, w h e reas  the  c lo sed  neural tube is negative; E, EphA2  is expressed  throughout 
the  caudal n eu ro ep ith e liu m  and in  the notochord, w ith  m uch  less in tense expression  in 
the do rsa l h indgu t; F , neuroep ithelia l expression  o f  EphA2  fo rm s a gradient, w ith 
strongest ex p ress io n  ventrally . V ery  strong expression  is p resen t in  the notochord. 
N ote  absence  o f  exp ression  from  the D L H Ps; G, strong  exp ression  o f  EphA2  is v isible 
at the po in t o f  n eu ra l fo ld  adhesion  and fusion, together w ith  a  g rad ien t o f  expression 
o f  EphA2  a lo n g  n eu roep ithe lium  (strongest ventrally). V e ry  strong  expression  persists 
in the no tocho rd ; H , EphA2  expression  is still v isib le  at the  po in t o f  neural fold 
adhesion  and  fusion , w h ich  has now  developed  in to  a b ridge-like  structure. EphA 2 
m R N A  seem s p resen t in  the  dorsal m ost part o f  th is bridge. E xpression  elsew here in 
the n eu ro ep ith e liu m  is reduced  in intensity; I, ephrinA3  is expressed  ub iquitously  
th roughou t the  P N P  bu t w ith  strongest expression  in  the  parax ial m esoderm  and 
surface ec toderm ; J, exp ression  o f  ephrinA3  in  the  surface ectoderm  has progressed  
dorsally , so it is now  adjacen t to the  tips o f  the neural folds; K , ephrinA3  is expressed 
in the la te ra l-m ost p a rax ia l m esoderm  together w ith  expression  th roughout the surface 
ectoderm  includ ing  the  site  ad jacent to the  tips o f  neura l folds; L, ephrinA3  is 
expressed  v e ry  s trong ly  in  the lateral-m ost parax ial m esoderm , bu t no t in the closed 
neural tube.
ephrinA 1 EphA2 ephrinA3
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2.4.4 ephrinAl, ephrinA3 and EphA2 proteins are expressed 
at the point of adhesion (POA)
Whole mount and section immunohistochemistry reveal that ephrinA l, ephrinA3 and 
EphA2 proteins are expressed at the tips o f the neural folds, and specifically at the 
point o f adhesion and fusion, in the PNP region (Fig.2.17 & Fig. 2.18). This pattern o f 
expression o f ephrinAl protein at the neural fold tips is confirmed in two other 
embryos (Fig. 2.18). Hence, ephrinAl protein is present at the point o f  adhesion and 
fusion o f the neural folds. In contrast, expression o f  ephrinAl in the rest o f  the 
neuroepithelium is significantly weaker.
EphrinAl is also expressed in the surface ectoderm particularly where this tissue 
overlies at the tips o f the neural folds (Fig. 2.18 A-H). EphrinA l protein is also 
expressed weakly throughout the paraxial mesoderm at both Mode 1 and M ode 2 (Fig.
2.17 C-E & Fig. 2.18 A-H). EphrinAl also appears to be expressed in the nucleus as 
well as in the cytoplasm (Fig. 2.18).
EphrinA3 protein, like ephrinAl is expressed at the tips o f the spinal neural folds prior 
to fusion (Fig. 2.17 M), however, unlike ephrinA l, ephrinA3 is also expressed 
throughout the closed neural tube (Fig. 2.17 N & O) so that the specificity for the 
neural fold tips is less striking. EphrinA3 protein is also expressed in the paraxial 
mesoderm (Fig. 2.17 M -  O).
EphA2 protein is not expressed throughout the neuroepithelium, nor in the paraxial 
mesoderm, but instead is expressed predominantly at the tips o f  the neural folds prior 
to closure. In the embryo in Fig. 2.17, staining appears more intense on the left tip 
than on the right although both neural fold tips are positive. Moreover, a group o f 
strongly EphA2-positive cells, which originate from the left sided surface ectoderm 
(Fig. 2.17H), appears in more rostral sections to have re-located into a position exactly 
between the apposing neural fold tips (Fig. 2.171). These EphA2-positive cells are 
still visible at the point o f adhesion and fusion in the recently closed neural tube (Fig.
2.17 J). This apparent detachment o f cells from the surface ectoderm during adhesion
o f the neural fold tips is examined in further detail, using electron microscopy, 
Chapter 4.
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Fig. 2.17 Immunostaining by whole mount (top two rows) and section 
immunohistochemistry (bottom three rows) shows expression of ephrinAl, 
EphA2 and ephrinA3 protein at the point of neural fold fusion. A -B , w hole  m ount 
im m u n o h is to ch em istry  o f  ep h rin A l; B, the en larged  v iew  show s p ro te in  expression  o f  
ep h rin A l at the  tip s o f  neu ra l folds in  the PN P; C -E , in  sections, ep h rin A l can  be seen 
to be  ex p ressed  sp ec ifica lly  at the  neural fold tips, p rio r to , du ring  and  im m ediately  
fo llow ing  c losu re ; F -G , w ho le  m ount im m unoh istochem istry  o f  E phA 2; d istinct and 
strong  p ro te in  ex p ress io n  o f  E phA 2 is seen on  the tips o f  neu ra l folds; H -J, in  sections 
E phA 2 is ex p ressed  specifica lly  on  the tips o f  the neu ra l fo lds p rio r to  during  and 
fo llow ing  c losu re ; K -L , w ho le  m ount im m unoh istochem istry  fo r ephrinA 3; pro tein  
expression  o f  ephrinA 3  is w eak ly  detectab le  on  the  tips o f  the  neu ra l folds in  the PN P; 
M -O , ephrinA 3 is exp ressed  strong ly  on the neura l fo lds p rio r to  closure, although 
expression  is p red o m in an t on  the surface ectoderm  at the  p o in t o f  c losure in the 
recen tly  c lo sed  neu ra l tube; P -Q , typical nega tive  con tro l for w hole  m ount 
im m u n o h is to ch em istry  (m inus p rim ary  antibody); R -T , typ ica l negative  contro ls for 
im m u n o h is to ch em istry  o n  paraffin  sections.
The scale b a r  in  A  rep resen ts  0.5 m m .
The scale  b a r  in  C rep resen ts  0.1 m m .
C, D  & E are  10 p m  seria l sections caudal to rostral th ro u g h  the  PN P, C, H  &  M
correspond  to  1 on  the  schem atic , D , I &  N  co rrespond  to  2 and E, J &  O  correspond
to 3.
C audal to  R ostra l
Section immunohistochemistry
mxmmm
Whole mount 
immunohistochemistry
VOVO
Fig. 2.18 EphrinAl protein is expressed at the tips of the neural folds in two independent 
embryos. Sequential paraffin  sections o f  10 pm  thickness from  rostral (A ,E) to caudal 
(D ,H ) in the PN P o f  tw o different em bryos. A-D, ephrinA l is expressed specifically  on the 
tips o f  the neural folds as the closure point is approached (in  D). E ph rinA l is also present 
in  the surface ectoderm  and paraxial m esoderm , w hereas expression is at low  in tensity  in 
the rest o f  the neuroepithelium . E-H , in  a second em bryo, ephrinA l is expressed strongly  in 
the surface ectoderm  and tips o f  the neural folds.
The scale bar represents 0.1 m m .
ephrinAl-embryo 1ephrinAl-embryo 2
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2.5 Discussion
This section summarizes the ephrin candidates that are expressed in the PNP during 
neurulation and also the possible Eph receptor candidates that might bind to and be 
activated by the ephrin ligands in the precise spatiotemporal sequence o f  events that 
culminates in neural fold adhesion and fusion in the PNP. The expression o f  possible 
downstream targets o f the ephrin Eph signaling in the PNP during neurulation is also 
discussed.
2.5.1 ephrinAl and ephrin A3 are binding partners for 
Eph receptors in the PNP during adhesion and 
fusion
The only 2 ephrin ligands that are expressed at the right time and in the right place to 
participate in spinal neural fold fusion (PNP) are ephrinAl and ephrinA3. However, it 
was notable that mRNA and protein localization o f ephrinAl and ephrinA3 do not 
completely correlate during neural tube closure. Neither mRNA for ephrinAl and 
ephrinA3 were detected at the point o f  adhesion and fusion, whereas protein 
expression was detected in each case.
This apparent discrepancy between mRNA expression and protein expression could be 
explained if the mRNA is constantly degraded in the cytoplasm, with a rate o f  
synthesis that is much more rapid than necessary to maintain a steady amount. This 
could mean that the ephrinA mRNA is degraded rapidly as it travels from the nucleus 
to the cytoplasm, but that sufficient is produced to be translated into ephrinA protein. 
Perhaps the transient nature o f the mRNA means that its level is below the detection 
limit o f whole mount in situ hybridization.
Localization o f  ephrinAl protein in the nucleus as well as in the cytoplasm may also 
suggest the possibility that there is an active requirement for ephrinA l to be 
transported into the nucleus after translation in the cytoplasm. There are num erous
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evidence which points to a role for ephrinA as a guidance cue which leads to its 
expression in the nucleus o f various cells including thalamic nuclei and lateral 
geniculate nucleus (Uziel et al. 2002; Pfeiffenberger et al. 2005).
The possibility o f there being an antibody specificity issue was addressed in Fig. 2.19 
which shows positive control for ephrinAl as well as two negative controls (minus 
primary antibody and the use o f a specific antibody blocker). The possible issue o f 
antibody specificity was further addressed in Chapter 4 (Fig. 4.14) as well as in 
Section 4.4.5.
EphrinA3 is also a candidate for participation in neural fold adhesion and fusion. 
However, ephrinA3 mRNA and protein are not distinctly expressed at the point o f 
adhesion and fusion, but rather are expressed in a more ubiquitous manner throughout 
the PNP. Nevertheless ephrinA3 and ephrinAl could play functionally redundant roles 
in neural fold adhesion.
There are no described gene-traps or knockouts o f mouse ephrinA l, although 
ephrinAl is known to impart cell adhesive capabilities to mouse embryonic fibroblasts 
(Carter et al. 2002). EphrinAl expression is induced by tumour necrosis factor-alpha 
in human epithelial cells (Cheng & Chen 2001), and it is interesting to note that 
tumour necrosis factor receptor associated factor 4 (Traf 4) knockout mice have spina 
bifida in 40% o f homozygous null embryos (Regnier et al. 2002). Hence ephrinAl 
could play a role in mediating the effects o f T raf 4 in neural tube closure.
The ephrinA3 gene knockout does not have neural tube defects, and displays defects 
in the olfactory system (Cutforth et al. 2003). While this suggests that ephrinA3 is not 
necessary, per se, for neural tube closure, a functionally redundant role with ephrinA l 
cannot be ruled out.
Fig. 2.19 Control immunostaining for ephrinAl (detection by DAB). A, expression of ephrinAl on 
lung tissue section of adult CD1 embryo as published previously in Wohlfahrt et al. 2004 (positive control); B, 
expression o f ephrinAl at the tips o f neural folds o f E8.5 wildtype CD1 embryo paraffin section; C, negative 
control tissue (E12.5 cranial mouse embryo paraffin section); D, Rabbit anti ephrinAl from Santa Cruz is 
successfully blocked by ephrinAl blocking peptide from Santa Cruz; E, expression of ephrinAl (Santa Cruz) 
on transverse section o f whole embryo through the cranial and spinal neural tube.
The scale bar in D & E represents 0.1 mm.
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2.5.2 The function of EphA2 may be compensated by EphAl, 
EphA3, EphA4 and EphA5
Nine Eph receptors (5 EphAs and 4 EphBs) are expressed in the PNP during 
neurulation, raising the possibility that the function o f  EphA2 in PNP closure is 
compensated by numerous other Eph receptors. Although in this study, the EphBs, 
EphB2 and EphB3 were also found to be expressed in the posterior neuropore during 
E8.5 and E9.5, the possibility that suggests that ephrinA may bind and functionally 
activate the EphBs as well as the EphAs is unlikely as the one example that ephrinA 
binds to EphB (Himanen et al. 2004) is highly controversial (Dr David W ilkinson; 
personal communication).
EphA4 is the most interesting Eph receptor, next to EphA2, as it is also expressed at 
the tips o f the neural fold prior to fusion. Its expression pattern in the PNP has 
previously been described by Niederreither et al. (2000). EphA4 null mice exhibit a 
hopping gait phenotype (Dottori et al. 1998) whereas in a different EphA4 null mouse 
model, hindlimb paralysis was observed (Kullander et al. 2001). The possible role o f 
EphA4 during adhesion and fusion o f the spinal neural tube have yet to be 
investigated.
Three EphA2 gene-trap lines have been produced (Chen et al. 1996; Naruse-Nakajima 
et al. 2001; Mitchell et al. 2001). Outwardly, all three EphA2 mutants display a 
normal phenotype, apart from one study in which homozygous mutant mice have 
short and kinked tails (Naruse-Nakajima et al. 2001). The mutant mice produced by 
Mitchell et al. (2001) were subsequently studied by Guo et al. (2006) who treated 
them with the tumour-inducing agent 7,12-dimethylbenz(a)anthracene/12-<9- 
tetradecanoylphorbol-13-acetate (DMBA/TPA). The EphA2 homozygous mutant 
developed skin tumours significantly faster than their wild-type and heterozygous 
counterparts.
The possibility that these gene-trap experiments did not fully inactivate the EphA2 
protein cannot be discounted. Moreover, as several Ephs are expressed in the PNP,
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there remains the possibility that loss o f EphA2 protein, in the gene trap mutents, may 
be compensated by other Eph proteins. An EphA2 knockout was made in 2003 
(Brantley-Sieders et al. 2004), but this mouse also did not display any outward 
defects, although it was found to display impaired ephrinA l-induced angiogenesis in 
vivo.
However, the question remains as to the integrity o f  the system being dependent on 5 
possible receptors (2 o f which are known to be expressed throughout the PNP whereas 
the other 2 are expressed specifically at the point o f adhesion and fusion), it begs the 
question why only one ligand (ephrinAl) as the functional ligand for adhesion and 
fusion in the PNP considering that the ephrinA3 knockout does not result in a spina 
bifida phenotype.
The various Eph and ephrin knockouts made as published in literature as summarized 
in Table 2.7 seems to suggest that the greater number o f  Ephs which are functionally 
ablated, the greater in severity the outcome o f  the defect. This seems to not be true for 
the ephrins which have a more severe defect when a single ephrin is genetically 
ablated as opposed to two or more ephrins ablated simultaneously. Among the 
examples noted are the ephrinB2 mutant mice which exhibit the same defect as that o f 
a double Eph knockout (EphB2/EphB3) which leads to incomplete urethral 
tubularization and severe anorectal malformation (Dravis et al. 2004). The triple 
ephrin knockout o f ephrinA2, ephrinA3 and ephrinA5 do not exhibit an outward 
defect although are required for eye-specific patterning during retinogeniculate 
mapping whereas the single knockout o f ephrinA5 exhibit 17% occurrence o f  
exencephaly in its mutants (Pfeiffenberger et al. 2005; Holmberg et al. 2000). This 
may suggest the possibility that the more ephrins expressed in the PNP, the greater the 
likelihood that the PNP will not close.
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Mouse Mutations of Eph 
and ephrin Genes
Method Phenotype Anatomical Defect
EphA2 (Chen et al. 1996) Gene trap strategy -  U30- 
geo retrovirus
No obvious phenotype No anatomical defect 
detected
EphA2 (Naruse-Nakajima 
etal. 2001)
Gene trap vector - 
ROSAN 0-geo
Kinky tail Kinky tail and ectopic 
vertebrae due to splitting 
of the notochord
EphA4 (Dottori et al. 
1998)
Gene replacement pgk- 
neo of ligand binding 
domain
Kangaroo-like (ROO) 
hopping gait
Abnormal corticospinal 
tracts; absent anterior 
commissure
EphA4 (Helmbacher et al. 
2000)
Replacement vector Exon 
1; lac Z reporter fusion
Hindlimb phenotype (club 
foot) high penetrance
Loss of dorsal hindlimb 
innervation (peroneal 
nerve); absent anterior 
commissure
EphA4 (Kullander et al. 
2001a)
EphA4 knock in strategy -  
control and signalling 
mutants
Hopping gait Signalling mutants; 
abnormal hopping gait;
EphA4 (Coonan et al. 
2001)
Dottori mice backcrossed 
onto a C57BL/6 
background
Hopping gait Axon guidance defect of 
the corticospinal tract
EphA8 (Park etal. 1997) Targeted disruption Exon 
1-lac Z
No discernible phenotype Defective superior 
colliculus commissural 
projection
EphrinA5 (Frisen et al. 
1998)
Replacement vector (pgk- 
neo)
Subpopulation (17%) 
midline defect dorsal head
Abnormal topographic 
mapping
EphrinA2/ EphrinA5 (Feng 
etal. 2000)
EphrinA2/ EphrinAS 
double knockout (Frisen 
etal. 1998)
None described Abnormal mapping of the 
phrenic nerve on 
diaphragm muscle
EphrinA2/ EphrinA5 
(Feldheim et al. 2000)
EphrinA2/ EphrinA5 
double knockout
Not described Severe disruption of retro- 
ectal topographic mappinq
EphrinA5 (Prakash et al. 
2000)
EphrinA5 (Frisen et al. 
1998)
Not described Malformation of the 
functional somatosensory 
cortex
EphrinA2/ EphrinA5 
(Lyckman et al. 2001)
EphrinA2/ EphrinA5 
double knockout
Not described Abnormal retino-thalamic 
projections
EphB2 (Henkemeyer et 
al. 1996)
Replacement vector (pgk- 
neo) & extracellular 
domain-0-galactosidase 
fusion reporter
No discernible phenotype Failure of formation of 
pars posterior of the 
anterior commissure
EphB3 (Orioli et al. 1996) Replacement vector (pgk- 
neo) kinase domain
No discernible phenotype Absent corpus collosum 
(low penetrance); normal
EphB2/EphB3 (Birgbauer 
etal. 2001)
EphB2/EphB3 double 
knockout
Cleft palate with perinatal 
lethality
Abnormal pathfinding of 
retinal ganglion cells 
(RGC) within the retina
ephrinB3 (Yokoyama et 
al. 2001; Kullander et al. 
2001b)
Replacement vector 
{ephrinB3-neo)] 
extracellular domain-lacZ 
fusion receptor; 
extracellular domain 
truncated
ephrinB3-neo hopping 
gait (similar EphA4 
knockout)
Defective corticospinal 
tracts pathfinding
ephrinB2 (Wang et al. 
1988)
Replacement vector; 
extracellular domain 
replaced lacZ
Embryonic lethal E11 
(100% penetrance)
Extensive disruption of 
angiogenesis in yolk sac
Table 2.7 Mouse mutations of Eph and ephrin genes (Modified from 
Coulthard et al. 2002.
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It is interesting to note that EphAl and EphA5 at the onset o f neurulation (E8.5 and 
E9.5) are expressed throughout the neuroepithelium whereas by 24-26 somite stage, 
both genes are expressed predominantly in the hindgut region (Fig. 2.10). EphAl has 
been noted to be significantly downregulated in the epidermis o f  Get-1 (GrhB) null 
fetuses (Yu et al. 2006). EphrinAl and ephrinA3 are also both expressed 
predominantly in the hindgut region from E8.5 -  E l0.5 (Fig. 2.15 & Fig. 2.16). The 
possibility that Ephs and ephrins might be downstream o f the transcription factor 
GrhB, the putative causative gene o f the curly tail mouse phenotype, is supported by 
its similar expression pattern to EphAl, EphA5, ephrinAl and ephrinA3 in the 
neuroepithelium and hindgut region. Moreover, GrhB  is also expressed in the 
neuroepithelium and hindgut region (Dr. Nick Greene; personal communication).
2.5.3 The pattern of EphA2 expression during adhesion and 
fusion
The pattern o f expression o f EphA2 during adhesion and fusion o f the tips o f the 
apposing neural folds is highly interesting. Firstly, the expression o f EphA2 directly at 
the point o f adhesion and fusion (clearly observed on whole mount embryos) is very 
distinct as it appears as a dot. The “dot” appears as a marker for adhesion and fusion 
as it occurs irrespective o f the spatiotemporal period o f neurulation and is consistent 
in every embryo undergoing adhesion and fusion.
However, the alternating expression o f EphA2 at the tips o f  the apposing neural folds 
as observed in 10pm sections (Fig. 2.14) is controversial as the alternating expression 
between left and right tips o f the neural folds is clearer in the sections than as 
observed in the whole mount embryos. The reason behind this could be that the salt 
and pepper expression o f EphA2 in the PNP after 2 hours o f development o f  colour 
reaction during whole mount in situs perhaps does not justifiably represent what is 
seen in sections as the whole embryos meant for sectioning were developed longer in 
the colour reaction mix meant for detecting gene expression. This was a necessary 
step as the 50pm vibratome sections consistently showed asymmetrical EphA2 
expression (Fig. 2.131 & M) prior to closure. Thinner sections (10 pm) were necessary
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to investigate this phenomena further, hence the requirement for longer treatment in 
the NBT-BCIP mix.
EphA2 remains the strongest Eph candidate required for adhesion and fusion because 
o f 3 reasons. Firstly, its pattern o f expression is broad but distinct at the tips prior to 
closure and during closure. Secondly, it acts as a marker gene for adhesion and fusion 
as its expression is turned on at the point o f adhesion and fusion irrespective o f  the 
period o f neurulation and thirdly, its controversial yet highly interesting pattern o f 
alternating expression between the left and right tips seems to suggest a control 
system which may affect the levels o f ephrin(s) bound at the tips o f the neural folds 
during the spatiotemporal period o f adhesion and fusion.
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CHAPTER 3
Perturbation of Neural Tube Fusion in Embryo
Culture
I l l
3.1 Introduction
As reviewed in Chapter 1, various experiments have suggested that cell surface 
glycoproteins (Sadler 1978), specifically GPI-anchored proteins (O 'Shea & Kaufman 
1980), are required for adhesion and fusion o f the spinal neural folds. Subsequent 
studies focused on a potential role for Eph/ephrin interactions, and suggest a 
requirement for ephrinA5 and EphA7 in the cranial, but not the spinal, region 
(Holmberg et al. 2000). The aim of the present chapter was to study the possible 
function o f ephrinA proteins in the closing spinal neural tube. In Chapter 2, ephrinA 
proteins, together with their EphA receptors, were shown to be expressed in the neural 
folds during the period o f adhesion and fusion. But whether or not one or more 
ephrinA molecules play a physiological role in enabling adhesion and fusion to occur 
is unknown.
Ephrins are membrane-bound proteins that bind to Eph receptors and trigger their 
phosphorylation (Davy et al. 1999). Initially, binding o f  a specific Eph by an ephrin 
leads to the formation o f an Eph-ephrin heterodimer which is the prevalent type o f 
complex formed in solution (Himanen et al. 2001). However, Eph receptors are not 
activated by soluble monomers such that for activation, a cluster o f two Eph receptors 
and two ephrin ligands must form (Poliakov et al. 2004; Vearing & Lackmann 2005). 
Structural studies suggest that higher order clusters may also form, since the pairs o f  
dimers may associate into tetramers, in which each receptor binds two ligand 
molecules and each ligand binds two receptors (Himanen et al. 2001; Himanen & 
Nikolov 2003). Upon formation o f complexes, both ligand and receptor must be 
oriented correctly to enable the active conformation for initiation o f signalling into 
both interacting cells (Himanen et al. 2001; Himanen & Nikolov 2003).
The formation o f complexes o f varying size may allow different levels o f  activation 
following initial binding (Flanagan & Vanderhaeghen 1998; Feldheim et al. 2000). In 
the developing retina and tectum, the expression o f  EphA and ephrinA is 
complementary, whereby the expression o f EphA increases where expression o f  
ephrinA decreases. In this situation different levels o f  activation may occur,
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influenced by different levels o f expression o f the Eph-ephrin complex (Flanagan & 
Vanderhaeghen 1998; Feldheim et al. 2000).
In this chapter, I made use o f soluble Eph protein fragments in order to attempt to 
experimentally manipulate the function o f endogenous ephrinA by blocking the 
binding to the endogenous Eph receptor. This method has previously been applied to 
various systems as summarised in Table 3.1. In principal, a soluble Eph or ephrin 
protein introduced into a physiological system can bind to the corresponding 
partner(s) (Fig. 3.1). This binding o f soluble Eph/ephrin to endogenous ligands may 
suppress endogenous signalling by competing for binding with endogenous 
membrane-bound ligands and receptors (Fig. 3.1). Alternatively, in some cases it is 
possible that these soluble EphA or ephrinA reagents may activate their endogenous 
binding partners. Soluble forms o f the ligands only trigger receptor activation if  their 
concentration is high enough to cause clustering (Davis et al. 1994; Bartley et al. 
1994). At moderate concentrations, therefore, soluble ephrinA ligands are likely to act 
in a dominant negative manner, as they can bind but fail to cluster and activate EphA 
receptors (Durbin et al. 1998; Lackmann et al. 1998). However, activation o f  Eph and 
ephrin interaction occurs around a large concentration range o f  1 OnM to 20pM  when 
the complex is in soluble form (Himanen et al. 2001; Himanen & Nikolov 2003), so 
the possibility o f activation o f endogenous Eph or ephrin by exogenous reagents must 
be considered when interpreting results.
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Fused neural tube
Unfused neural tube
GPI anchor
ephrinAs a
E p h A s :
EphA3-AP: AP
Neural fold Neural fold
Fig. 3.1 Use of soluble EphAs as dominant negative tools to disrupt 
endogenous Eph/ephrin signalling. T h e  p h y s i o l o g i c a l  r o l e  o f  
e p h r i n A s ,  a n d  s p e c i f i c a l l y  e p h r i n A l ,  w a s  i n v e s t i g a t e d  b y  i n j e c t i n g  
e x c e s s  a m o u n t s  o f  E p h A 3 - A P  ( c a p a b l e  o f  b i n d i n g  t o  e p h r i n A l ,  
e p h r i n A 2 ,  e p h r i n A 3 ,  e p h r i n A 4  a n d  e p h r i n A 5 )  a n d  E p h A l - F c  ( b i n d s  
o n l y  e p h r i n A l )  f u s i o n  p r o t e i n s  i n t o  t h e  a m n i o t i c  s a c .  E n d o g e n o u s  
e p h r i n A s  ( s h o w n  a s  p i n k  b l o c k s  a b o v e )  o n  t h e  n e u r a l  f o l d s  a r e  
p r e v e n t e d  f r o m  b i n d i n g  t o  e n d o g e n o u s  E p h A  r e c e p t o r s  ( s h o w n  i n  
g r e e n )  o n  t h e  c e l l  s u r f a c e .
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Eph/ephrin Organism Inhibitor Function of 
Inhibitor
R esult o f  
experim ent
R eference
EphrinA5 Chick Pyrazolopyrimidine
(PP2)
Inactivates
Src-family-
kinases
Abolishes EphA- 
mediated repulsive 
axon guidance
Knoll &
Drescher
2004
EphrinA5 Xenopus ephrinA5-Fc
EphrinAs 
repel or attract 
retinal axons 
depending 
upon either 
type of 
substratum 
bound to or 
substrate 
immersed in
EphrinAs able to 
guide axons in 
immobilized bound 
form as well as in 
the form of soluble 
molecules
Weinl et al. 
2003
EphrinA2 Chick MAb B3 (Function- 
blocking 
monoclonal 
antibody raised 
against chick 
ephrinA2)
Blocks 
function of 
chick 
ephrinA2
EphrinA2 
contributes to the 
establishment of 
the chick 
retinotectal 
projection
Yamada et al. 
2001
EphrinA5
EphA6
Mouse EphA-Fc laminin Attracts axons EphA attracts 
vomeronasal axons
Knoll etal. 
2001
EphrinA2 Chick PIPLC Cleaves GPI-
anchored
molecules
Differential ligand 
expression on 
retinal axons 
determines 
retinotectal 
projection
Hornberger et 
al. 1999
EphrinA5
EphrinA2
Chick EphrinA2-AP
EphrinA2-myc
Blocks striped 
outgrowth of 
retinal axons
Dimeric ephrinA 
induces EphA 
receptor 
phosphorylation
Ciossek et al. 
1998
Table 3.1 Blocking experiments and stripe assays used to investigate the 
function of Ephs and ephrins
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3.2 Materials and Experimental Procedures
All materials were obtained from Sigma unless specified. This section describes the 
various steps required to study the effects o f exogenous substances on whole embryos 
in vitro.
3.2.1 Whole Embryo Culture
Mice were killed by cervical dislocation at E8.5 and the uterus was explanted into 
Dulbecco’s Modified Eagle's Medium (Gibco BRL) containing 10 % FCS (Sigma). 
Embryos contained were explanted from the maternal decidua with an intact visceral 
yolk sac and ectoplacental cone, and placed in pre-warmed rat serum (prepared 
according to Cockroft 1990, see below) at 38°C. Culture tubes were filled with a gas 
mixture containing 5 % oxygen, 5 % carbon dioxide and 90 % nitrogen and incubated 
at 38°C in a roller bottle incubator. Embryos were allowed to recover over a 1 hour 
period o f culture before microinjection was performed. After microinjection, embryos 
were re-gassed (with the same mixture as above) and returned to the incubator.
3.2.2 Preparation of Rat Serum
Wistar rats were anaesthetised using diethyl ether and then dissected to reveal the 
dorsal aorta. A 21 gauge needle attached to a 20 ml syringe was inserted into the 
dorsal aorta and blood was extracted. The diaphragm was punctured to ensure the rat 
could not survive post-operation. The extracted blood was immediately centrifuged 
for 5 minutes at 4000 rpm. The blood which had by then separated into plasm a and 
red blood cells was left at room temperature to allow clotting. The resulting fibrin clot 
was then squeezed to allow a maximal amount o f serum to be collected. Serum was 
removed and centrifuged again for 5 minutes at 4000 rpm to remove any residual 
blood cells. Serum was then heat inactivated at 56°C for 30 minutes, and allowed to 
cool to room temperature before aliquoting into bijoux tubes for storage at -20°C.
1 1 6
3.2.3 Preparation of Microinjection Solutions
Whole embryo culture has been used as a screening technique for teratogens since the 
1980s (Sadler et al. 1982). Different methods for delivering substances to the cultured 
embryo include (a) in the serum, (b) injection into amniotic cavity (c) injection into 
yolk sac circulation. In the present study, the aim was to deliver PIPLC enzyme or 
Eph fusion proteins directly to the neural fold cell surface. Since exposure to PIPLC 
via the culture medium was suspected to be toxic to rodent embryos (O ’Shea & 
Kaufman 1980), it was decided to inject PIPLC directly into the amniotic cavity in 
order to bypass the yolk sac. This maximised the chance o f  embryos developing a 
healthy yolk sac circulation which is essential for growth and development o f  embryos 
in culture (Cockroft 1990).
A food colouring agent, Fast Green was used (0.5% solution) as an injection marker, 
with phosphate buffered saline (PBS) as the diluting agent for the enzyme or fusion 
protein. 1 to 2 pi o f this solution was injected into the amniotic sac (Fig. 3.2A). 
Embryos were discarded if  most o f  the injected substance was not retained in the 
amniotic sac, or if  there was significant leakage from the yolk sac. Microinjections 
were performed using a hand-held microinjection pipette made o f 1 mm glass 
capillary, pulled using a model P-87 Flaming/Brown micropipette puller (Sutter 
Instrument Co.). Needle tips were positioned in the amniotic cavity by traversing the 
visceral yolk sac and amniotic membrane (Hartig & Hunter III 1998).
Solution volumes for microinjection were calculated as follows. The average volume 
o f liquid in the amniotic sac o f an E8.5 (6-8 somite) embryo was assumed to be 5 pi. 
Therefore:
Volume to be injected, in pi = 5 x Desired molarity in amniotic sac 
Molarity o f stock solution
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3.2.4 Calculation of concentrations of PIPLC, EphA3-AP, 
EphAl-Fc and ephrinA1-Fc
PIPL C  (0.8 mg) was resuspended in 100 pi o f  10 mM TrisHCl pH 7.4 to make a 
stock o f 5 U o f enzyme. A 10 pi aliquot o f stock was added to 20 pi o f  0.25 %. Fast 
Green dye stock plus 70 pi PBS to make a working solution o f  0.005 U o f  PIPLC. The 
final working solution o f  Fast Green dye in PBS was 0.05 %. The embryos were 
injected with various doses o f  PIPLC from 0.0005 U to 0.01 U as shown in Table 3.2.
EphA3-AP fusion protein (gift o f  Dr. Uwe Drescher) was supplied at a concentration 
o f 30 nM and diluted to a working concentration o f  15 nM in PBS, 0.5 % Fast Green. 
The volume injected was calculated to be 2.5 pi in order to produce a final 
concentration o f 15 nM EphA3-AP in the amniotic sac. The same principle was 
applied to the control sample which comprised 25 nM alkaline phosphatase (AP), PBS 
and 0.5 % Fast Green. The volume injected was 3 pi in order to achieve a final 
concentration o f 15 nM AP in the amniotic sac.
E phA l-F c (R & D Systems) fusion protein was prepared as a 47.6 pM  stock solution 
by adding 50 pi o f PBS to 0.2 mg o f  the fusion protein (molecular weight o f the 
monomeric protein is 84 kDa). A volume o f  72.6 pi o f  0.5 % Fast Green was added to 
1 pi (47.6 pM) o f  the stock solution o f  E phA l-Fc fusion protein. A volume o f  652.4 
pi o f PBS was then added to the mixture to make a final concentration o f  0.05 % Fast 
Green in the working solution. Using the formula in section 3.2.3, it was calculated 
that 1 pi EphA l-Fc fusion protein needed to be injected into the amniotic sac in order 
to give a final concentration o f  13 nM. The control sample, Fc peptide (R & D 
Systems; 0.1 mg with molecular weight o f  26.6 kDa), was mixed with PBS and 0.5% 
Fast Green and a 1.3 pi volume was injected into the amniotic sac, in order to achieve 
a final concentration o f 13 nM.
E phrinA l-F c  fusion protein (R & D Systems) was prepared as a stock solution o f
85.4 pM by adding 50 pi o f  PBS to 0.2 mg o f  fusion protein (molecular weight o f  the 
monomeric protein is 46.8 kDa). A volume o f 170.8 pi o f  0.5 % Fast Green was 
added to 1 pi o f the stock solution, and 1536.2 pi o f  PBS was then added to achieve a 
final concentration o f 0.05 % Fast Green. 1 pi o f  ephrinA 1-Fc fusion protein was
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injected into the amniotic sac to achieve a final concentration o f  10 nM EphA l-Fc. 
Similarly, 1 pi Fc was injected in order to give a final concentration o f  10 nM in the 
amniotic sac.
Substance Injected Concentration (Volume in brackets)
PIPLC 0.0005 U (1.0 pi), 0.001 U (2.0 pi), 0.005 U 
(1.0 pi), 0.01 U (2.0 pi)
EphA3-AP 10 nM (2.1 pi), 15 nM (2.5 pi)
AP 10 nM (2.5 pi), 15 nM (3.0 pi)
EphA1-Fc 10 nM (0.8 pi), 13 nM (1.0 pi)
Fc 10 nM (1.0 pi), 13 nM (1.3 pi)
ephrinAl-Fc 10 nM (1.0 pi)
Table 3.2 List of substances injected into amniotic cavity of E8.5 CD1 mouse 
embryos.
3.2.5 Assessment of embryos after culture
Yolk sac circulation was scored as an indicator o f embryo health. Yolk sac scores 
were: 3, for a smooth yolk sac exterior, with vigorous circulation and vascularisation 
throughout the yolk sac; 2, for a smooth yolk sac exterior, with extensive 
vascularisation and good circulation, albeit with slightly slower blood movement than 
grade 3; 1, where the circulation was evident only in certain regions o f  the yolk sac; 0, 
for embryos without any yolk sac circulation. Embryos were only included in the 
analysis if  they had a yolk sac circulation between 2 and 3, while embryos with a 
score o f 1 or 0 were discarded from further analysis.
Crown rump length was measured as shown in Fig. 3.2B, as an indicator o f  embryo 
growth. Embryos were injected at the 6 to 8 somite stage and were cultured for 8 
hours. At the end o f  the culture period, embryos typically had developed to the 10 to 
12 somite stage, and were still in the unturned conformation, although in some cases 
embryos were more advanced and had turned.
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3.2.6 Measurements and Statistical Analysis
Embryonic measurements (posterior neuropore length and crown rump length) were 
taken with an eyepiece graticule on a Zeiss SV6 microscope. The measurements were 
in graticule units. In order to express distances in mm, the graticule units were divided 
by 100, then multiplied by length in mm corresponding to the objective zoom position 
as listed in Table 3.3. The comparison o f posterior neuropore length between treated 
and untreated embryos was performed using SigmaStat and SigmaPlot (SPSS Inc).
Magnification of objective mm corresponding to 100 graticule units
0.8 12.5
1.0 10.0
1.2 8.33
1.6 6.25
2.0 5
2.5 4
3.2 3
4.0 2.5
5.0 2
Table 3.3 Length of measurement corresponding to desired objective zoom 
position.
3.2.7 Receptor affinity probe (RAP) assay (modified from 
Knoll etal. 2001)
Embryos were dissected free o f extra-embryonic membranes and placed in a 1:1 ratio 
o f OCT and PBS until they sank to the bottom o f the tube. The mixture was replaced 
by 100 % OCT, for equilibration, and then the embryos were orientated in plastic 
moulds. The mould was snap-frozen in liquid nitrogen for 5 seconds and the frozen 
moulds were stored at -80°C.
Prior to sectioning, the frozen block containing the embryo was removed from the 
mould and left in the cryostat chamber for 20 minutes with the cutting blade and
120
plastic Perspex in place, to allow equilibration o f  temperature o f  all the required 
instruments. The temperature o f  the chamber was set at -25°C and the specimen 
temperature was set at -20°C. The equilibrated block was then mounted on a metal 
chuck using OCT and frozen rapidly using Quick freeze spray (Bright). The cryostat 
was set to cut 15 pm sections and the block was sectioned. The sections were 
collected on Superfrost plus slides and stored in an airtight box at -80°C.
The basis o f the RAP assay is that a soluble receptor ectodomain with a tagged C- 
terminus is used as a probe to detect the localization o f  endogenous ligands. In this 
case an Eph A3 fragment with heat-stable human placental alkaline phosphatase (AP) 
as a C-terminus tag (Flanagan et al. 2000) was used to detect ephrin binding sites.
Sections were re-hydrated for 10 minutes in HBHA (0.5 mg/ml BSA, 0.1 % sodium 
azide, 20 mM Hepes pH 7.0 in Hanks Balanced Salt Solution), incubated with 30 nM 
EphA3-AP fusion protein in HBHA for two hours, and then rinsed 4 times in HBS (20 
mM Hepes pH 7.0 and 150 mM NaCl) for 5 minutes each. The sections were fixed for 
90 seconds in 60 % acetone, 3.7 % formaldehyde and 20 mM Hepes pH 7.0 and then 
washed 6 times (five minutes each) in HBS. Endogenous AP was inactivated by 
incubating slides at 65°C for 1 hour. EphA3 fragment tagged with placental alkaline 
phosphatase, which is not affected by the 65°C heat-inactivation step, enabled specific 
detection o f binding partners to EphA3. Sections were then equilibrated for 10 
minutes in AP buffer (0.1 M Tris HC1 pH 9.5, 0.1 M NaCl, 5 mM M gCb in MilliQ 
water), and NBT-BCIP mix in AP buffer was added to the sections, which were 
incubated in the dark for colour development.
3.2.8 Receptor Affinity Probe Whole Mount Embryos
Embryos were dissected free o f extra-embryonic membranes in ice-cold HBSS. The 
samples were dehydrated by successive 20 minute washes in 25 % methanol followed 
by 50 %, 75 % and 100 % methanol. The samples were incubated further in 100 % 
methanol overnight. The next day, the embryos were re-hydrated in 70 % methanol 
followed by 50 % and 30 % methanol for 15 minutes each. The embryos were then
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washed in buffer 3 (HBSS with 20 mM HEPES-pH 7.0 and 0.5 mg/ml BSA) 3 times 
for 10 minutes each. Next, the embryos were incubated overnight with the EphA3-AP 
fusion protein (30 nM) on a shaker at 4°C. The following day, the embryos were 
washed 6 times for 10 minutes each in buffer 3 and then fixed in 4 % PFA for 3 
minutes. This was followed by washing 3 times in buffer 4 (HBSS with 20 mM 
HEPES pH 7.0 and 150 mM NaCl). Endogenous alkaline phosphatase was inactivated 
by incubating the embryos at 65°C for 25 minutes. The embryos were then 
equilibrated in AP buffer and alkaline phosphatase activity was revealed using 
NBT/BCIP.
3.3 Results
3.3.1 Removal of GPI-anchored molecules delays PNP 
closure
Non-mutant CD1 mouse embryos were cultured in varying concentrations o f  PIPLC 
for 8 hours. Treatment with PIPLC to remove GPI-anchored ephrinA ligands from a 
diverse array o f  tissues has been previously reported (Monschau et al. 1998; 
Hornberger et al. 1999). M icroinjection o f  PIPLC into the amniotic cavity resulted in 
a longer and wider PNP (Fig. 3.2 D & F). The cranial region o f  the developing 
embryo also appeared to be wider after PIPLC treatm ent (Fig. 3.2D). In contrast, the 
somites and other aspects o f  PIPLC-treated embryos appeared unaffected.
Two sets o f PIPLC infection experiments were performed at different times (Figs. 3.3, 
3.4). In the first experiment, PIPLC was injected in a total volume o f 1 pi (0.0005 U 
and 0.005 U doses) while in the second experiment the total injection volume was 2 pi 
(0.001 U and 0.01 U). Figs. 3.3 and 3.4 depict the two sets o f  PIPLC -injected 
embryos by different coloured histogram bars to indicate this m ethodological 
difference.
Student’s t-test was used to evaluate the statistical significance between PIPLC-treated 
and PBS-treated control embryos. At concentrations o f  0.005 U and 0.01 U, PIPLC
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caused an increase in the length o f  the PNP (Fig. 3.2 D & F). At the dose o f 0.005 U, 
PIPLC had no effect on crown rump length or somite number, compared to control 
embryos (PBS/FG) (Fig. 3.3 C & E), whereas embryos treated with 0.01 U PIPLC 
suffered significant growth retardation in comparison to control embryos as seen in 
the mean crown rump length graph (Fig. 3.4B).
The PNP o f  PIPLC-treated embryos was observed to be wider, as well as longer, than 
in the control embryos (Fig. 3.2F). In order to determine whether PIPLC had altered 
the relationship between PNP length and width, linear regression graphs were plotted 
to analyse the relationship between closure length and width o f  the PNP under PIPLC 
and control conditions (Fig. 3.3B). The gradient o f the length vs.width graphs differed 
between the PIPLC-treated and control embryos. Therefore, the length and width o f 
the PNP were not found to be correlated between the PIPLC-treated and control 
embryos. This suggests that, as the increase in PIPLC-treated PNP length occurs, the 
width increases even more. Therefore, the relationship between the length and width 
appears to be perturbed in PIPLC-treated embryos, suggesting a greater effect on 
width than length.
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Fig.3.2 Microinjection of PIPLC affects PNP closure in whole embryo culture. A, Whole embryos 
with intact yolk sac, amniotic sac and ectoplacental cone that had received intra-amniotic 
injections o f PIPLC plus fast green dye as an injection marker; B, The position at which crown- 
rump length was measured is denoted by the length o f arrow in schematic diagram of an E8.5 
embryo which has yet to turn at the end o f the culture period (10-12 somite stage) and an E9.5 
embryo after it has turned (12-15 somite stage); C, Typical embryo after culture following 
injection o f PBS/Fast Green; D, Typical example o f an embryo after culture following treatment 
with 0.005 U PIPLC; E, F, Magnified images of PNPs in C and D respectively.
Scale bar: 0.5 mm
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Fig. 3.3 Posterior neuropore analysis after treatment with PIPLC.
A, Dose response effect o f PIPLC. Numbers in bars indicate 
sample size. Values indicate means + standard error. Asterisks 
indicate a statistically significant difference between treated 
(PIPLC) and untreated (control) embryos (Student’s /-test); B, 
linear regression graphs o f posterior neuropore width upon 
posterior neuropore length. PIPLC-treated embryos (black dots) 
are longer and wider compared to control embryos (white dots). 
Red line indicates best fit linear regression line through PIPLC- 
treated embryos (y=0.32x + 0.15) and black line indicates best fit 
linear regression line through control embryos (y=0.56x-0.015).
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Fig. 3.4 Somite n u m b er (A) and  crow n rum p  length (B) a fte r tre a tm e n t
w ith PIPLC .
PIPLC  trea tm en t a t a  dose o f  0 .005 U , w h ich  cau ses  a  lo n g er and  w id e r P N P  
(Fig. 3 .3A ), does n o t a ffec t em bryon ic  size (c ro w n  ru m p  len g th ) o r stage  o f  
deve lopm en t (num ber o f  som ites). N um b ers  in  b a rs  sh o w  sam p le  size . V a lu es  
ind ica te  m ean  + standard  error. A ste risk s  in d ica te  s ta tis tica l s ig n ifican ce  
be tw een  trea ted  (P IP L C ) and u n trea ted  (co n tro l)  e m b ry o s  (S tu d e n t’s t-test).
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Fig. 3.5 Whole embryo culture with PIPLC does not affect the formation of MHP but removes ephrinAs from the
neuroepithelium. A, PBS treated  control em bryo w ith  in tact M H P (arrow ) at E8.5; B, P IPL C -treated  em bryo also has 
in tact M H P at E8.5; C, eph rinA l is d istinctly  expressed at the tips o f  the  neural folds o f  m ore advanced  (M ode 2) PBS 
control em bryo (red arrow heads); D , expression o f  eph rinA l is absent from  the neuroepithelium  o f  P IPL C -treated  
em bryo; E, R A P assay for ephrins is positive in the neuroepithelium  on  cryosection o f  PB S-treated  control em bryo; F, 
RA P assay is negative on cryosection o f  P IPL C -treated  em bryo; G, w hole m ount R A P assay (fo llow ed b y  sectioning) 
show s positive signal on neuroepithelium , especially  the apical surface, o f  PB S-treated  control em bryo; H , w hole 
m ount R A P assay gives m uch less in tense signal in P IPL C -treated  em bryo.
ne: neuroepithelium  
nt: notochord
Scale bar in  A-F: 0.1 m m  
Scale bar in G  & H: 0.03 m m
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Since embryos mostly had 10-12 somites at the end o f the culture period, they were 
expected to exhibit Mode 1 morphology in the PNP, in which a median hinge point 
(MHP) but not dorsolateral hinge points (DLHPs) are present (Shum and Copp, 1996) 
(Fig. 3.5B). This was studied in embryos that had been sectioned and stained with 
haematoxylin and eosin. Both control and PIPLC-treated (0.005U) embryos exhibit a 
clearly-formed MHP (Fig. 3.5A, B), showing that increased length o f  PNP in PIPLC- 
treated embryos cannot be attributed to a lack o f  MHP formation or maintenance.
Use o f the RAP assay shows that PIPLC does indeed cleave o ff GPI-anchored 
proteins. No expression whatsoever o f any o f the 5 possible ephrinAs that could be 
recognised by the EphA3-AP probe was detected by the assay in PIPLC-treated 
embryos, whereas PBS-treated controls yielded a strong signal (Fig. 3.5 E-H). The 
morphology o f RAP assayed cryosections was poor as they could not be well 
preserved (Fig. 3.5 E & F), all fixatives having proven to interfere with the assay (see 
Discussion). Nevertheless whole mount RAP assayed embryos gave a similar result as 
the cryosections (Fig 3.5 G, H). Moreover, the experiment was repeated using 
immunohistochemistry for ephrinA l, which showed a lack o f  expression in an 
advanced (Mode 2-stage) PIPLC-treated embryo (Fig. 3.5 D.) In contrast, control 
sections from a Mode 2-stage PBS-treated embryo displayed expression o f ephirinA l 
throughout the neural plate, and particularly at the tips o f  the neural folds (Fig. 3.5 C). 
Hence, PIPLC, which has a specific effect in delaying PNP closure when used at 
0.005 U, can be seen to remove GPI-anchored ephrins from the neural plate surface.
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3.3.2 Injecting exogenous EphA3-AP fusion protein 
delays posterior neuropore closure
In order to investigate a possible role for GPI-anchored ephrins in adhesion and fusion 
o f the neural folds, an EphA3-AP fusion protein was used as a tool to manipulate the 
binding capabilities o f the ephrins, as explained schematically in Fig. 3.1. EphA3-AP 
was injected into the amniotic cavity o f E8.5 CD1 embryos at two concentrations (10 
nM and 15 nM). After 8 hours incubation, PNP closure was significantly affected in 
comparison to control embryos that were injected with the same concentration o f  AP 
(Fig. 3.6 A-D). Embryos treated with both 10 nM and 15 nM concentrations o f  
EphA3-AP show longer PNPs than AP-controls although only 15 nM produces a 
statistically significant difference (Fig. 3.7). In contrast, EphA3-AP (15 nM) had no 
effect on crown rump length or somite number compared to control embryos (Fig. 3.8 
A & B) arguing for a specific effect on PNP closure, and not a general retarding effect 
on the entire embryo.
EphA3-AP treated embryos were sectioned and stained with haematoxylin and eosin. 
At the E8.5 stage, a clearly formed MHP was present, as in AP-treated controls (Fig. 
3.6 E, F) while in more advanced embryos both M HP and DLHPs were clearly visible 
(Fig. 3.6 G, H). Expression o f  ephrinAl in Fig. 3.5C (sections through PNP o f control 
embryos) was detected in the nucleus as well as in the cytoplasm whereas expression 
o f ephrinAl in sections through the PNP o f  PIPLC treated embryos was hardly 
detectable. This would suggest that removal o f  ephrinA molecules from the surface o f 
the neuroepithelium had occurred after treatm ent with PIPLC enzyme. Further 
discussion o f the binding specificity o f  the Eph and ephrin antibodies is included in 
Section 3.4.2 and Section 4.4.5.
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Fig. 3.6 Microinjection of EphA3-AP delays PNP closure in whole embryos cultured for 8 hours, but does not 
affect formation of MHP and DLHPs. A, typical em bryo in jected  w ith  alkaline phosphatase pro tein  (AP); 
B, typical em bryo in jected  w ith EphA 3-A P; C, D, m agnified im ages o f  PN P in A and B respectively. N ote 
the enlarged PN P in the E phA 3-A P treated  em bryo; E, F, E phA 3-A P treated  em bryos have an intact M H P 
(vertical arrow s) w ith a closely sim ilar appearance to A P-treated  control em bryos (E); G, H, E phA 3-A P 
treated  em bryos have intact M H P and D L H Ps (oblique arrow s) at E9 (H), as do A P-treated  controls (G).
Scale bar in A & C: 0.5 m m  
Scale bar in E: 0.1 m m
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Fig. 3.7 Posterior neuropore length after treatm ent with EphA3-AP.
Embryos treated with 15 nM EphA 3-A P exhibit a significantly longer 
posterior neuropore than AP controls. N um bers on bars show sam ple 
sizes. Bar values indicate mean + standard error. A sterisk indicates 
statistical significance between treated (EphA 3-A P) and control (AP) 
embryos (S tudent’s /-test).
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Fig.3.8 Crown rump length and somite count after treatm ent with EphA3-
AP. A & B, EphA3-AP treatm ent does not affect size (crown rum p 
length) or stage o f  developm ent achieved (num ber o f  som ites) by 
embryos in culture. Num bers on bars show sam ple sizes. Values 
indicate mean + standard error.
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3.3.3 Injecting exogenous EphAl-Fc fusion protein 
results in an enlarged posterior neuropore
In Chapter 2, ephrinAl was found to be expressed in the PNP, specifically at the point 
o f adhesion and fusion. EphrinAl is unique as being the only ligand that binds to 
EphA l. By adding exogenous EphA l fusion protein into the PNP o f  cultured embryos 
therefore, the expectation was that there would be a specific effect, mediated through 
binding o f ephrinA l. The fusion protein EphA l-Fc was injected at 13 nM 
concentration into the amniotic cavity o f  E8.5 CD1 embryos using injections o f  Fc 
fragment alone as a control. After 8 hours o f  incubation, PNP closure was markedly 
delayed in EphA l-Fc treated embryos compared with the PNP o f  Fc-treated control 
embryos (Fig.3.9 A-D). Statistical analysis shows a significant difference (P= 0.004) 
between PNP lengths o f EphA l-Fc and control embryos at 13 nM  concentration (Fig. 
3.11).
Despite this effect on PNP closure, EphA l-Fc treatment had no effect on crown rump 
length or somite number compared to control embryos (Fig. 3.9 A-D). Moreover, 
both MHP and DLHPs were present in EphA l-Fc treated embryos, arguing for a 
specific effect o f EphA l-Fc on neural fold adhesion/fusion in this study.
3.3.4 Treatment of cultured embryos with ephrinA 1 
fusion protein
In a 'reciprocal' experiment, ephrinA l-Fc fusion protein was applied to E8.5 embryos. 
After 8 hours o f incubation in 10 nM ephrinA 1-Fc, PNP length was not significantly 
affected compared to the PNP o f  control embryos that were injected with the same 
concentration o f Fc protein (Fig. 3.13). Crown-rump length and somite number were 
not significantly affected by exposure to ephrinA 1-Fc (Fig. 3.14 A, B).
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Fig. 3.9 M icroinjection of E phA l-F c delays PN P closure in em bryos cu ltu red  fo r 8 
hours. E m bryos trea ted  w ith  13 nM  E p h A l-F c  ex h ib it a  m ark ed ly  lo n g er P N P  
than  Fc-treated  contro ls. A , typ ica l exam ple o f  em bryo  in jec ted  w ith  Fc; B, 
typ ical exam ple o f  em bryo in jec ted  w ith  E p h A l-F c ; C , D , m ag n ified  im ag es  o f  
PN P in A  and B respectively .
Scale bar in A  & C: 0.5 m m
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Fig. 3.10 Haematoxylin and eosin stained sections of two different EphAl-Fc treated embryos at the 16 
somite stage (Mode 2). E phA l treatm ent does not perturb  form ation o f  either the M H P (arrow s) or 
D LH Ps (arrow heads). A, E, sections are slightly  oblique, giving the asym m etrical appearance o f  the 
D LH Ps. C audal sections are on the left, and rostral on  the right.
Embryo 2 Embryo 1
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Fig. 3.11 P o ste rio r n eu ro p o re  length  a f te r  tre a tm e n t w ith  E p h A l-F c . A,
Embryos treated with 13 nM E phA l-F c (light green bar) develop a 
significantly longer PNP than control em bryos treated w ith Fc alone 
(dark green bar). Num bers on bars show sam ple sizes. V alues are m ean 
+ standard error. Asterisk indicates a statistically significant difference 
between treated (E phA l-Fc) and control (Fc) em bryos (S tuden t’s t- 
test).
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Fig. 3.12 C row n ru m p  length and  som ite n u m b e r  a f te r  t re a tm e n t  w ith  
E p h A l-F c . T h e r e  i s  n o  s i g n i f i c a n t  e f f e c t  o n  e i t h e r  p a r a m e t e r ,  
c o m p a r i n g  E p h A l - F c  t r e a t e d  e m b r y o s  w i t h  F c  t r e a t e d  c o n t r o l s .  
N u m b e r s  o n  b a r s  s h o w  s a m p l e  s i z e s .  V a l u e s  i n d i c a t e  m e a n  +  s t a n d a r d  
e r r o r .
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Fig. 3.13 P o s te rio r n eu ro p o re  c losure  is no t a ffec ted  s ig n ifican tly  by 
tre a tm e n t w ith e p h rin A l-F c . A, Em bryos treated w ith 10 nM  
ephrinA 1-Fc or with the same concentration o f  Fc as control. N um bers 
on bars show sample sizes. Values are m ean +  standard error. 
Statistical comparison is non-significant (p > 0.05).
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Fig. 3.14 C row n rum p  length and  som ite n u m b e r  a f te r  t re a tm e n t  w ith  
e p h rin A l-F c . There is no significant effect on either param eter, 
comparing EphrinA 1-Fc treated em bryos w ith Fc treated controls. 
Numbers on bars show sample sizes. Values indicate m ean + standard 
error.
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3.4 Discussion
EphrinAl appears a strong candidate to play a role in adhesion and fusion o f the spinal 
neural tube based upon three critical experiments as reported in this chapter. Firstly, 
ephrinAs o f  which ephrinA l is a member are apparently removed by PIPLC treatment 
which causes delay o f  PNP closure in whole embryo culture. Secondly, closure o f the 
spinal neural tube is delayed in cultured embryos treated with EphA3-AP fusion 
protein treated embryos. Since EphA3 binds to all 5 ephrinAs, this makes ephrinAl a 
possible candidate for functional involvement. Finally, closure o f the spinal neural 
tube is delayed in EphA l-Fc fusion protein-treated embryos. Because EphAl binds 
specifically to ephrinA l, and yet is still able to retard PNP closure, this finding 
strongly implicates ephrinA l as functionally the most important ephrinA in neural 
fold adhesion and fusion.
3.4.1 GPI-anchored proteins are required for PNP closure
Treatment o f cultured mouse embryos with 0.005 U o f  phosphatidylinositol 
phospholipase C (PIPLC) caused PNP enlargement in the present experiments. An 
enlarged PNP at E9.5-E10.5 indicates a markedly increased risk o f an embryo 
eventually developing spina bifida as growth progresses (Copp et al. 1990; Copp et al. 
2003). In the present study, it is difficult to predict whether PIPLC-treated embryos 
would have developed spina bifida as the PIPLC effect was not permanent. The rate o f 
PNP closure normalised as the enzyme diffused out o f the amniotic sac and/or was 
degraded.
PNP width also increased following PIPLC treatment, raising the question o f  whether 
PIPLC specifically affects PNP width independently o f  PNP length, or whether the 
increase in PNP width is merely a secondary effect o f increased PNP length. The 
linear regression graph plotted to address these possibilities shows that the increased 
PNP width is dependent upon PNP length. Hence, the occurrence o f  a very wide PNP 
in 10-12 somite stage PIPLC-treated embryos at the end o f  the culture period appears 
to be a secondary effect o f  delay in PNP closure.
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GPI-anchored molecules are specifically cleaved o ff the neuroepithelial cell surface 
by PIPLC as shown by use o f  the receptor affinity probe (RAP) assay. Preservation o f 
embryos by fixation is a crucial step in obtaining good m orphology in sectioned 
embryos, but it was found that fixation in 4 % glutaraldehyde adversely affected the 
RAP assay. Similarly, the assay did not work in embryos that were fixed in 4 % 
paraformaldehyde, as also observed in previous experimental work (Dr. Andrew 
Stoker, personal communication). Moreover, it was particularly difficult to 
cryosection very immature embryos (E8.5) due to their small size, m aking it alm ost 
impossible to discern the presence and position o f  the tissue once frozen in OCT. 
Hence, conclusions drawn in the RAP section assay must be considered tentative, as 
the morphology o f  embryos was poor. On the other hand, whole m ount RAP 
straining, and immunohistochemistry for ephrinA l, confirmed that surface GPI- 
anchored proteins are removed by PIPLC treatm ent.
3.4.2 ephrinA ligands are required for PNP closure
The whole mount RAP assay also suggested that ephrinAs are localised on the apical 
membrane o f neuroepithelial cells. However, although this assay is predicted to show 
localisation o f  ephrinA proteins there were some differences to the results obtained 
using antibodies against ephrinA l and ephrinA3 (Chapter 2). In particular, 
immunohistochemical analysis showed ephrinA l and A3 proteins were localised at 
the tips o f  the neural folds (Fig. 2.17, 2.18 and 3.5C), whereas the RAP assay detected 
ephrinAs all along the neuroepithelium  except the tip. The failure to detect ephrinAs 
at the tips o f  the neural folds by RAP assay could possibly be explained by co­
expression and binding o f  EphA receptors and ephrinAs at these sites (Sobieszczuk & 
W ilkinson 1999). In such a situation the Eph binding site on ephrinA would be 
occupied, thereby masking the site for the RAP probe. The ephrins expressed at the 
tips (ephrinAl and ephrinA3) are most likely bound to one or more o f  the EphAs 
(EphA l, EphA2, EphA3, EphA4 and EphA5) expressed in the neuroepithelium . Thus, 
EphA3-AP fusion protein failed to detect ephrinAs (ephrinA l and ephrinA3) at the 
tips o f the neural folds as the ephrinAs were bound to their respective Eph partner. 
The possibility o f  the EphA fusion receptor binding to other m olecules apart from 
ephrinAs also could not be discounted. Recent unpublished work in other laboratories
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has shown that the Trk group o f  m olecules (TrkA and TrkB) interact with ephrinA 
molecules (Dr. Uwe Drescher, personal comm unication).
In order to determine the function o f  ephrinAs in neural tube closure, the EphA3-AP 
fusion protein was used. EphA3-AP, like PIPLC, delayed neural tube closure, as 
shown by an enlarged PNP. EphA3-AP fusion protein most likely blocks the function 
o f ephrinAs expressed endogenously on the neuroepithelium  by preventing binding o f  
ephrinA to endogenous EphA. It is unlikely that the fusion protein activates ephrinAs 
as the alkaline phosphatase protein is unable to dim erize and would not be able to 
cluster, such that activation o f  endogenous ephrin is unlikely to occur. This finding 
suggests that ephrinAs play a physiological role in neural tube closure. Since EphA3 
binds to all 5 ephrinAs (see Chapter 1), this result is consistent with the possibility that 
any o f  the 5 ephrins m ight be functional during neurulation.
PIPLC treated em bryos were also observed to have weaker staining, including what is 
presumably background in the nuclei (Fig. 3.5). The reason for this may be that the 
PIPLC treatm ent is severe (PIPLC has a severe effect on embryos which is why short 
culture experim ent was done) which may well make sections from PIPLC treated 
embryos not o f  the best quality to do imm unohistochem istry. This m ay have then led 
to the imm unohistochem ical staining in this case to be sub-optimal and it is therefore 
difficult to resolve the discrepancy in the results.
The specificity o f  the ephrinA l antibody was ascertained to be o f  good quality based 
upon control experim ents done in Chapter 2 (Fig. 2.19). Im m unoelectron m icroscopy 
o f ultra-thin sections in Chapter 4 (Fig. 4.11 & Fig. 4.14) also further support the 
binding specificity o f  both EphA2 and ephrinA l antibodies as explained in Section 
4.4.5.
3.4.3 ephrinAl is required for PNP closure
The most important finding o f  this chapter was that E phA l-Fc delays PNP closure. 
EphrinAl is the only known ligand which can activate EphA l fully (Gale et al. 1996;
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Coulthard et al. 2001). Indeed, surface plasm on resonance using soluble recom binant 
and native EphA l has identified ephrinA l as the highest affinity ligand for this 
receptor (Coulthard et al. 2001; Lickliter et al. 1996). M oreover, Parri et al. (2005), 
who also utilized EphA l fusion protein in cell culture, found that ephrinA l-expressing 
cells retracted after interacting with the binding partner E phA l, suggesting a true 
inhibition o f  cell function after binding to soluble EphA l fusion protein. Hence, this 
experiment strongly im plicates ephrinA l as a key functional molecule in PNP closure. 
Moreover, perturbing ephrinA l function with excess EphA l did not exhibit a 
detrimental effect on neurulation in the cranial region (Fig. 3.9B; data not shown), 
suggesting that ephrinA l plays a specific physiological role during spinal neurulation.
One model for the effect o f  E phA l-F c would envisage that the fusion protein binds to 
ephrinA l and thereby prevents binding to EphA l on another cell, on the opposing 
neural fold. However, in areas where ephrinA l protein and EphA proteins (E phA l, 
EphA2, EphA3, EphA4, EphA5) are co-expressed, injection o f  EphA l-Fc may also 
exacerbate the effect o f  Eph-ephrin cis interactions (bound ephrinA l to EphAs on the 
same cell). In both m odels, E phA l-F c m ay com pete with endogenous EphA for 
binding to unbound ephrinA l and thereby suppress Eph-ephrin function (Yin et al. 
2004; Egea & Klein 2007), resulting in the consistent delay o f  spinal neural tube 
closure seen in every em bryo treated w ith E phA l-Fc. E phA l-Fc could also block the 
function o f  endogenous EphA receptors instead o f  blocking ephrinA thus disrupting 
the function o f  ephrinA l from binding to its respective Eph partner in the PNP 
(W im mer-Kleikam p et al. 2004).
It is possible that the delay in spinal neural tube closure following treatm ent with 
exogenous E phA l-Fc fusion protein does not result simply from blocking ephrinA l 
function. E phA l-Fc in excess am ounts can dimerize and cluster in the area where 
ephrinAl is expressed. E phA l-F c may thereby activate ephrinA l and trigger 
downstream signalling. A high level o f  activation o f  ephrinA l by E phA l-F c fusion 
protein could lead to repulsion and not adhesion (Himanen et al. 2001; H im anen et al. 
2004; Pasquale 2005), thus causing a delay in spinal neural tube closure. Although, 
the experiments in this chapter do not differentiate between the possible effects o f  
EphA l-Fc on ephrinA function, it does seem clear that perturbation o f  Eph/ephrin
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function, whether through activation or suppression o f  function, has a deleterious 
effect on closure o f the spinal neural folds.
3.4.4 Molecular action of soluble Eph and ephrin fusion 
proteins in delaying PNP closure
Unlike the EphA l-Fc fusion protein, treatment o f embryos with lOnM ephrinA 1-Fc 
fusion protein did not delay PNP closure. This may have been because the 
concentration o f ephrinA 1-Fc was not high enough. For example, the EphA l-Fc 
fusion protein may bind only to a single ephrin (ephrinAl), because o f its binding 
specificity. In contrast, RT-PCR and in situ hybridisation studies (Chapter 2) revealed 
that several EphAs are expressed in the PNP, such that ephrinA 1-Fc could possibly 
bind to 5 different EphAs in the PNP: EphA l, A2, A3, A4, A5. Hence, the range o f 
possible binding partners for ephrinAl might have "titrated out" the ephrinA 1-Fc 
fusion protein. However, this may not be the reason for the lack o f an effect, as while 
ephrinA 1-Fc may indeed bind to many receptors, it would only be “titrated out” if  it is 
in limiting amounts. Future studies would need to repeat the ephrinA 1-Fc experiment 
using higher concentrations o f fusion protein to test whether concentration was 
limiting in the present study.
An alternative explanation, for the lack o f an apparent effect o f  ephrinA 1-Fc, is that 
EphA-Fc and ephrinA-Fc have different effects on Eph/ephrin activation and cell 
responses. EphA-Fc may activate ephrinA and block EphA whereas ephrinA may 
activate EphA and block ephrinA (Poliakov et al. 2004; Sela-Donenfeld & Wilkinson 
2005). EphrinA 1-Fc fusion protein could potentially activate one or more o f the 5 
possible EphA receptors expressed in the PNP, leading to different cellular effects to 
the blocking or activation o f  endogenous ephrinAl mediated by EphA l-Fc. This could 
even enhance the adhesive properties o f the neural folds if binding o f ephrinA 1-Fc 
fusion protein to Eph stimulates assembly o f the cytoskeleton leading to an adhesive 
response.
One possible effect o f soluble ephrinA could be induction o f  apoptosis in the neural 
folds. For example, ectopic expression o f ephrinA5 in EphA7-expressing cortical
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CHAPTER 4
Electron Microscopy Studies of Spinal Neural 
Tube Adhesion And Fusion
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4.1 Introduction
The ultrastructure o f  the neural folds during the adhesion and fusion stages o f  
neurulation has been the subject o f  many studies in different species over a 30 year 
period (W aterman 1975; W aterm an 1976; Geelen & Langm an 1979; M orriss-Kay 
1981). Characteristic lam ellipodia- and filopodia-like protrusions have been described 
emanating from the tips o f  the neural folds, with the implication (so far, unproven) 
that these structures are directly responsible for neural fold adhesion and fusion.
The purpose o f  the present chapter was, first, to describe the ultrastructures ( if  any) 
present on the neural fold tips during adhesion and fusion in the PNP and, second, to 
correlate the expression o f  Ephs and ephrins with these ultrastructural features. An 
unexpected outcom e o f  the study was the finding o f  asym m etrical structures 
associated with the neural fold tips, using both scanning electron m icroscopy (SEM ) 
and transmission electron m icroscopy (TEM ). Interestingly, review  o f  previous 
published literature (for chick, frog and m ouse neurulation) reveals the presence o f  
asymmetrical structures also in these studies (Fig. 4.1; van Straaten et al. 1993b; M ak 
1978; M orriss-Kay 1981).
Hence, this Chapter considers not only the issue o f  Eph/ephrin expression at the neural 
fold tips, as detected by TEM , but also the concept that neural fold adhesion and 
fusion, at the ultrastructural level, m ay be an asym m etrical process.
4.2 Materials and Experimental Procedures
All materials were obtained from A gar Scientific unless specified. Three different 
experimental procedures were undertaken for the study o f  specific adhesion and 
fusion structure(s). First, SEM  was perform ed on w ild-type CD1 em bryos at the 6-10 
and 12-15 somite stages. Second, TEM  was perform ed on 70 nm sections (ultra-thin 
sections) o f  these em bryos. Sections o f  1 pm  thickness were also exam ined, preceding 
and following the ultra-thins. Third, protein expression w as exam ined on the u ltra­
structures using DAB im m unodetection as the secondary antibody conjugate.
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4.2.1 Preparation of embryos for scanning electron 
microscopy
Embryos were dissected quickly in DMEM (Sigma) containing 10 % FBS (Sigma) 
and all extra-embryonic membranes were removed. The embryos were then given a 
quick and thorough wash in ice-cold PBS before being transferred into ice-cold 2.5 % 
glutaraldehyde, l % PFA and O.l M sucrose in 0.05 M sodium cacodylate and 5 mM 
calcium chloride buffer, pH 7.4 and kept at 4°C overnight. Samples were transferred 
into 2 % aqueous osmium tetroxide in 0.4 M sodium cacodylate for an hour, after 
which the embryos were rinsed in 100 % alcohol for 10 minutes, then washed twice in 
acetone for 10 minutes each. Next, the samples were critical point dried before being 
mounted. The embryos were sputter gold coated (Emscope) and viewed on a JEOL 
5140 Lv (JEOL Japan) scanning electron microscope.
4.2.2 Preparation of embryos for transmission electron 
microscopy
Deciduas containing embryos were quickly dissected from the uterus in DMEM 
containing 10 % FBS, transferred into cold fixative (2.5 % glutaraldehyde, 1 % PFA 
and 0.1 M sucrose in 0.05 M sodium cacodylate and 5 mM calcium chloride buffer, 
pH 7.4) and dissected further until all extra-embryonic membranes had been removed. 
The embryos were then rinsed in fixative and kept overnight in the same solution.
The embryos were rinsed twice for 5 minutes in 0.05 M sodium cacodylate and then 
transferred to 1 % osmium tetroxide buffered in 0.1 M sodium cacodylate for 2 hours. 
Next, the embryos were rinsed by 2 brief washes o f distilled water. The samples were 
subsequently washed in 0.5 % aqueous uranyl acetate for 30 minutes at 4°C, which 
was then followed by two 5 minute washes with distilled water. The embryos were 
dehydrated through a series o f ethanol washes beginning with 25 % ethanol followed 
by 50 % ethanol, for 5 minutes each. This was then followed by two 10 minutes 
washes o f 70 %  ethanol, followed by two 10 minutes washes o f  90 % ethanol. All 
aqueous remnants were completely removed by four 10 minute washes in 100 %  
ethanol. This step was followed by 3 changes o f propylene oxide at 3 different ratios
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(1:2; 1:1; 2:1) for 30 m inutes each. The sample was then left in Agar 100 epoxy resin 
at room temperature for 3 hours before being transferred to a 60°C oven overnight to 
allow polymerization o f  the resin to occur.
Ultra-thin sections were cut on a RMC M T6000 ultramicrotome, using a Diatome 
diamond knife. Sections were then stained briefly in 0.01 M lead citrate and 
subsequently collected on mesh copper grids and slot grids. The grids were examined 
using a JEOL 1010EX electron microscope. Semi-thin sections cut for light 
microscopy were stained with 1 % toluidine blue/ 1 %  borax.
4.2.3 Gene expression analysis using transmission 
electron microscopy
Deciduas containing embryos were quickly dissected from the uterus in DMEM 
containing 10 % FBS. The deciduas were then transferred into cold fixative (0.01 % 
glutaraldehyde, 2 % PFA and 0.1 M sucrose in 0.05 M sodium cacodylate and 5 mM 
calcium chloride buffered solution at pH 7.4) and dissected further until all extra- 
embryonic m em branes had been removed. The embryos were then rinsed in the 
fixative and kept overnight in the same solution for 2 hours. All following steps were 
performed on ice. The embryos were washed extensively in 0.01%  T riton-100 
buffered PBS for a total o f  3 hours with 3 changes o f  washing solution. These washing 
steps are extrem ely critical to prevent background staining.
The embryos were then incubated with prim ary antibody, diluted as listed in Table 2.4 
(Chapter 2), overnight at 4°C. The next day the embryos were washed extensively as 
previously explained. The embryos were then incubated overnight at 4°C with 
secondary antibody, goat anti-rabbit horseradish peroxidase, diluted 1:100 in 0.01%  
Triton-100 buffered PBS. The next day the embryos were washed extensively as 
previously explained. DAB solution (Vectastain) was prepared in a 5 ml volume. The 
embryos were immersed in DAB for 1 minute and then washed in distilled water 
before being kept overnight at 4°C in fixative (0.01 %  glutaraldehyde, 2 % PFA and
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0.1 M sucrose in 0.05 M sodium cacodylate and 5 mM calcium  chloride buffered 
solution at pH 7.4).
The embryos were then rinsed in two 5 minute washes in 0.05 M sodium cacodylate. 
The sample was transferred to 1 % osmium tetroxide buffered in 0.1 M sodium 
cacodylate for 2 hours. Next the embryos were rinsed in 2 b rief w ashes o f  distilled 
water. The embryos were then dehydrated through a series o f  ethanol washes 
beginning with 25 % ethanol followed by 50 % ethanol for 5 m inutes each. This was 
followed by two 10 m inutes washes o f  70 % ethanol followed by two 10 m inutes 
washes o f  90 % ethanol. All aqueous rem nants were com pletely rem oved by four 10 
minutes washes o f  100 % ethanol.
This step was then followed by 3 changes o f  propylene oxide at 3 different ratios (1:2; 
1:1; 2:1) for 30 m inutes each. The sample was then left in Agar 100 epoxy resin at 
room tem perature for 3 hours before being transferred to a 60°C oven overnight to 
allow polymerization o f  the resin to occur.
Ultra-thin sections were cut on an RM C M T6000 ultram icrotom e, using a Diatom e 
diamond knife. Sections were then stained briefly with lead citrate and subsequently 
collected on mesh copper grids and slot grids. The grids were exam ined in the JEOL 
1010EX electron m icroscope. Sem i-thin sections cut for light m icroscope 
examinations were stained with 1 %  toluidine blue/ 1 %  borax.
4.3 Results
In keeping with previous SEM and TEM  studies o f  neurulation, ultrastructures were 
observed on the neural folds at the point o f  adhesion and fusion in the PNP. In each 
wild-type CD1 em bryo, there was a single lam ellipodia-like protrusion which 
occurred prior to adhesion, and a single apoptotic cell at the point o f  fusion (Section 
4.3.1). Im m uno-electron m icroscopy revealed expression o f  both EphA2 and 
ephrinAl on the ultrastructures at the neural fold tips (Section 4.3.2). E phA l-F c  
microinjected em bryos exhibited particular alterations in ultrastructural appearance,
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with excessive lam ellipodia formation, at the point o f  adhesion and fusion in the PNP 
(Section 4.3.3).
4.3.1 Ultrastructures present at tips of neural folds during 
adhesion and fusion of PNP
The PNP was studied carefully by SEM at various angles, in order to observe the 
precise m orphology during the process o f  adhesion and fusion (Fig. 4.2). An 
asymmetrical protrusion em anating from the tip o f  the left neural fold was observed in 
scanning electron m icrographs (Figs. 4.3, 4.4, 4.5, 4.6 and 4.7), transm ission electron 
micrographs (Fig. 4.8) and sem i-thin sections stained with toluidine blue (Fig. 4.9) 
prior to adhesion and fusion o f  the spinal neural tube.
Six out o f  eight em bryos subjected to 3-dim ensional SEM analysis (Fig. 4.3, two 
embryos; Fig. 4.4, one em bryo; Fig. 4.5, one em bryo; Fig. 4.6, one em bryo; Fig. 4.7, 
one embryo) displayed a lam ellipodia-like protrusion em anating from the tip o f  the 
left neural fold prior to closure. The protrusion is described as lam ellipodial based 
upon its m orphology which is broad and sheet-like. The other two em bryos (Fig. 4.6 
C, D) did not show any lam ellipodia-like protrusions or any protrusions em anating 
from either side o f  the neural folds. In one o f  these, the right neural fold was 
considerably sm oother than the left (Fig. 4.6B). The surface o f  the em bryo w as also 
considerably sm oother com pared with the neural plate groove, which had a cobble 
stone appearance at its edges.
Two embryos were sectioned at 70 nm thickness and subsequently view ed by TEM . 
Both displayed a broad, frond-like protrusion em anating from the left neural fold tip 
(Fig. 4.8). Upon closer inspection, this protrusion appears to arise from betw een the 
surface ectoderm and the neuroepithelium  (Fig. 4.8), although it is d ifficult to be 
absolutely conclusive about the precise tissue o f  origin (see also Section 4.3.2). 
Therefore, for the purposes o f  figure description, the neural fold tip is defined as 
encompassing both non-neural ectoderm  and neuroepithelium  (Fig. 4.8).
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Fig. 4.9 shows four closely spaced semi-thin sections which sum m arise the sequence 
of events from appearance o f  a protrusion from the left neural fold (Fig. 4.9A), its 
extension to the right neural fold (Fig. 4.9B), initial adherence o f  the two folds (Fig. 
4.9C) and rem odelling to give rise to a continuous layer o f  neuroepithelium  covered 
by surface ectoderm (Fig. 4.9D). Ruffle-like structures were also som etim es observed 
across the fusion point (Fig. 4.4 and Fig. 4.7 D). These structures may be present due 
to technical m anipulation during SEM that causes shearing o f  the tissue at the point o f 
adhesion and fusion as the tissue may som etim es expand due to surface tension caused 
by the critical point drying step. The term inology: "enveloping o f  a rounded/apoptotic 
cell" was used in the knowledge that these ruffle-like structures may be an artifact.
Slightly rostral to the location o f  the asym m etrical lam ellipodia-like protrusion, a 
rounded cell or a cell which appears apoptotic (bum py and perforated) is alm ost 
always present at the point o f  adhesion and fusion. Such a rounded/apoptotic cell was 
observed in 7 out o f  8 em bryos analysed by SEM (Fig. 4.3 -  Fig. 4.7). In Fig. 4.6B, 
the rounded cell situated at the point o f  adhesion and fusion appears to be undergoing 
apoptosis as half o f  the cell is sm ooth whereas the other h a lf  appears bum py and 
perforated. Fig. 4.10 shows two apoptotic cells, as judged by their staining 
characteristics in sem i-thin (Fig. 4.10A) and ultra-thin (Fig. 4.1 OB) sections at the site 
o f neural fold adhesion and fusion.
The findings from SEM s, TEM s and semi-thin observations on CD1 w ild-type 
embryos are sum m arized in Table 4.1 below.
Study Asymmetrical left lamellipodial 
protrusion
Presence of apoptotic cell 
where left and right neural 
folds meet
Scanning Electron Microscopy 6(8) 7(8)
Transmission Electron Microscopy 2(2 ) 2 (2 )
Semi Thin Sections (700 nm -  1 jam) 3(4) 2 (2 )
Table 4.1 Electron microscopy analysis of spinal neural tube adhesion and 
fusion. Table sum m arises the num ber o f  embryos in which particular ultrastructures 
were observed, with total num bers o f  em bryos analysed in parentheses.
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Fig. 4.2 View of posterior neuropore via SEM in embryos at E8.5 and E9.5. A, dorsal view o f gold
sputter-coated E8.5 embryo placed on stub. The rostral (anterior; arrowhead) and caudal (posterior; 
arrow) ends o f the axis exhibit open neural folds at this stage. The red box indicates the area of the 
PNP undergoing adhesion and fusion. Yellow arrow points to the site o f adhesion and fusion. Red 
arrows indicate rostral end (R). The anterior end o f the embryo has been twisted due to physical 
manipulation whilst placing the embryo on the stub. B, view o f PNP of second embryo viewed 
dorsally; C, 50x magnification o f B, to show structures associated with the point o f fusion o f the 
neural folds; D, PNP of a third embryo (late E9.5) viewed postero-laterally. E, higher magnification 
dorsal view o f the point o f fusion o f neural folds in the embryo in D.
Scale bar: 0.05 mm.
Abbreviations:
SE: Surface ectoderm 
N F: Neural fold
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Fig. 4.3 SEM images of two E8.5 CD1 embryos (A-B and C-D) focussing on the spinal neural folds at the site 
of closure. A-B, a single lam ellipodium  (w hite arrow ) can be seen pro truding  from  the left spinal neural 
fold im m ediately  before adhesion and fusion occurs. B is an en largem ent o f  A. C-D , a single 
lam ellipodium  w ith  sim ilar m orphology to that in A (w hite arrow ) can be seen protruding from  the left 
spinal neural fold im m ediately  before adhesion  and fusion occurs. D is an en largem ent o f  C. In addition, a 
rounded single cell can also be seen at the point o f  fusion in A, C and D (show n by arrow head). A 
lam ellipodia-like structure appears to em anate from  the left o f  the rounded cell in C (red arrow).
Scale bar: 10 pm .
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Fig. 4.4 SEM images of a single CD1 embryo (E9.5) at the point of fusion of the apposing neural
folds. A single lam ellipodial protrusion, show n from  various angles (w hite arrow s) appears to be 
enveloping a single apoptotic  cell (arrow heads). The lam ellipodium  em anates from  the left spinal 
neural fold.
Scale bar: 10 pm .
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Fig. 4.5 SEM images of a CD1 embryo (E8.5) at the point of fusion of the apposing neural 
folds. A single lamellipodium (white arrow) can be seen protruding from the left spinal 
neural fold in A and B (enlargement o f A) before fusion occurs. A rounded apoptotic cell 
(arrowheads) can be seen at the point of fusion.
Scale bar: 10 pm
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Fig. 4.6 SEM images of three CD1 embryos (E8.5) (A, C and D) at the point of fusion of the neural
folds. A single lamellipodium (white arrow) can be seen protruding from the left spinal neural fold 
in A and B (enlargement o f A) before fusion occurs. Embryos in C and D do not have obvious 
protrusions from the left neural fold. A rounded single cell which is becoming apoptotic can be 
seen at the point o f fusion in C (arrowhead). In D, a single rounded cell (arrowhead) appears to be 
flanked by lamellipodia as fusion o f the left and right neural folds occurs.
Scale bar: 10 pm
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Fig. 4.7 SEM images of a CD1 (E9.5) embryo at the point of fusion of the neural folds. A single
lamellipodium (white arrows) can be seen protruding from the left spinal neural fold in A, B, C and 
D before fusion occurs. Two rounded cells (arrowheads) can also be seen at the point o f fusion in A, 
B, C and D. In B and D, the rounded cells appear to be flanked and enveloped by lamellipodia (red 
arrows) as fusion occurs.
Scale bar: 10 pm
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Fig. 4.8 TEM images of two CD1 embryos (A and B; E8.5) at the point of adhesion and fusion of 
the neural folds. A, the tip o f the left neural fold (red arrow) shows a broad frond-like protrusion extending 
towards a denser and more compact cell on the right, which corresponds to the tip o f the right neural fold 
(Embryo A sectioned by Ms Kerrie Venner, Electron Microscopy Unit, Institute o f Neurology); B1-B3, 
successive ultrathin sections through a second embryo approaching the point o f fusion (B3). In B l, the tip o f 
the left neural fold (red arrow) shows a similar frond-like protrusion which emanates from the tip o f the left 
neural fold, pointing towards the tip o f the right neural fold; in B2, the protrusion from the left neural fold 
(red arrow) is approaching the right neural fold; in B3, the tip o f the left neural fold has (red arrow) adhered to 
the tip o f the right neural fold forming structures that have the darkened "railway-like" track appearance of 
tight junctions.
Scale bar: 10 pm.
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Fig. 4.9 Semi-thin sections through the PNP of a CD1 (E9.5) embryo during neural fold adhesion 
and fusion. A, the apposing neural folds prior to closure. A distinct protrusion can be seen 
emanating from the tip o f the left neural fold, and approaching the tip o f the right neural fold. 
B, the left neural fold tip is beginning to adhere to the right neural fold tip. C, the tips of the 
apposing neural folds have adhered. D, the roof o f the neural tube is complete, with the 
formation of a continuous surface ectoderm.
Scale bar: 0.1 mm.
Prior to closure
Point of Fusion
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Surface ectoderm sealed
Fig. 4.10 An apoptotic cell is usually present in the neuroepithelium after adhesion and fusion 
has occurred. A, Apoptotic cell at the site o f adhesion has a very dark appearance 
following toluidine blue staining in a semi-thin section. B, Apoptotic cell has a dark 
appearance due to osmium tetroxide staining compared with adjacent cells, in a TEM 
micrograph.
Scale bars: A & C, 10 pm; B, 0.1 mm.
Embryo 1 Embryo 2
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4.3.2 EphA2 and ephrinAI are expressed specifically on 
the ultrastructure(s) present at the tips of the 
neural folds during adhesion and fusion
Im m unoelectron m icroscopy shows that EphA2 and ephrinAI are both expressed 
throughout the cytoplasm  o f  cells o f  the surface ectoderm , as well as in the 
lam ellipodial protrusions that em anate from the left neural fold tip (Fig. 4.11 & Fig. 
4.14). EphA2 is not expressed in the nuclei o f  these cells (Fig. 4.11) but ephrinA I is 
clearly expressed in the nucleus as well as in the cytoplasm (Fig. 4.14). In contrast, 
EphA2 and ephrinA I are not expressed in the neuroepithelium  imm ediately adjacent 
to the surface ectoderm . This discrepancy with the expression pattern o f  EphA2 and 
ephrinAI as observed by light m icroscopy (Chapter 2) is considered in the Discussion 
o f  this Chapter (Section 4.4.5). The fact that the lam ellipodia-like structures which 
protrude towards the opposing neural fold, are Eph/ephrin-positive argues for a 
surface ectoderm  origin o f  the protrusions. M oreover, the Eph/ephrin-positive nature 
o f  the surface ectoderm  highlights the way in which this cell layer dips into the 
luminal area, between the neural folds, apparently enveloping neuroepithelial cells 
beneath (Figs. 4.11. 4.12, 4.13).
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Fig. 4.11 EphA2 is expressed in cells of the surface ectoderm, including a lamellipodia-like protrusion 
extending towards the opposing neural fold. A, Expression o f EphA2 protein detected by 
immunoelectron microscopy, in which DAB gives a dark, grainy, electron-dense appearance to the 
section. Expression is clearly seen within the surface ectoderm cells (excluding the nuclei), as well 
as in a lamellipodia-like protrusion which extends towards the opposite neural fold (red arrow). 
The neuroepithelial cells immediately adjacent to the surface ectoderm do not express EphA2 
(yellow arrowheads). B, is magnification of A. C is a 40X magnification of a section closely 
adjacent to B.
Scale bar: 9 pm.
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Fig. 4.12 Immunoelectron microscopy of ephrinAI and EphA2 expression at the neural fold tip.
The surface ectoderm dips into the luminal area and envelops the dorsal-most neuroepithelial 
cells. The leading edge surface ectoderm can be seen to express both ephrinAI (A&B) and 
EphA2 (C). This continuation o f the surface ectoderm extends over the edge o f the neural fold 
into the luminal area and envelops the dorsal-most cells o f the neuroepithelium, which are 
negative for ephrinAI and EphA2 (yellow arrowheads)
Scale bar: 2 pm.
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Fig. 4.13 Im m unoelectron microscopy for ephrinA I at the neural fold tip. A ,  c e l l s  o f  t h e  s u r f a c e  e c t o d e r m  
e x p r e s s  e p h r i n A I  w h e r e a s  n e u r o e p i t h e l i a l  c e l l s  a r e  n e g a t i v e  ( y e l l o w  a r r o w h e a d s ) .  B ,  a  l a m e l l i p o d i a -  
l i k e  p r o t r u s i o n  c a n  b e  s e e n  e x t e n d i n g  f r o m  t h e  e p h r i n A  1 - p o s i t i v e  s u r f a c e  e c t o d e r m .
Scale bar: 5 pm. ochJ
Fig. 4.14 Immunoelectron microscopy of two different embryos demonstrates expression of 
ephrinAI at the point of adhesion and fusion. EphrinAI is expressed in the surface 
ectoderm and at the point o f adhesion (A, D) and fusion (B, E; enlarged in C, F) (black 
arrows); Note the presence of an apoptotic cell in the midline at the point o f fusion (red arrow 
in C). EphrinAI is expressed in a lamellipodial extension from the left neural fold (white 
arrows in D-F).
Scale bar: 10 pm.
Point of adhesion Enlarged POFPoint of fusion (POF)
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4.3.3 Injection o f EphA1-Fc leads to filopodia-like
protrusions and an increase in apoptotic cells at 
the point o f adhesion and fusion
Tw o em bryos that were treated with the E phA l-Fc fusion protein (as described in 
Chapter 3) were analysed by SEM. The m icrographs reveal protrusions em anating 
from the left neural fold which differ from those o f  untreated em bryos in both 
m orpohology and num bers (Figs. 4 .15 -4 .16). M ultiple protrusions can be seen along 
the left sided neural fold near to the site o f  closure (Fig. 4 .15), with either a rosette- 
m orphology (like m ultiple lam ellipodia-like structures clum ping together) or a 
m ultiple filopodia-like form ation (Fig. 4 .16). Hence, despite the neural fold 
protrusions rem aining predom inantly left-sided, there is a dram atic change in 
m orphology in E phA l-F c treated em bryos from a single lam ellipodia-like structure to 
m ultiple filopodial protrusions.
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Fig. 4.15 SEM appearance of EphAl-Fc treated embryos. A, the enlarged PNP of an EphAl-Fc
treated embryo which has taken on an exaggerated lateral curve o f the body axis; B, Point of 
adhesion and fusion o f EphAl-Fc treated embryo, showing multiple apoptotic cells just 
caudal to, and at the point o f closure; C, lOx magnification o f B. The rounded cells have a 
perforated appearance suggesting they are apoptotic. D, a second EphAl-Fc treated embryo 
exhibiting several protrusions from the left sided neural fold. These protrusions appear to be 
filopodial in nature, in contrast to the lamellipodial appearance o f the protrusion in untreated 
embryos.
Scale bar: 10 pm
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Fig. 4.16 Filopodial protrusions from the neural folds of an EphAl-Fc treated embryo. A, low
magnification SEM view of the point o f closure in an EphAl-Fc treated embryo; B, C and 
D, higher magnification views of A at different angles. B, Note the filopodia-like structures 
which clump together at the point o f adhesion and fusion (red arrow); C, D, Higher 
magnification shows that the filopodia emanate from the left side of the neural tube
Scale bar: 10 pm
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4.4 Discussion
4.4.1 A single lamellipodial structure protrudes from the 
left neural fold prior to fusion
The neural folds o f  m am m als such as the hamster and the mouse have previously been 
noted to exhibit ruffles (both lam ellipodia-like and filopodia-like) on the apposing 
neural folds (W aterm an 1975; W aterman 1976). The observation o f  a specific 
asym m etrical lam ellipodia-like structure during the events o f  adhesion and fusion was 
observed in the present study and, in retrospect, can also be seen in m icrographs from 
previous studies o f  several species (M ak 1978; Geelen & Langman 1979; Morriss- 
Kay 19 8 1; van Straaten et al. 1993b). Taking present and previous observations 
together, it appears that adhesion and fusion o f  the spinal neural folds may be 
m ediated by left-sided, asym m etric, lam ellipodia-like structures.
Lam ellipodia are best known as the structures enabling m otility o f  cultured cells. 
Extending this concept, lam ellipodia have also been shown to be required for in vivo 
cell m ovem ents such as am phibian convergent extension (Shih & Keller 1992). The 
broad sheet-like appearance o f  lam ellipodia appears to be required for lateral cell 
m ovem ents in Xenopus convergent extension, which was suggested to inhibit anterior- 
posterior polarisation o f  the chordam esoderm  (Ninomiya et al. 2004). The 
participation o f  sim ilar asymm etrical structures in the adhesion step o f  primary 
neurulation therefore adds to the growing list o f  asym m etry-generating events o f  early 
em bryogenesis, which includes heart tube looping and embryonic axial rotation. The 
latter process seem s to result from an increase in mitosis on the left side o f  the 
em bryonic body (Poelm ann et al. 1987).
A convenient model (Fig. 4 .17) for the asymm etric process o f  neural fold adhesion 
and fusion could view the lam ellipodia-like protrusion from the neural fold as acting 
like Velcro tape which attaches to the complem entary Velcro fastening on the right 
non-neural ectoderm al tip. As such, the process o f  neural fold adhesion and fusion 
appears different from other systems in which adhesion and fusion has previously
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been studied. For exam ple, D rosophila  dorsal epithelial closure involves cell 
intercalation which has been shown to depend on filopodia-like protrusions (Jacinto et 
al. 2000; Jacinto et al. 2001; Jacinto et al. 2002; Wood et al. 2002). A nother exam ple 
is the palate which requires epithelial to m esenchym al transition as the culm ination o f  
the fusion o f  the apposing palatal shelves (M artinez-A lvarez et al. 2000).
An average lam ellipodium  m oves at the rate o f  0.05 to 0.5 jam per second in cultured 
cells (Bray 2001). W hen the lam ellipodial protrusion appears from the left neural fold, 
the distance between the unfused tips o f  the neural folds is approxim ately 10 p.m. 
Therefore, in the tim e-fram e o f  neurulation, it is feasible that lam ellipodia protruding 
from the left non-neural ectoderm al tip could cross the gap between left and right 
neural fold tips and form an adhesive junction before the next non-neural ectoderm  
cell, caudally, begins to extend its own lam ellipodial protrusion. A ccording to this 
idea, neurulation progresses caudally as a progressive series o f  lam ellipodial 
protrusion events from successive left neural fold ectoderm al cells, each o f  which 
sends out a protrusion towards the opposite fold, adhering and draw ing the folds 
together.
4.4.2 An apoptotic cell is present at the point of adhesion 
and fusion
The occurrence o f  a rounded cell, which in many cases was clearly becom ing 
apoptotic, at the site o f  closure w as observed in alm ost every SEM m icrograph. It 
could be hypothesized that this rounded / apoptotic cell plays a role analogous to that 
seen in w ound healing, w here cells that are about to undergo apoptosis signal to 
overlying cells to seal the gap. The question then arises: is apoptosis required for 
progression o f  spinal neural tube closure?
Only one study has previously provided evidence that apoptosis is required for neural 
tube closure (W eil et al. 1997). Inhibition o f  apoptosis by the anti-caspase Zvad-fm k 
peptide prevented fusion o f  the chick spinal neural tube, although the exact 
m echanism  o f  this effect w as not determ ined. In another study, inhibition o f  p53 in
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Splotch  mutant m ouse embryos rescued neural tube defects, suggesting that the 
abolition o f  excess apoptosis in these m utants could overcom e the neurulation defect 
(Pani et al. 2002). However, neither o f  these studies conclusively answer the question 
o f  whether apoptosis is an essential feature o f  neural tube closure. Future studies will 
need to address this issue using an experim ental approach. It will also be important to 
resolve whether EphA2 and/or ephrinA l may be involved in stim ulating apoptosis, 
given that both genes can be regulated by p53, with a higher level o f  apoptosis where 
EphA2 is upregulated (Dohn et al. 2001).
4.4.3 Lamellipodial protrusions from the surface ectoderm 
may be required for closure: evidence from morphology 
and expression of EphA2
Studies in this chapter show that EphA2 is expressed not only in the surface ectoderm 
but also in the lam ellipodia-like structures during neural fold adhesion and fusion. 
EphA2 is known to prom ote cell m otility associated with tum ourigenesis (Fang et al. 
2005), while EphA 2-deficient mice exhibit reduced tum our angiogenesis and 
metastatic progression (Brantley-Sieders et al. 2005). Importantly, EphA2 deficient 
cells also fail to activate Rac upon stimulation (Brantley-Sieders et al. 2003), a 
significant finding in view  o f  the dependence o f  lam ellipodia formation on Rac 
activation (Katoh et al, 2006).
EphA2 and EphA4 are the only Eph receptors to respond (becom ing tyrosine- 
phosphorylated) to stim ulation by ephrinA l in tissue culture (Carter et al. 2001). 
EphrinA l is known to suppress the action o f  Rac (M iao et al. 2003). Hence, it can be 
predicted that, as E phA l-F c  binds endogenous ephrinA l, Rac cannot be suppressed. 
When Rac is constitutively activated in Drosophila  undergoing dorsal closure, 
lamellipodial protrusions are over-produced, closely resem bling the SEM appearance 
o f  EphA l-Fc-treated  em bryos in the present chapter. Dorsal closure is then inhibited 
owing to a m ism atch o f  the intercalation process that is necessary for the sweep o f  
epithelial closure to occur (W oolner et al. 2005). In the same experim ent, dom inant
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negative Rac w as found to lead to an absence protrusions em anating from either side 
o f  the dorsal opening, also causing inhibition o f  dorsal closure (W oolner et al. 2005).
A
Fig. 4.17 S ch em atic  d ia g ra m  o f  an  a sy m m e tric a l lam ellipod ia l p ro tru s io n  
ex tend ing  ac ro ss  th e  g a p  b e tw een  o p p o sin g  n e u ra l folds (A) an d  fusing  w ith  r ig h t 
n o n -n eu ra l e c to d e rm a l t ip  (B). A dhesion o f  the protrusion to the right non-neural 
ectoderm  appears to result in the form ation o f  tight junctions (in red), providing 
strength to the new ly form ed contact.
4.4.4 EphrinAl is expressed at the point of adhesion and 
fusion
Im m unoelectron m icroscopy in th is C hapter also shows that ephrinA l is expressed at 
the point o f  neural fold adhesion and fusion, providing further evidence for a role o f  
this protein in neurulation. The tips o f  extending protrusions such as lam ellipodia and 
filopodia form  adhesion con tacts know n as focal adhesions (Petit & Thiery 2000). 
Focal adhesion kinase (FA K ) phosphorylation plays a key role in focal adhesion 
form ation (B urridge et al. 1992), probably by organizing the adhesion-related 
rem odelling centre (Sastry  and H orw itz 1996). Therefore, it seem s likely that focal 
adhesion com plexes are form ed during the process o f  neural fold adhesion and fusion.
Focal adhesion com plexes m ay function as an im m ature form o f  tight junction  (G eiger 
& Bershadsky 2002). Subsequent form ation o f  definitive tight junctions is crucial for
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the formation o f  coherent epithelial sheets (Helfrich et al. 2006; Brandner et al. 2006). 
The TEM preparations in the present study suggested the presence o f  tight junctions at 
the points o f  left-right neural fold fusion. It is tem pting to suggest, therefore, that 
ephrin/Eph interactions activate form ation o f  focal adhesions, that subsequently 
become stabilised by the form ation o f  tight junctions.
4.4.5 Leading edge of surface ectoderm expresses ephrinAl 
and EphA2 and is required for PNP closure
The finding that, at the electron m icroscopic level, both EphA2 and ephrinA l are 
expressed in the surface ectoderm  but not in the neuroepithelium, is interesting in 
view o f  the known regulation by E-cadherin o f  several Eph receptors and ephrins 
(E phA l, EphB4, eph rinB l, ephrinB2) (Zantek et al. 1999; Newgreen et al. 1997; 
Orsulic & Kem ler 2000). E-cadherin is the classic m arker for surface ectoderm 
whereas N-cadherin expression specifically m arks the neuroepithelium . The two genes 
do not overlap in expression during early developm ent (Gilbert 2003).
However, there is a clear discrepancy between the pattern o f  EphA2 and ephrinA l 
protein expression found, in the present thesis, at the level o f  light microscopy and 
electron m icroscopy. A lthough localized at the tip o f  the neural fold by both methods, 
it is striking that light m icroscopy detected both proteins in the neuroepithelium  and 
surface ectoderm  w hereas electron m icroscopy detected EphA2 and ephrinA l only in 
the surface ectoderm  and, in the case o f  EphA2, in lamellipodia originating from the 
surface ectoderm . This discrepancy can perhaps be explained by the greater thickness 
o f  light m icroscope sections com pared to those used for electron microscopy (142 x 
difference). There rem ains the possibility that expression o f  EphA2 is also present at 
low intensity in the neuroepithelium  but that the highly-specific electron m icroscopy 
method was unable to detect low level expression in the neuroepithelium .
The possibility o f  antibody non-specificity was also further discounted in this chapter 
as it is evident that the detection o f  ephrinA l and EphA2 expression were very 
specific. In Fig. 4.11 (A-C), EphA2 is clearly seen in the cytoplasm  but not at all in
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the nucleus where as the expression o f  ephrinA l is so specific that it may be expressed 
in the nucleus and cytoplasm  o f  one cell but not at all in the cell adjacent to it (Fig. 
4.14A).
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CHAPTER 5
General Discussion
197
The overall aim o f  this thesis was to investigate the molecular basis o f neural fold 
adhesion and fusion during spinal neural tube closure. To achieve this goal, the initial 
approach was to study the expression pattern o f  the family o f  ephrinA molecules, 
which had been implicated previously as adhesion/fusion m olecules in cranial 
neurulation. Subsequently, ephrin function was experimentally manipulated in whole 
embryo culture to test the role o f  ephrins in spinal neurulation. Finally the process o f 
neural fold adhesion and fusion was studied at the ultra-structural level.
In Chapter 2, expression o f  the ephrins and their various Eph receptors, was 
investigated using in situ hybridization and immunohistochemistry. Among the five 
ephrinAs in the m ouse genome, ephrinA l and ephrinA3 were identified as being 
expressed at the closure site. EphA2 was also studied in detail, because it was known 
to be activated by ephrinA l in various systems. EphA2 was found to be expressed at 
specific sites in the neural folds during neurulation with a pattern which correlates 
with the process o f  adhesion and fusion. Chapter 2 also describes expression o f  other 
Eph receptors in the mouse PNP. Among those with an expression pattern suggesting 
a potential role in adhesion and fusion is EphA4, a receptor that is expressed in the 
spinal cord and has been implicated as playing a role in the spinal cord during walking 
(Kullander et al. 2003; Dottori et al. 1998). Interestingly, the EphA4 m utant loses the 
left-right asym m etry required for walking and instead exhibits synchrony o f  limb 
movements.
Chapter 3 describes studies designed to experimentally test the physiological role o f 
Ephs and ephrins in spinal neurulation. By using soluble receptor or ligand fusion 
proteins bind to their respective partners, the binding effect o f  these reagents was 
utilised to investigate o f  the function o f  the endogenous receptor or ligand. These 
studies suggest that ephrinA l is the family member most likely to be required for 
adhesion and fusion o f  the mouse spinal neural tube.
Chapter 4 describes the ultrastructures that arise on the neural folds and may be 
involved in m ediating the process o f  adhesion and fusion o f  the spinal neural tube. An 
asymmetrical lam ellipodial structure appears from the left side imm ediately prior to 
closure, extending towards and eventually contacting the right neural fold.
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Interestingly, both the cell giving rise to the lamellipodial protrusion and the cells 
contacted on the right neural fold, appear to be o f  non-neural (surface) ectodermal 
origin, as judged by the strong expression o f  EphA2. Hence the surface ectoderm may 
play a more prom inent role in neurulation than previously thought.
5.1 A possible role for Ephs and ephrins in neural tube 
closure
Ephs and ephrins have previously been studied during adhesion and fusion in several 
systems, in the m idbrain o f  the neurulating mouse embryo (Holmberg et al. 2000), 
cloacal fusion o f  the m ouse (Dravis et al. 2004), ventral closure o f  the worm, 
Caenorhabditis elegans (George et al. 1998), coronal suture fusion which leads to 
bone formation o f  the skull (M errill et al. 2006) as well as formation o f  the 
atrioventricular valves and septa o f  the m ouse heart (Stephen et al. 2007).
As in spinal neural tube closure studied in the present project, closure o f  the cranial 
neural tube involves the apposition and fusion o f  the tips o f  neural folds. In the cranial 
region this process appears to depend on ephrinA5 and EphA7, since null m utant 
embryos exhibit cranial NTDs. In contrast, ephrinA5 and EphA7 are not apparently 
required for spinal neurulation, suggesting there may be different m olecular 
requirem ents for closure at different axial levels. Cloacal fusion is a septation event 
that separates the cloaca into two endoderm  compartm ents (urinary and fecal), and this 
occurs in m ales and females. Hypospadias results from failure o f  urethral 
tubularisation (Dravis et al. 2004). EphB2, EphB3 and ephrinB2 are required for the 
normal developm ent o f  the urethra and cloaca, as null m utant embryos (single 
knockout o f  ephrinB2 and double knockout o f  EphB2/EphB3) exhibit hypospadias 
(Dravis et al. 2004). Ventral closure in C.elegans requires the VariableAbnormall 
(V ab l) gene which encodes an Eph receptor, expressed in neuroblasts and neuronal 
cells o f  the worm (George et al. 1998). The neuroblasts and neuronal cells influence 
epidermal m orphogenesis which is crucial for the successful fusion o f  the ventral 
mid line o f  C. elegans (George et al. 1998).
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Ephs are integral membrane proteins whereas ephrinAs are linked to the plasma 
membrane by a GPI anchor, such that Ephs and ephrins expressed on different cells 
can interact, so called trans-interaction (Henkemeyer et al. 1994; Davis et al. 1994; 
Pasquale 2005). It seems likely that neural tube closure requires an interaction o f  Eph 
and ephrin molecules on apposing tips o f  the neural tube, which would therefore 
involve a trans-interaction. In fact this may be a two-way process in which Ephs and 
ephrins on one tip interact with ephrins and Ephs on the opposing tip, with consequent 
activation o f  signalling in both neural fold tips. In this way the adhesion o f  the neural 
folds may differ from tissues, such as the tectum, in which Ephs and ephrins are 
reciprocally compartmentalized (Drescher et al. 1997b).
Ephs and ephrins are bidirectional signaling molecules whereby signaling downstream 
o f  the Eph receptor is recognized as forward signaling and downstream o f  the ligand 
ephrin as reverse (W ilkinson 2001). Thus, ephrinA l-Fc may block reverse signaling 
by blocking the binding o f  EphA to endogenous ephrinA (Fig. 5.1 A and B). When 
excess exogenous ephrin fusion protein is added to embryos in culture (Chapter 3), 
there is no difference between the rate o f  closure o f  control embryos (Fc injected 
embryos) and treated embryos (ephrinAl fusion protein injected embryos) (Fig. 5.1 A 
& B) and closure continues unperturbed. Assuming that the ephrinAl fusion protein 
did block activation o f  endogenous ephrinA l, this data suggests that reverse signaling 
through ephrinA is dispensable for spinal neurulation.
In contrast to ephrinA 1-Fc, EphA l-Fc inhibits spinal neural tube closure (Chapter 3). 
Among the possible events which occur following EphA-Fc m icroinjection into the 
amniotic sac o f  neurulating embryo is that EphA-Fc fusion protein inhibit forward 
signaling, by blocking activation o f endogenous EphA by endogenous ephrinA. In 
addition, EphA-Fc could potentially elicit ephrin-mediated cell autonom ous reverse 
signaling (Fig. 5.1C). The finding that EphA l-Fc has a negative effect on spinal 
neurulation suggests that, 1) ephrinA mediated downstream signalling may not be 
required for closure and/or 2) reverse signaling occurs but has a repulsive effect. 
Although ephrin-mediated signalling (reverse signalling) can cause inhibition o f  cell­
cell adhesion (Deroanne et al. 2003; Winning et al. 1996; George et al. 1998), it seems 
unlikely in the context o f  spinal neurulation as the presence o f  endogenous Eph-ephrin
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m olecules at the site o f  closure appears to suggest a role in adhesion rather than 
repulsion.
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Fig. 5.1 Schematic figure showing the possible Eph-ephrin interaction in
the spinal neural tube. A, In a control em bryo, a trans-interaction betw een Eph- 
ephrin m olecules on apposing neural fold tips are proposed to  facilitate closure. B, It 
is possible that c is-in teractions occur betw een Ephs and ephrins on the same cell, but 
the possible role in closure is unknow n. C. E phA l-F c  treatm ent m ay prevent trans­
interaction betw een m olecules on opposing neural folds, and inhibits closure. Reverse 
signaling m ay occur. D. EphrinA  1-Fc treatm ent hypothetically blocks interaction o f  
endogenous Ephs and ephrins, but forw ard signaling through EphA receptors m ay 
occur. C losure is not inhibited suggesting forw ard signaling m ay be sufficient to allow  
adhesion.
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Trans Eph-ephrin interaction (Fig. 5.1 D) w ould be predicted to facilitate closure o f  the 
spinal neural tube by enabling the opposing tips o f  the neural fold to adhere to each 
other. D ifferent levels o f  expression o f  ephrinA l on the left and right tips in 
com parison to different levels o f  expression o f  EphA2 on left and right tips m ay 
indicate different levels o f  activation at a given tim e as shown in the expression 
chapter (C hapter 2). This distinctive pattern o f  expression m ay support the possibility  
o f  phosphorylation and dephosphorylation occurring in the Eph-ephrin com plex 
during the spatiotem poral period o f  adhesion and fusion.
Cis interactions are known to inhibit trans-in teractions in certain cellu lar contexts (Yin 
et al. 2004). The functional role o f  these cis-in teractions is not com pletely defined, 
however, in cultured axons it seem s that the presence o f  cis-interacting ephrinA s m ay 
reduce the response o f  EphA receptors to trans ephrinA s on apposing cells (Y in et al. 
2004). In spinal neural tube closure, it is not clear w hether cis interactions occur (Fig. 
5 . IB), or if  present w hat functional role they play. Both ephrinA l and EphA 2 are 
expressed in the surface ectoderm  and neural folds prior to closure and during 
adhesion and fusion (C hapter 2 and C hapter 4), suggesting that c is-in teractions could 
occur. It could be envisaged that cis-in teractions act in a m odulatory m anner in spinal 
neural tube closure (as in o ther system s) w hereby they transform  a uniform  
expression pattern o f  Eph into a gradient o f  “active” receptor w ith stronger tran s­
signalling the low er the level o f  co-expression o f  ephrinA  (H ornberger et al. 1999; 
Yin et al. 2004; Egea & Klein 2007). C is-in teractions o f  co-expressed EphA and
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ephrinA could also lead to forward signaling through the Eph receptor (Fig. 5 .IB) 
which may be an important mechanism  in spinal neural tube closure.
In this thesis I have not been able to test whether Eph-ephrin interactions in the spinal 
neural tube were indeed trans-interactions and not cis-interaction. One approach to test 
this would be to perform genetic ablation experim ents in order to prevent bidirectional 
signaling such as in mice in which EphB2, EphB3 or ephrinB3 are m utated (Dravis et 
al. 2004). I f  trans-interaction is required in spinal neural tube closure, then the 
question would rem ain, as to whether cis-interactions would facilitate or prevent 
closure.
Eph/ephrin interactions m ay affect various cellular processes such as cell death, cell 
proliferation and cell polarity and each o f  these could be envisaged to play a role in 
closure o f  the spinal neural tube (Depaepe et al. 2005; H olm berg et al. 2000; W inning 
et al. 2001; Zhu et al. 2006). EphA3 m utant m ouse em bryos display failure o f  fusion 
o f  the atriventricular endocardial cushions at E l 1.5. The m echanism  underlying this 
defect is thought to involve reduced proliferation which causes hypoplasticity in the 
endocardial cushions and in turn leads to less tissue available to span the 
atrioventricular canal in com parison to wildtype hearts (Stephen et al. 2007). 
Increased apoptosis m ay also be a contributing factor in the failure o f  fusion o f  the 
heart tissue in EphA3 m utant em bryos (Stephen et al. 2007).
5.2 Adhesion and Fusion As A Physiological Process -  
involvement of cellular protrusions
Fusion events occur at both sub-cellular and tissue levels. For exam ple, fusion events 
within cells include vesicle fusion events in leukocytes (Huynh et al. 2004), 
mitochondrial fusion (Ingerm an et al. 2007) and m yoblast fusion (M assarw a et al. 
2007). Tissue fusion events include cloacal fusion, palatal she lf fusion, lip 
morphogenesis and fusion, eyelid fusion and neural tube fusion (D ravis et al. 2004; 
M artinez-A lvarez et al. 1996; Li et al. 2003; Zenz et al. 2003; Kang & Svoboda 2005; 
Holmberg et al. 2000; Copp et al. 2003). Certain m olecules m ay play a role in fusion 
events in different tissues. For exam ple, gene targeting o f  the tyrosine phosphatase,
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MEG2, leads to a neural tube defect phenotype (both spina bifida and exencephaly), 
whereas this protein is also involved in vesicle fusion events in leucocytes (Huynh et 
al. 2004; Wang et al. 2005).
The process o f  fusion has long been thought to involve cellular ultrastructures 
(lam ellipodia, filopodia and cilia) which are thought to em anate in a sym m etrical 
m anner from the two opposing tissues to enable them to adhere to each other and 
ultimately fuse. However, these have only been observed and confirm ed at the 
electron m icroscopy level in a few systems. Am ong the system s o f  adhesion and 
fusion in which ultrastructures have been confirm ed to occur in a sym m etrical m anner 
is eyelid fusion, which occurs at E l 6.5. Conditional inativation o f  c-Jun causes eyelid 
fusion to fail (Zenz et al. 2003), but in both m utant and w ildtype em bryos filopodia 
are present on the opposing eyelids, and are thought to interact to allow adhesion. 
These filopodias em anate from apposing sides and intercalate with one another. 
Similarly, a symm etrical process has also observed in D rosophila  dorsal closure, in 
which filopodia and lam ellipodia were found to be essential in facilitating fusion o f  
the leading epithelial margin. The filopodia and lam ellipodia which em anate from 
both opposing epithelial m argins m ediate dorsal closure which is driven by 
contraction o f  the cells at the leading epithelial edge (Jacinto et al. 2000; W ood et al. 
2002).
The adhesion and fusion o f  the palatal shelves provides another m odel system  in 
which the epithelial edges o f  apposing tissues fuse. A t the ultra-structural level, short 
rod-like structures, detected by SEM  and suggested to be filopodia, protrude from the 
medial edge epithelial cells o f  the palatal shelf (Taya et al. 1999). An earlier 
publication describing data from low vacuum  scanning electron m icroscopy showed 
symmetrical bulges, but no protrusions resem bling lam ellipodia, filopodia and/or cilia 
were described (M artinez-A lvarez et al. 1996). Bulges m ay indicate suboptim al 
preservation o f  tissue as opposed to a defined structure such as lam ellipodia and 
filopodia (Crawford & Burke 2004). However, im m unohistochem ical studies showing 
the localization o f  vinculin in the m ouse palatal shelves also show the appearance o f  
symmetrical bulges (M artinez-A lvarez et al. 2000).
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Failure o f  the leading edge o f  the urethral plate epithelial cells in the urethral fold to 
adhere and fuse in the m idline results in hypospadias (Sadler 1995; Dravis et al. 
2004). Palatal fusion and cloacal fusion appear to be very sim ilar to each other but 
quite different from dorsal closure in D rosophila  which, perhaps, is the m ost sim ilar 
process o f  adhesion and fusion to mouse spinal neural tube closure. This is because 
palatal and cloacal fusion involve two sym m etric shelves com ing together in an effort 
to adhere and fuse sim ultaneously whereby the space which separates the two 
symmetric shelves is o f  a consistent length. This is very m uch different from that o f  
Drosophila  dorsal closure and m ouse spinal neural tube closure which involves 
progressive closure o f  folds and thus gradual closure o f  an open region. Such a 
process requires tensile strength from the initial process o f  adhesion and fusion to aid 
the opposing sides further caudal to be brought closer to each other (van Straaten et al. 
1997; Copp et al. 2003; Jacinto et al. 2000).
The process o f  adhesion and fusion o f  the spinal neural tube closure, eyelid fusion in 
the mouse (Zenz et al. 2003) and dorsal closure in D rosophila  (Jacinto et al. 2000) all 
proceed in a unidirectional manner. Adhesion and fusion in these three system s differs 
from the process o f  wound healing which involves a circular contraction in a purse- 
string like m anner (M artin and Lewis 1992). Perhaps, the end process o f  spinal 
neurulation which leaves the PNP as a small, rounded opening, m ay indeed occur in a 
m anner sim ilar to that o f  wound healing.
5.3 Possible asymmetry in spinal neural tube fusion
Asym metry in Eph and ephrin signalling has been described in Ciona em bryos 
whereby directional Eph-ephrin signalling polarizes the notochord/neural m other cell, 
leading to asym m etric m odulation o f  the FG F-Ras-ERK pathw ay betw een the 
daughter cells and ultim ately to their differential fate specification. D isruption o f  
contacts with the signalling cells or inhibition o f  the Eph-ephrin signal results in the 
symmetric division o f  the m other cell (Picco et al. 2007). A nother exam ple o f  
asymm etrical Eph signalling have been shown to occur in zebrafish at the level o f  
somite 3 where the Eph receptor rtk2 is expressed on the right side in the endoderm al
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precursors o f  the visceral organs and not on the left (Schilling et al. 1999). In the 
studies described in this thesis there may be some asym m etry in the fusion process as 
EphA2 is apparently expressed at higher level on one neural fold at the site o f  fusion. 
Thus, forward signaling may be activated to a greater extent on this side, although the 
functional requirem ent for this asym m etry is yet to be tested.
This thesis puts forth the idea that spinal neural tube adhesion and fusion occurs with 
the aid o f  an asym m etrical lam ellipodia which em anates from the left non-neural 
ectoderm which reaches across the lumen and binds to the right non-neural ectoderm . 
This process o f  adhesion and fusion in the spinal neural tube however only explains 
the chain o f  events which occur directly at the point when it is about to fuse and does 
not describe the events which occur along the spinal non-neural ectoderm  further 
caudally. The existence o f  protrusions and blebs further caudal from the point o f  
fusion were not investigated in detail. However, there does appear to be a relative 
absence o f  protrusions and blebs em anating from the right side o f  the neural fold (non- 
neural and neural ectoderm ) as observed in the scanning electron m icrographs which 
were shown and explained in detail in Chapter 4.
Preservation o f  ultrastructures is a critical issue in the attem pt to observe and exam ine 
their possible role in vivo (M cKinnell et al. 2004; Griffith & Hay 1992). In this thesis, 
measures were taken in order to ensure optim al preservation, both for 
im m unohistochem istry at light m icroscopy level and electron m icroscopy level. 
Am ong them were the use o f  only short periods o f  preservation in freshly m ade 
paraform aldehyde for imm ature em bryos (E8.5), in order to ensure tissue viability for 
light m icroscopy. For SEM s, em bryos were im m ediately washed in ice-cold 
phosphate buffer after dissection, quickly followed by preservation in freshly m ade 
ice-cold preservative, com prising a mix o f  electron m icroscopy grade glutaraldehyde, 
paraform aldehyde and sucrose for SEM s. For TEM s (as well as sem i-thin sections), 
embryo were dissected in ice-cold preservative com prising o f  a m ix o f  electron 
m icroscopy grade glutaraldehyde, paraform aldehyde and sucrose. The difference 
between treatm ent for SEM s and TEM s is the necessity for having a cleaner sample 
for SEMs in order to prevent protein debris from sticking onto the sam ple. In contrast 
the speed o f  preservation o f  ultrastructures was the key param eter for TEM s and was
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regarded as being more critical than a cleaner sample (Mr. M ark Turm aine, personal 
communication). All forceps used for dissection for the purpose o f  transm ission 
electron m icroscopy (as well as semi-thin sections) were washed and cleaned before 
being kept in ice-cold preservative com prising o f  a mix o f  electron m icroscopy grade 
glutaraldehyde, paraform aldehyde and sucrose before use (Dr. T im othy Baldwin, 
personal comm unication).
More experim ents need to be conducted to investigate the possibility o f  an 
asymm etrical protrusion em anating from the left side o f  the spinal neural tube. A m ong 
the experiments which should be undertaken is the use o f  phalloidin which binds 
specifically and strongly to filam entous actin and also prevents the disassem bly o f  
globular actin. Phalloidin thus serves as a fixative type chem ical to prevent 
depolym erization o f  actin, and there acts as preservative agent o f  actin allow ing 
subsequent visualization (Bray et al. 2001). The use o f  phalloidin enables stabilisation 
o f  ultrastructures which m ay be damaged by harsher chem icals such as glutaraldehyde 
which is crucial to visualization via electron m icroscopy.
Another crucial experim ent which needs to be conducted is the use o f  a specific 
inhibitor such as NSC-23766 to perturb the form ation o f  lam ellipodia (Ray et al. 
2007). One approach could be to culture em bryos in the presence o f  an inhibitor, such 
as NSC-23766, that perturbs form ation o f  lam ellipodia. M easurem ents o f  posterior 
neuropore length m ay indicate w hether loss o f  lam ellipodia suppresses closure, 
arguing for a requirem ent for these structures.
In order to investigate the possibility that the ultrastructure at the site o f  fusion is 
asymm etric and consistently found on the left neural fold, it w ould be interesting to 
examine embryos in which laterality is reversed. The inversin m utant m ouse is a 
exhibits situs inversus, a condition whereby visceral organs which are asym m etrical 
are com pletely inverted (Y okoyam a et al. 1993; M organ et al. 1998). I f  the 
lam ellipodia at the site o f  fusion is indeed asym m etric then it w ould be expected to 
emanate from the right neural fold tip in the inversin m utant m ouse. This w ould 
indeed strengthen the evidence that the protrusion em anating from the tip o f  the spinal
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neural fold during adhesion and fusion is not only asym m etrical, but that the sidedness 
depends on correct determination o f  the left-right axis o f  the embryo.
The three suggestions above describe approaches to detect ultrastructures during 
adhesion and fusion o f  the mouse spinal neural tube in a preserved embryo. A m uch 
stronger evidence for asymm etry would be to view the left neural fold tip derived 
lam ellipodia in a live embryo. Profilin binds actin m onom ers and is required for the 
nucleation o f  actin filaments and the addition o f  m onom ers to their barbed ends (Bray 
2001). The profilin-GFP  m ouse expresses profilin tagged with green fluorescent 
protein. Profilin expression can be visualised as early as the m orula stage and is 
detected in the actin cytoskeleton throughout the em bryo as late into developm ent as 
E l 5.5 (Gurniak & W itke 2007). Profilin can be used as a m arker for localization o f  
actin filaments and thus would serve to enable the visualization o f  the lam ellipodia- 
like structure (made up entirely o f  actin). By viewing the posterior neuropore 
specifically at the site o f  adhesion and fusion in a live profilin-G FP expressing 
embryo, we would expect to view a green lam ellipodia em anating from the left spinal 
neural fold tip. A nother interesting experim ent which could be done is to generate a 
transgenic inversin m utant mouse which expresses profilin-GFP. This w ould serve as 
a control experim ent in which any asym m etry detected in a profilin-G FP em bryo 
might be expected to be reversed.
5.4 A possible hypothesis to explain how the spinal neural 
tube undergoes adhesion and fusion
Fig. 5.2 shows a hypothetical series o f  signalling events that m ay underlie neural fold 
adhesion and fusion. A protrusion em anating from the neural fold plate was first 
suggested to be involved in adhesion and fusion by Geelen & Langm an (1979). The 
protrusion appears to be lam ellipodial (shown in Chapter 4), based on m orphology 
(Bray 2001). EphA2 is expressed on the lam ellipodium  and this receptor, when 
activated may bind to focal adhesion kinase (FAK), in association w ith form ation o f  
focal adhesions, (M iao et al. 2000; M iao et al. 2001; M iao et al. 2003). Protrusion o f  
the lam ellipodia would require polym erization o f  actin filam ents and m icrotubules 
(Small et al. 2002; W ittm ann et al. 2003), a  process involving Rac activity (Rodriguez
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et al. 2003). Lam ellipodia are known to be regulated by Rac which is a key GTPase 
responsible for regulating cell migration (Lee et al. 2006; Hiram oto et al. 2006).
In lamellipodial protrusions the EphA2 tyrosine kinase binds to FAK in its resting 
state (Carter et al. 2002). In fibroblasts ephrinA l induces cell adhesion and actin 
cytoskeletal changes in a FAK and p l30cas dependent manner, through activation o f  
EphA2 (Carter et al. 2002). Thus, it is possible that interaction o f  ephrinA l and 
EphA2 on the neural folds, involves alteration in FAK activity and m odification o f  the 
cytoskeleton.
EphrinAl is also known to suppress action o f  Rac and p21 activated kinase (PAK), 
whereas RhoA activation can occur, thus preserving stress fibres (M iao et al. 2003). 
Repression o f  Rac am plifies ephrinA l-induced inhibition o f  spreading (D eroanne et 
al. 2002), thus enabling the inhibition o f  EphA2 lam ellipodia branching.
Upon the interaction o f  EphA2 and ephrinA l in PC-3 cells, EphA2 is activated and 
phosphorylated and the protein tyrosine phosphatase Shp2 is recruited to EphA2; this 
is followed by dephosphorylation o f  FAK and paxillin, and dissociation o f  the FAK- 
EphA2 com plex (M iao et al. 2000). The action o f  Shp2 appears to be im portant for 
spinal neural tube closure as among chineras for a null allele o f  Shp2, 59%  exhibit 
spina bifida (Saxton & Pawson 1999). A ctivated EphA2 im pairs anti-apoptotic 
signalling by disrupting focal adhesions (Dohn et al. 2001) which causes cell rounding 
o f  EphA2 expressing cells (M iao et al. 2000). Hence, the apoptotic cell observed at the 
site o f  fusion in the present study (Chapter 4) m ay be the result o f  interaction betw een 
ephrinA l and EphA2. The apoptotic cell may signal a wound healing response in the 
surface ectoderm , in order to aid closure.
209
• i ;
Fig. 5.2 Suggested pathway of EphA2 interaction with ephrinA l in 
adhesion and fusion of the mouse spinal neural tube. Steps 1 to 3 explain the 
m olecular basis o f  adhesion and fusion. 1, G PI-anchored ephrinA l attracts 
lam ellipodium  expressing EphA2 bound to FAK; 2, Upon activation by ephrinA l o f  
the EphA 2-FA K  com plex, FAK and paxillin are dephosphorylated, enabling Shp2 
recruitm ent; 3, E phrinA l then binds to phosphorylated EphA 2 enabling adhesion and 
fusion to occur.
5.5 Construction of ephrinAl conditional knockout as a step 
towards elucidation of the mechanism of spinal neural fold 
adhesion and fusion
The evidence o f  this thesis points to the G PI-anchored ephrinA l as a likely candidate 
in m ediating posterior neural fold adhesion and fusion. E phrinA l protein is expressed 
specifically at the point o f  adhesion and fusion w here the left and the right tips o f  the 
neural folds adhere and fuse to each other. M oreover, rem oval o f  G PI-anchored 
proteins o f  which ephrinA l is a m em ber delays closure, w hile perturbing the function 
o f  ephrinA l delays closure.
€ EphA2/ Eph tyrosine kinase
C Phosphorylated EphA2/ Eph
m ephrinAl
-------- GPI anchor
■ FAK
Shp2
p
Release of phosphate 
group
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A prediction, therefore, is that removal o f  ephrinA l expression during neurulation 
may result in failure o f  adhesion and fusion o f  the m ouse spinal neural tube. 
Completion o f  the following gene targeting experiment, planned for future work, 
should allow ablation o f  the ephrinA l gene from the m ouse genom e specifically 
during adhesion and fusion.
The following paragraphs describe the initial work tow ards achieving conditional 
knock out o f  ephrinA 1. As a first step towards construction o f  the targeting vector, a 
genomic clone for ephrinA l was isolated from a mouse genom ic library (Stratagene). 
The genomic clone was m apped and the final construct was designed as shown in Fig. 
5.3. The ephrinA l gene is located at 48.5 cM on Chrom osom e 3 o f  the Mus musculus 
genome. The genomic coordinates o f  the ephrinA l gene Efna\ are from 89028210 to 
89036115 (Chromosom e 3). The 1.8 kb fragm ent and the 9 kb fragm ent (Fig. 5.3) 
were designed to act as regions o f  hom ology to allow  hom ologous recom bination 
between the construct and the mouse genome in transfected ES cells.
The isolated clone from the mouse genomic library was m anipulated to generate the 
long hom ologous recom bination arm with appropriate unique restriction enzym e sites. 
Long range PCR was then employed to generate the short hom ologous recom bination 
arm (Picom axx, Stratagene). The pGEM 3z vector (Prom ega) w as m odified by 
removing EcoR l and P st\ sites and adding P acl and C la\ sites. A loxP  sequence was 
then ligated into the E coK\ site. The plasm id carrying the frt-N eo-frt cassette 
(courtesy o f  Dr J.P. M artinez-Barbera) was then inserted into the £<%>R1 site, and a 
second loxP  sequence was inserted into the Sal 1 site. Finally, the long hom ologous 
recom bination arm was cloned into the m odified short hom ologous recom bination arm 
plasmid.
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Exon 1 =  191 bp
1.8 kb frt-Neo-frt 9 kb
i
3.145 kb
Fig. 5.3 EphrinAl gene targeting construct. The boxed areas show regions o f
hom ology to the ephrinA l genome. Blue and yellow  arrow heads are loxP  sites.
As ephrinA l is involved in a variety o f  biological processes, including angiogenesis 
and vascularization (O jim a et al. 2006; M cBride & Ruiz 1998), it is possible that an 
ephrinA l knockout may produce an em bryonic lethal m ouse. The strategy adopted 
therefore, is to m ake a conditioned ephrinA l m utant that can be recom bined 
specifically in the neural folds. The only gene that is know n to be expressed 
specifically at the point o f  adhesion and fusion in the PNP is the EphA 2 gene. It seem s 
m ost appropriate, therefore, to cross the ephrinA l conditional knockout (once created) 
with an EphA 2-Cre m ouse. Com pletion o f  this gene targeting experim ent w ill be a 
goal for future research and will enable a test o f  the eph rinA l/E ph  A2 hypothesis 
developed in this thesis.
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